502 results on '"Cicuttini, FM"'
Number of results to display per page
Search Results
2. Acetabular Dysplasia Is A Risk Factor For Developing Radiographic Hip Osteoarthritis; Data From The World Coach Consortium
- Author
-
Riedstra, NS, Boel, F, van Buuren, MM, Ahedi, H, Arbabi, V, Arden, N, Bierma-Zeinstra, SM, Boer, CG, Cicuttini, FM, Cootes, TF, Felson, DT, Gielis, WP, Kluzek, S, Lane, NE, Lindner, C, Lynch, J, van Meurs, J, Nelson, AE, Nevitt, MC, Oei, EH, Runhaar, J, Spector, TD, Tang, J, Weinans, HH, and Agricola, R
- Subjects
Biomedical Engineering ,Clinical Sciences ,Human Movement and Sports Sciences ,Arthritis & Rheumatology - Published
- 2023
3. THE WORLDWIDE COLLABORATION ON OSTEOARTHRITIS PREDICTION FOR THE HIP (WORLD COACH) CONSORTIUM: DESIGN AND RATIONALE OF A CONSORTIUM USING INDIVIDUAL PARTICIPANT DATA FROM PROSPECTIVE COHORT STUDIES
- Author
-
van Buuren, MM, Ahedi, H, Arbabi, V, Arden, NK, Bierma-Zeinstra, SM, Boer, CG, Cicuttini, FM, Cootes, TF, Felson, DT, Gielis, WP, Jones, G, Lane, NE, Lindner, C, Lynch, J, van Meurs, JB, Nelson, AE, Nevitt, MC, Oei, EH, Riedstra, NS, Runhaar, J, Spector, TD, Tang, J, Weinans, H, and Agricola, R
- Subjects
Biomedical Engineering ,Clinical Sciences ,Human Movement and Sports Sciences ,Arthritis & Rheumatology - Published
- 2022
4. Trajectories of body mass index from early adulthood to late midlife and incidence of total knee arthroplasty for osteoarthritis: findings from a prospective cohort study
- Author
-
Hussain, SM, Ackerman, IN, Wang, Y, English, DR, Wluka, AE, Giles, GG, Cicuttini, FM, Hussain, SM, Ackerman, IN, Wang, Y, English, DR, Wluka, AE, Giles, GG, and Cicuttini, FM
- Abstract
OBJECTIVE: To examine the association between body mass index (BMI) trajectories from early adulthood to late midlife and risk of total knee arthroplasty (TKA) for osteoarthritis. METHODS: 24,368 participants from the Melbourne Collaborative Cohort Study with weight collected during 1990-1994, 1995-1998, and 2003-2007, recalled weight at age 18-21 years, and height measured during 1990-1994 were included. Incident TKA from 2003 to 2007 to December 2018 was determined by linking cohort records to the National Joint Replacement Registry. RESULTS: Using group-based trajectory modelling, six distinct trajectories (TR) of BMI from early adulthood (age 18-21 years) to late midlife (approximately 62 years) were identified: lower normal to normal BMI (TR1; 19.7% population), normal BMI to borderline overweight (TR2; 36.7%), normal BMI to overweight (TR3; 26.8%), overweight to borderline obese (TR4; 3.5%), normal BMI to class 1 obesity (TR5; 10.1%), overweight to class 2 obesity (TR6; 3.2%). Over 12.4 years, 1,328 (5.4%) had TKA. The hazard ratios for TKA increased in all TR compared to TR1 [from TR2: 2.03 (95% CI 1.64-2.52) to TR6: 8.59 (6.44-11.46)]. 28.4% of TKA could be prevented if individuals followed the trajectory one lower, an average weight reduction of 8-12 kg from early adulthood to late midlife, saving $AUS 373 million/year. Most reduction would occur in TR2 (population attributable fraction 37.9%, 95% CI 26.7-47.3%) and TR3 (26.8%, 20.0-31.2%). CONCLUSIONS: Prevention of weight gain from young adulthood to late midlife in order to reduce overweight/obesity has the potential to significantly reduce the cost and burden of TKA.
- Published
- 2023
5. Negative back beliefs are associated with increased odds of low back pain and disability: a 10-year cohort study in men.
- Author
-
Estee, MM, Wang, Y, Heritier, S, Urquhart, DM, Cicuttini, FM, Kotowicz, MA, Brennan-Olsen, SL, Pasco, JA, Wluka, AE, Estee, MM, Wang, Y, Heritier, S, Urquhart, DM, Cicuttini, FM, Kotowicz, MA, Brennan-Olsen, SL, Pasco, JA, and Wluka, AE
- Abstract
OBJECTIVE: Although negative back beliefs are associated with high-intensity low back pain (LBP)/disability, whether they influence incident high-intensity LBP/high-disability over the long-term is unknown. This study aimed to investigate whether negative back beliefs were associated with developing high-intensity LBP and/or high-disability over 10 years in men. METHODS: Men with no or low-intensity LBP and/or disability attending the Geelong Osteoporosis Study between 2006-2010 were included. Data on age, body mass index, mobility, education, back beliefs (Back Beliefs Questionnaire), LBP and disability (Graded Chronic Pain Scale) were collected between 2006-2010. Beliefs, LBP and disability were re-assessed in 2016-2021. Binary logistic regression was used to examine the association between negative back beliefs and incident high-intensity pain and/or high-disability, adjusting for age, body mass index, mobility, and education. RESULTS: At baseline, 705 participants (mean age 53.8 years) had no or low LBP and no or low-disability; 441 (62.6%) participants completed a 10-year follow-up. Of these, 37 (8.4%) developed high-intensity pain and/or high-disability. In multivariate analyses, participants with more negative back beliefs at baseline were more likely to develop high-intensity pain and/or high-disability (Odds ratio 1.05, 95% CI 1.00-1.11). Developing more negative back beliefs was also associated with incident high-intensity pain and/or high-disability (Odds Ratio 1.20, 95% CI 1.12-1.30). CONCLUSION: In a male community-based population, negative beliefs regarding the consequences of LBP were associated with an increased likelihood of developing high-intensity pain and/or high-disability. Addressing negative back beliefs in the community may reduce the incidence of high-intensity pain and/or high-disability over 10 years in men.
- Published
- 2023
6. Association between popliteal artery wall thickness and structural progression in patients with symptomatic knee osteoarthritis
- Author
-
Wang, Y, Pontoh, EW, Hussain, SM, Lim, YZ, Jones, G, Hill, CL, Wluka, AE, Tonkin, A, Ding, C, Cicuttini, FM, Wang, Y, Pontoh, EW, Hussain, SM, Lim, YZ, Jones, G, Hill, CL, Wluka, AE, Tonkin, A, Ding, C, and Cicuttini, FM
- Abstract
OBJECTIVE: There is increasing evidence for the involvement of vascular disease in the pathogenesis of knee OA. Popliteal artery wall thickness can be used as a surrogate marker of atherosclerosis. We examined the association between popliteal artery wall thickness and knee cartilage volume in individuals with symptomatic knee OA. METHODS: This prospective cohort study analysed 176 participants from a randomized placebo-controlled trial examining the effect of atorvastatin on structural progression in knee OA. The participants underwent MRI of the study knee at baseline and 2-year follow-up. Popliteal artery wall thickness and tibial cartilage volume were measured from MRI using validated methods. The top quartile of the rate of tibial cartilage volume loss was defined as rapid progression. RESULTS: At baseline, every 10% increase in popliteal artery wall thickness was associated with 120.8 mm3 (95% CI 5.4, 236.2, P = 0.04) lower of medial tibial cartilage volume and 151.9 mm3 (95% CI 12.1, 291.7, P = 0.03) lower of lateral tibial cartilage volume. Longitudinally, for every 10% increase in popliteal artery wall thickness, the annual rate of medial tibial cartilage volume loss was increased by 1.14% (95% CI 0.09%, 2.20%, P = 0.03), and there was a 2.28-fold (95% CI 1.07, 4.83, P = 0.03) risk of rapid progression of medial tibial cartilage loss, adjusted for age, sex, BMI, tibial bone area, smoking, vigorous physical activity, and intervention group allocation. CONCLUSION: The findings support a role for vascular pathology in the progression of knee OA. Targeting atherosclerosis has the potential to improve outcomes in knee OA.
- Published
- 2023
7. Association between weight gain and knee osteoarthritis: a systematic review
- Author
-
Solanki, P, Hussain, SM, Abidi, J, Cheng, J, Fairley, JL, Page, MJ, Cicuttini, FM, Wluka, AE, Solanki, P, Hussain, SM, Abidi, J, Cheng, J, Fairley, JL, Page, MJ, Cicuttini, FM, and Wluka, AE
- Abstract
OBJECTIVE: Although weight loss is recommended to manage knee osteoarthritis (KOA), adults tend to gain weight with age which may affect KOA symptoms and progression. We conducted a systematic review and data synthesis to investigate the association between weight gain and KOA, defined by clinical features, structural progression, and total knee replacement (TKR). DESIGN: MEDLINE and EMBASE were systematically searched for controlled trials and cohort studies of participants with (or at risk of) KOA examining the relationship between weight gain and KOA clinical features (pain, function, quality of life), structural progression, and TKR. Risk of bias was assessed using the ROBINS-I tool. Results were organised by outcome, with meta-analyses performed where appropriate. RESULTS: Twenty-three studies were included. Results showed significant detrimental effects of weight gain on pain (4 of 7 studies), stiffness (2 of 2 studies), function (5 of 6 studies), and the single studies examining quality of life, and clinical and radiographic KOA. Weight gain adversely affected cartilage (6 of 9 studies), bone marrow lesions (1 of 4 studies), meniscal damage (1 of 3 studies) and effusion/synovitis (1 of 1 study). Weight gain significantly increased TKR (3 of 6 studies): meta-analysis of 2 with available data demonstrated significant increases in TKR/5 kg weight gain in women, HR 1.34 (95% CI 1.18-1.51), and in men, HR 1.25 (95% CI 1.16-1.34). CONCLUSIONS: Weight gain in adults is associated with increased clinical and structural KOA and TKR. Prevention of weight gain should be considered to improve outcomes in KOA.
- Published
- 2023
8. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
- Author
-
Collaborators, GAM, Ward, JL, Azzopardi, PS, Francis, KL, Santelli, JS, Skirbekk, V, Sawyer, SM, Kassebaum, NJ, Mokdad, AH, Hay, SI, Abd-Allah, F, Abdoli, A, Abdollahi, M, Abedi, A, Abolhassani, H, Abreu, LG, Abrigo, MRM, Abu-Gharbieh, E, Abushouk, AI, Adebayo, OM, Adekanmbi, V, Adham, D, Advani, SM, Afshari, K, Agrawal, A, Ahmad, T, Ahmadi, K, Ahmed, AE, Aji, B, Akombi-Inyang, B, Alahdab, F, Al-Aly, Z, Alam, K, Alanezi, FM, Alanzi, TM, Alcalde-Rabanal, JE, Alemu, BW, Al-Hajj, S, Alhassan, RK, Ali, S, Alicandro, G, Alijanzadeh, M, Aljunid, SM, Almasi-Hashiani, A, Almasri, NA, Al-Mekhlafi, HM, Alonso, J, Al-Raddadi, RM, Altirkawi, KA, Alvis-Guzman, N, Amare, AT, Amini, S, Aminorroaya, A, Amit, AML, Amugsi, DA, Ancuceanu, R, Anderlini, D, Andrei, CL, Androudi, S, Ansari, F, Ansari, I, Antonio, CAT, Anvari, D, Anwer, R, Appiah, SCY, Arabloo, J, Arab-Zozani, M, Ärnlöv, J, Asaad, M, Asadi-Aliabadi, M, Asadi-Pooya, AA, Atout, MMW, Ausloos, M, Avenyo, EK, Avila-Burgos, L, Quintanilla, BPA, Ayano, G, Aynalem, YA, Azari, S, Azene, ZN, Bakhshaei, MH, Bakkannavar, SM, Banach, M, Banik, PC, Barboza, MA, Barker-Collo, SL, Bärnighausen, TW, Basu, S, Baune, BT, Bayati, M, Bedi, N, Beghi, E, Bekuma, TT, Bell, AW, Bell, ML, Benjet, C, Bensenor, IM, Berhe, AK, Berhe, K, Berman, AE, Bhagavathula, AS, Bhardwaj, N, Bhardwaj, P, Bhattacharyya, K, Bhattarai, S, Bhutta, ZA, Bijani, A, Bikbov, B, Biondi, A, Birhanu, TTM, Biswas, RK, Bohlouli, S, Bolla, SR, Boloor, A, Borschmann, R, Boufous, S, Bragazzi, NL, Braithwaite, D, Breitborde, NJK, Brenner, H, Britton, GB, Burns, RA, Nagaraja, SB, Butt, ZA, dos Santos, FLC, Cámera, LA, Campos-Nonato, IR, Rincon, JCC, Cárdenas, R, Carreras, G, Carrero, JJ, Carvalho, F, Castaldelli-Maia, JM, Castañeda-Orjuela, CA, Castelpietra, G, Catalá-López, F, Cerin, E, Chandan, JS, Chang, H-Y, Chang, J-C, Charan, J, Chattu, VK, Chaturvedi, S, Choi, J-YJ, Chowdhury, MAK, Christopher, DJ, Chu, D-T, Chung, MT, Chung, S-C, Cicuttini, FM, Constantin, TV, Costa, VM, Dahlawi, SMA, Dai, H, Dai, X, Damiani, G, Dandona, L, Dandona, R, Daneshpajouhnejad, P, Darwesh, AM, Dávila-Cervantes, CA, Davletov, K, De la Hoz, FP, De Leo, D, Dervenis, N, Desai, R, Desalew, A, Deuba, K, Dharmaratne, SD, Dhungana, GP, Dianatinasab, M, da Silva, DD, Diaz, D, Didarloo, A, Djalalinia, S, Dorostkar, F, Doshi, CP, Doshmangir, L, Doyle, KE, Duraes, AR, Kalan, ME, Ebtehaj, S, Edvardsson, D, Tantawi, ME, Elgendy, IY, El-Jaafary, SI, Elsharkawy, A, Eshrati, B, Eskandarieh, S, Esmaeilnejad, S, Esmaeilzadeh, F, Esteghamati, S, Faro, A, Farzadfar, F, Fattahi, N, Feigin, VL, Ferede, TY, Fereshtehnejad, S-M, Fernandes, E, Ferrara, P, Filip, I, Fischer, F, Fisher, JL, Foigt, NA, Folayan, MO, Fomenkov, AA, Foroutan, M, Fukumoto, T, Gad, MM, Gaidhane, AM, Gallus, S, Gebre, T, Gebremedhin, KB, Gebremeskel, GG, Gebremeskel, L, Gebreslassie, AA, Gesesew, HA, Ghadiri, K, Ghafourifard, M, Ghamari, F, Ghashghaee, A, Gilani, SA, Gnedovskaya, EV, Godinho, MA, Golechha, M, Goli, S, Gona, PN, Gopalani, SV, Gorini, G, Grivna, M, Gubari, MIM, Gugnani, HC, Guimarães, RA, Guo, Y, Gupta, R, Haagsma, JA, Hafezi-Nejad, N, Haile, TG, Haj-Mirzaian, A, Hall, BJ, Hamadeh, RR, Abdullah, KH, Hamidi, S, Handiso, DW, Hanif, A, Hankey, GJ, Haririan, H, Haro, JM, Hasaballah, AI, Hashi, A, Hassan, A, Hassanipour, S, Hassankhani, H, Hayat, K, Heidari-Soureshjani, R, Herteliu, C, Heydarpour, F, Ho, HC, Hole, MK, Holla, R, Hoogar, P, Hosseini, M, Hosseinzadeh, M, Hostiuc, M, Hostiuc, S, Househ, M, Hsairi, M, Huda, TM, Humayun, A, Hussain, R, Hwang, B-F, Iavicoli, I, Ibitoye, SE, Ilesanmi, OS, Ilic, IM, Ilic, MD, Inbaraj, LR, Intarut, N, Iqbal, U, Irvani, SSN, Islam, MM, Islam, MS, Iso, H, Ivers, RQ, Jahani, MA, Jakovljevic, M, Jalali, A, Janodia, MD, Javaheri, T, Jeemon, P, Jenabi, E, Jha, RP, Jha, V, Ji, JS, Jonas, JB, Jones, KM, Joukar, F, Jozwiak, JJ, Juliusson, PB, Jürisson, M, Kabir, A, Kabir, Z, Kalankesh, LR, Kalhor, R, Kamyari, N, Kanchan, T, Karch, A, Karimi, SE, Kaur, S, Kayode, GA, Keiyoro, PN, Khalid, N, Khammarnia, M, Khan, M, Khan, N, Khatab, K, Khater, MM, Khatib, MN, Khayamzadeh, M, Khazaie, H, Khoja, AT, Kieling, C, Kim, Y-E, Kim, YJ, Kimokoti, RW, Kisa, A, Kisa, S, Kivimäki, M, Koolivand, A, Kosen, S, Koyanagi, A, Krishan, K, Kugbey, N, Kumar, GA, Kumar, M, Kumar, N, Kurmi, OP, Kusuma, D, La Vecchia, C, Lacey, B, Lal, DK, Lalloo, R, Lan, Q, Landires, I, Van Charles Lansingh, Larsson, AO, Lasrado, S, Lassi, ZS, Lauriola, P, Lee, PH, Lee, SWH, Leigh, J, Leonardi, M, Leung, J, Levi, M, Lewycka, S, Li, B, Li, M-C, Li, S, Lim, L-L, Lim, SS, Liu, X, Lorkowski, S, Lotufo, PA, Lunevicius, R, Maddison, R, Mahasha, PW, Mahdavi, MM, Mahmoudi, M, Majeed, A, Maleki, A, Malekzadeh, R, Malta, DC, Mamun, AA, Mansouri, B, Mansournia, MA, Martinez, G, Martinez-Raga, J, Martins-Melo, FR, Mason-Jones, AJ, Masoumi, SZ, Mathur, MR, Maulik, PK, McGrath, JJ, Mehndiratta, MM, Mehri, F, Memiah, PTN, Mendoza, W, Menezes, RG, Mengesha, EW, Meretoja, A, Meretoja, TJ, Mestrovic, T, Miazgowski, B, Miazgowski, T, Michalek, IM, Miller, TR, Mini, G, Mirica, A, Mirrakhimov, EM, Mirzaei, H, Mirzaei, M, Moazen, B, Mohammad, DK, Mohammadi, S, Mohammadian-Hafshejani, A, Mohammadifard, N, Mohammadpourhodki, R, Mohammed, S, Monasta, L, Moradi, G, Moradi-Lakeh, M, Moradzadeh, R, Moraga, P, Morrison, SD, Mosapour, A, Khaneghah, AM, Mueller, UO, Muriithi, MK, Murray, CJL, Muthupandian, S, Naderi, M, Nagarajan, AJ, Naghavi, M, Naimzada, MD, Nangia, V, Nayak, VC, Nazari, J, Ndejjo, R, Negoi, I, Negoi, RI, Netsere, HB, Nguefack-Tsague, G, Nguyen, DN, Nguyen, HLT, Nie, J, Ningrum, DNA, Nnaji, CA, Nomura, S, Noubiap, JJ, Nowak, C, Nuñez-Samudio, V, Ogbo, FA, Oghenetega, OB, Oh, I-H, Oladnabi, M, Olagunju, AT, Olusanya, BO, Olusanya, JO, Bali, AO, Omer, MO, Onwujekwe, OE, Ortiz, A, Otoiu, A, Otstavnov, N, Otstavnov, SS, Øverland, S, Owolabi, MO, Mahesh, PA, Padubidri, JR, Pakshir, K, Palladino, R, Pana, A, Panda-Jonas, S, Pandey, A, Panelo, CIA, Park, E-K, Patten, SB, Peden, AE, Pepito, VCF, Peprah, EK, Pereira, J, Pesudovs, K, Pham, HQ, Phillips, MR, Piradov, MA, Pirsaheb, M, Postma, MJ, Pottoo, FH, Pourjafar, H, Pourshams, A, Prada, SI, Pupillo, E, Syed, ZQ, Rabiee, MH, Rabiee, N, Radfar, A, Rafiee, A, Raggi, A, Rahim, F, Rahimi-Movaghar, V, Rahman, MHU, Rahman, MA, Ramezanzadeh, K, Ranabhat, CL, Rao, SJ, Rashedi, V, Rastogi, P, Rathi, P, Rawaf, DL, Rawaf, S, Rawal, L, Rawassizadeh, R, Renzaho, AMN, Rezaei, N, Rezai, MS, Riahi, SM, Rickard, J, Roever, L, Ronfani, L, Roth, GA, Rubagotti, E, Rumisha, SF, Rwegerera, GM, Sabour, S, Sachdev, PS, Saddik, B, Sadeghi, E, Moghaddam, SS, Sagar, R, Sahebkar, A, Sahraian, MA, Sajadi, SM, Salem, MR, Salimzadeh, H, Samy, AM, Sanabria, J, Santric-Milicevic, MM, Saraswathy, SYI, Sarrafzadegan, N, Sarveazad, A, Sathish, T, Sattin, D, Saxena, D, Saxena, S, Schiavolin, S, Schwebel, DC, Schwendicke, F, Senthilkumaran, S, Sepanlou, SG, Sha, F, Shafaat, O, Shahabi, S, Shaheen, AA, Shaikh, MA, Shakiba, S, Shamsi, M, Shannawaz, M, Sharafi, K, Sheikh, A, Sheikhbahaei, S, Shetty, BSK, Shi, P, Shigematsu, M, Shin, JI, Shiri, R, Shuval, K, Siabani, S, Sigfusdottir, ID, Sigurvinsdottir, R, Silva, DAS, Silva, JP, Simonetti, B, Singh, JA, Singh, V, Sinke, AH, Skryabin, VY, Slater, H, Smith, EUR, Sobhiyeh, MR, Sobngwi, E, Soheili, A, Somefun, OD, Sorrie, MB, Soyiri, IN, Sreeramareddy, CT, Stein, DJ, Stokes, MA, Sudaryanto, A, Sultan, I, Tabarés-Seisdedos, R, Tabuchi, T, Tadakamadla, SK, Taherkhani, A, Tamiru, AT, Tareque, I, Thankappan, KR, Thapar, R, Thomas, N, Titova, MV, Tonelli, M, Tovani-Palone, MR, Tran, BX, Travillian, RS, Tsai, AC, Tsatsakis, A, Car, LT, Uddin, R, Unim, B, Unnikrishnan, B, Upadhyay, E, Vacante, M, Tahbaz, SV, Valdez, PR, Varughese, S, Vasankari, TJ, Venketasubramanian, N, Villeneuve, PJ, Violante, FS, Vlassov, V, Vos, T, Vu, GT, Waheed, Y, Wamai, RG, Wang, Y, Wang, Y-P, Westerman, R, Wickramasinghe, ND, Wu, A-M, Wu, C, Jabbari, SHY, Yamagishi, K, Yano, Y, Yaya, S, Yazdi-Feyzabadi, V, Yeshitila, YG, Yip, P, Yonemoto, N, Yoon, S-J, Younis, MZ, Yousefinezhadi, T, Yu, C, Yu, Y, Yuce, D, Zaidi, SS, Bin Zaman, S, Zamani, M, Zamanian, M, Zarafshan, H, Zarei, A, Zastrozhin, MS, Zhang, Y, Zhang, Z-J, Zhao, X-JG, Zhu, C, Patton, GC, Viner, RM, Collaborators, GBD 2019 Adolescent Mortality, Ward, J. L., Azzopardi, P. S., Francis, K. L., Santelli, J. S., Skirbekk, V., Sawyer, S. M., Kassebaum, N. J., Mokdad, A. H., Hay, S. I., Abd-Allah, F., Abdoli, A., Abdollahi, M., Abedi, A., Abolhassani, H., Abreu, L. G., Abrigo, M. R. M., Abu-Gharbieh, E., Abushouk, A. I., Adebayo, O. M., Adekanmbi, V., Adham, D., Advani, S. M., Afshari, K., Agrawal, A., Ahmad, T., Ahmadi, K., Ahmed, A. E., Aji, B., Akombi-Inyang, B., Alahdab, F., Al-Aly, Z., Alam, K., Alanezi, F. M., Alanzi, T. M., Alcalde-Rabanal, J. E., Alemu, B. W., Al-Hajj, S., Alhassan, R. K., Ali, S., Alicandro, G., Alijanzadeh, M., Aljunid, S. M., Almasi-Hashiani, A., Almasri, N. A., Al-Mekhlafi, H. M., Alonso, J., Al-Raddadi, R. M., Altirkawi, K. A., Alvis-Guzman, N., Amare, A. T., Amini, S., Aminorroaya, A., Amit, A. M. L., Amugsi, D. A., Ancuceanu, R., Anderlini, D., Andrei, C. L., Androudi, S., Ansari, F., Ansari, I., Antonio, C. A. T., Anvari, D., Anwer, R., Appiah, S. C. Y., Arabloo, J., Arab-Zozani, M., Arnlov, J., Asaad, M., Asadi-Aliabadi, M., Asadi-Pooya, A. A., Atout, M. M. W., Ausloos, M., Avenyo, E. K., Avila-Burgos, L., Ayala Quintanilla, B. P., Ayano, G., Aynalem, Y. A., Azari, S., Azene, Z. N., Bakhshaei, M. H., Bakkannavar, S. M., Banach, M., Banik, P. C., Barboza, M. A., Barker-Collo, S. L., Barnighausen, T. W., Basu, S., Baune, B. T., Bayati, M., Bedi, N., Beghi, E., Bekuma, T. T., Bell, A. W., Bell, M. L., Benjet, C., Bensenor, I. M., Berhe, A. K., Berhe, K., Berman, A. E., Bhagavathula, A. S., Bhardwaj, N., Bhardwaj, P., Bhattacharyya, K., Bhattarai, S., Bhutta, Z. A., Bijani, A., Bikbov, B., Biondi, A., Birhanu, T. T. M., Biswas, R. K., Bohlouli, S., Bolla, S. R., Boloor, A., Borschmann, R., Boufous, S., Bragazzi, N. L., Braithwaite, D., Breitborde, N. J. K., Brenner, H., Britton, G. B., Burns, R. A., Burugina Nagaraja, S., Butt, Z. A., Caetano dos Santos, F. L., Camera, L. A., Campos-Nonato, I. R., Campuzano Rincon, J. C., Cardenas, R., Carreras, G., Carrero, J. J., Carvalho, F., Castaldelli-Maia, J. M., Castaneda-Orjuela, C. A., Castelpietra, G., Catala-Lopez, F., Cerin, E., Chandan, J. S., Chang, H. -Y., Chang, J. -C., Charan, J., Chattu, V. K., Chaturvedi, S., Choi, J. -Y. J., Chowdhury, M. A. K., Christopher, D. J., Chu, D. -T., Chung, M. T., Chung, S. -C., Cicuttini, F. M., Constantin, T. V., Costa, V. M., Dahlawi, S. M. A., Dai, H., Dai, X., Damiani, G., Dandona, L., Dandona, R., Daneshpajouhnejad, P., Darwesh, A. M., Davila-Cervantes, C. A., Davletov, K., De la Hoz, F. P., De Leo, D., Dervenis, N., Desai, R., Desalew, A., Deuba, K., Dharmaratne, S. D., Dhungana, G. P., Dianatinasab, M., Dias da Silva, D., Diaz, D., Didarloo, A., Djalalinia, S., Dorostkar, F., Doshi, C. P., Doshmangir, L., Doyle, K. E., Duraes, A. R., Ebrahimi Kalan, M., Ebtehaj, S., Edvardsson, D., El Tantawi, M., Elgendy, I. Y., El-Jaafary, S. I., Elsharkawy, A., Eshrati, B., Eskandarieh, S., Esmaeilnejad, S., Esmaeilzadeh, F., Esteghamati, S., Faro, A., Farzadfar, F., Fattahi, N., Feigin, V. L., Ferede, T. Y., Fereshtehnejad, S. -M., Fernandes, E., Ferrara, P., Filip, I., Fischer, F., Fisher, J. L., Foigt, N. A., Folayan, M. O., Fomenkov, A. A., Foroutan, M., Fukumoto, T., Gad, M. M., Gaidhane, A. M., Gallus, S., Gebre, T., Gebremedhin, K. B., Gebremeskel, G. G., Gebremeskel, L., Gebreslassie, A. A., Gesesew, H. A., Ghadiri, K., Ghafourifard, M., Ghamari, F., Ghashghaee, A., Gilani, S. A., Gnedovskaya, E. V., Godinho, M. A., Golechha, M., Goli, S., Gona, P. N., Gopalani, S. V., Gorini, G., Grivna, M., Gubari, M. I. M., Gugnani, H. C., Guimaraes, R. A., Guo, Y., Gupta, R., Haagsma, J. A., Hafezi-Nejad, N., Haile, T. G., Haj-Mirzaian, A., Hall, B. J., Hamadeh, R. R., Hamagharib Abdullah, K., Hamidi, S., Handiso, D. W., Hanif, A., Hankey, G. J., Haririan, H., Haro, J. M., Hasaballah, A. I., Hashi, A., Hassan, A., Hassanipour, S., Hassankhani, H., Hayat, K., Heidari-Soureshjani, R., Herteliu, C., Heydarpour, F., Ho, H. C., Hole, M. K., Holla, R., Hoogar, P., Hosseini, M., Hosseinzadeh, M., Hostiuc, M., Hostiuc, S., Househ, M., Hsairi, M., Huda, T. M., Humayun, A., Hussain, R., Hwang, B. -F., Iavicoli, I., Ibitoye, S. E., Ilesanmi, O. S., Ilic, I. M., Ilic, M. D., Inbaraj, L. R., Intarut, N., Iqbal, U., Irvani, S. S. N., Islam, M. M., Islam, S. M. S., Iso, H., Ivers, R. Q., Jahani, M. A., Jakovljevic, M., Jalali, A., Janodia, M. D., Javaheri, T., Jeemon, P., Jenabi, E., Jha, R. P., Jha, V., Ji, J. S., Jonas, J. B., Jones, K. M., Joukar, F., Jozwiak, J. J., Juliusson, P. B., Jurisson, M., Kabir, A., Kabir, Z., Kalankesh, L. R., Kalhor, R., Kamyari, N., Kanchan, T., Karch, A., Karimi, S. E., Kaur, S., Kayode, G. A., Keiyoro, P. N., Khalid, N., Khammarnia, M., Khan, M., Khan, M. N., Khatab, K., Khater, M. M., Khatib, M. N., Khayamzadeh, M., Khazaie, H., Khoja, A. T., Kieling, C., Kim, Y. -E., Kim, Y. J., Kimokoti, R. W., Kisa, A., Kisa, S., Kivimaki, M., Koolivand, A., Kosen, S., Koyanagi, A., Krishan, K., Kugbey, N., Kumar, G. A., Kumar, M., Kumar, N., Kurmi, O. P., Kusuma, D., La Vecchia, C., Lacey, B., Lal, D. K., Lalloo, R., Lan, Q., Landires, I., Lansingh, V. C., Larsson, A. O., Lasrado, S., Lassi, Z. S., Lauriola, P., Lee, P. H., Lee, S. W. H., Leigh, J., Leonardi, M., Leung, J., Levi, M., Lewycka, S., Li, B., Li, M. -C., Li, S., Lim, L. -L., Lim, S. S., Liu, X., Lorkowski, S., Lotufo, P. A., Lunevicius, R., Maddison, R., Mahasha, P. W., Mahdavi, M. M., Mahmoudi, M., Majeed, A., Maleki, A., Malekzadeh, R., Malta, D. C., Mamun, A. A., Mansouri, B., Mansournia, M. A., Martinez, G., Martinez-Raga, J., Martins-Melo, F. R., Mason-Jones, A. J., Masoumi, S. Z., Mathur, M. R., Maulik, P. K., Mcgrath, J. J., Mehndiratta, M. M., Mehri, F., Memiah, P. T. N., Mendoza, W., Menezes, R. G., Mengesha, E. W., Meretoja, A., Meretoja, T. J., Mestrovic, T., Miazgowski, B., Miazgowski, T., Michalek, I. M., Miller, T. R., Mini, G. K., Mirica, A., Mirrakhimov, E. M., Mirzaei, H., Mirzaei, M., Moazen, B., Mohammad, D. K., Mohammadi, S., Mohammadian-Hafshejani, A., Mohammadifard, N., Mohammadpourhodki, R., Mohammed, S., Monasta, L., Moradi, G., Moradi-Lakeh, M., Moradzadeh, R., Moraga, P., Morrison, S. D., Mosapour, A., Mousavi Khaneghah, A., Mueller, U. O., Muriithi, M. K., Murray, C. J. L., Muthupandian, S., Naderi, M., Nagarajan, A. J., Naghavi, M., Naimzada, M. D., Nangia, V., Nayak, V. C., Nazari, J., Ndejjo, R., Negoi, I., Negoi, R. I., Netsere, H. B., Nguefack-Tsague, G., Nguyen, D. N., Nguyen, H. L. T., Nie, J., Ningrum, D. N. A., Nnaji, C. A., Nomura, S., Noubiap, J. J., Nowak, C., Nunez-Samudio, V., Ogbo, F. A., Oghenetega, O. B., Oh, I. -H., Oladnabi, M., Olagunju, A. T., Olusanya, B. O., Olusanya, J. O., Omar Bali, A., Omer, M. O., Onwujekwe, O. E., Ortiz, A., Otoiu, A., Otstavnov, N., Otstavnov, S. S., Overland, S., Owolabi, M. O., P A, M., Padubidri, J. R., Pakshir, K., Palladino, R., Pana, A., Panda-Jonas, S., Pandey, A., Panelo, C. I. A., Park, E. -K., Patten, S. B., Peden, A. E., Pepito, V. C. F., Peprah, E. K., Pereira, J., Pesudovs, K., Pham, H. Q., Phillips, M. R., Piradov, M. A., Pirsaheb, M., Postma, M. J., Pottoo, F. H., Pourjafar, H., Pourshams, A., Prada, S. I., Pupillo, E., Quazi Syed, Z., Rabiee, M. H., Rabiee, N., Radfar, A., Rafiee, A., Raggi, A., Rahim, F., Rahimi-Movaghar, V., Rahman, M. H. U., Rahman, M. A., Ramezanzadeh, K., Ranabhat, C. L., Rao, S. J., Rashedi, V., Rastogi, P., Rathi, P., Rawaf, D. L., Rawaf, S., Rawal, L., Rawassizadeh, R., Renzaho, A. M. N., Rezaei, N., Rezai, M. S., Riahi, S. M., Rickard, J., Roever, L., Ronfani, L., Roth, G. A., Rubagotti, E., Rumisha, S. F., Rwegerera, G. M., Sabour, S., Sachdev, P. S., Saddik, B., Sadeghi, E., Saeedi Moghaddam, S., Sagar, R., Sahebkar, A., Sahraian, M. A., Sajadi, S. M., Salem, M. R., Salimzadeh, H., Samy, A. M., Sanabria, J., Santric-Milicevic, M. M., Saraswathy, S. Y. I., Sarrafzadegan, N., Sarveazad, A., Sathish, T., Sattin, D., Saxena, D., Saxena, S., Schiavolin, S., Schwebel, D. C., Schwendicke, F., Senthilkumaran, S., Sepanlou, S. G., Sha, F., Shafaat, O., Shahabi, S., Shaheen, A. A., Shaikh, M. A., Shakiba, S., Shamsi, M., Shannawaz, M., Sharafi, K., Sheikh, A., Sheikhbahaei, S., Shetty, B. S. K., Shi, P., Shigematsu, M., Shin, J. I., Shiri, R., Shuval, K., Siabani, S., Sigfusdottir, I. D., Sigurvinsdottir, R., Silva, D. A. S., Silva, J. P., Simonetti, B., Singh, J. A., Singh, V., Sinke, A. H., Skryabin, V. Y., Slater, H., Smith, E. U. R., Sobhiyeh, M. R., Sobngwi, E., Soheili, A., Somefun, O. D., Sorrie, M. B., Soyiri, I. N., Sreeramareddy, C. T., Stein, D. J., Stokes, M. A., Sudaryanto, A., Sultan, I., Tabares-Seisdedos, R., Tabuchi, T., Tadakamadla, S. K., Taherkhani, A., Tamiru, A. T., Tareque, M. I., Thankappan, K. R., Thapar, R., Thomas, N., Titova, M. V., Tonelli, M., Tovani-Palone, M. R., Tran, B. X., Travillian, R. S., Tsai, A. C., Tsatsakis, A., Tudor Car, L., Uddin, R., Unim, B., Unnikrishnan, B., Upadhyay, E., Vacante, M., Valadan Tahbaz, S., Valdez, P. R., Varughese, S., Vasankari, T. J., Venketasubramanian, N., Villeneuve, P. J., Violante, F. S., Vlassov, V., Vos, T., Vu, G. T., Waheed, Y., Wamai, R. G., Wang, Y., Wang, Y. -P., Westerman, R., Wickramasinghe, N. D., Wu, A. -M., Wu, C., Yahyazadeh Jabbari, S. H., Yamagishi, K., Yano, Y., Yaya, S., Yazdi-Feyzabadi, V., Yeshitila, Y. G., Yip, P., Yonemoto, N., Yoon, S. -J., Younis, M. Z., Yousefinezhadi, T., Yu, C., Yu, Y., Yuce, D., Zaidi, S. S., Zaman, S. B., Zamani, M., Zamanian, M., Zarafshan, H., Zarei, A., Zastrozhin, M. S., Zhang, Y., Zhang, Z. -J., Zhao, X. -J. G., Zhu, C., Patton, G. C., Viner, R. M., Value, Affordability and Sustainability (VALUE), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Microbes in Health and Disease (MHD), Bill & Melinda Gates Foundation, Ward J.L., Azzopardi P.S., Francis K.L., Santelli J.S., Skirbekk V., Sawyer S.M., Kassebaum N.J., Mokdad A.H., Hay S.I., Abd-Allah F., Abdoli A., Abdollahi M., Abedi A., Abolhassani H., Abreu L.G., Abrigo M.R.M., Abu-Gharbieh E., Abushouk A.I., Adebayo O.M., Adekanmbi V., Adham D., Advani S.M., Afshari K., Agrawal A., Ahmad T., Ahmadi K., Ahmed A.E., Aji B., Akombi-Inyang B., Alahdab F., Al-Aly Z., Alam K., Alanezi F.M., Alanzi T.M., Alcalde-Rabanal J.E., Alemu B.W., Al-Hajj S., Alhassan R.K., Ali S., Alicandro G., Alijanzadeh M., Aljunid S.M., Almasi-Hashiani A., Almasri N.A., Al-Mekhlafi H.M., Alonso J., Al-Raddadi R.M., Altirkawi K.A., Alvis-Guzman N., Amare A.T., Amini S., Aminorroaya A., Amit A.M.L., Amugsi D.A., Ancuceanu R., Anderlini D., Andrei C.L., Androudi S., Ansari F., Ansari I., Antonio C.A.T., Anvari D., Anwer R., Appiah S.C.Y., Arabloo J., Arab-Zozani M., Arnlov J., Asaad M., Asadi-Aliabadi M., Asadi-Pooya A.A., Atout M.M.W., Ausloos M., Avenyo E.K., Avila-Burgos L., Ayala Quintanilla B.P., Ayano G., Aynalem Y.A., Azari S., Azene Z.N., Bakhshaei M.H., Bakkannavar S.M., Banach M., Banik P.C., Barboza M.A., Barker-Collo S.L., Barnighausen T.W., Basu S., Baune B.T., Bayati M., Bedi N., Beghi E., Bekuma T.T., Bell A.W., Bell M.L., Benjet C., Bensenor I.M., Berhe A.K., Berhe K., Berman A.E., Bhagavathula A.S., Bhardwaj N., Bhardwaj P., Bhattacharyya K., Bhattarai S., Bhutta Z.A., Bijani A., Bikbov B., Biondi A., Birhanu T.T.M., Biswas R.K., Bohlouli S., Bolla S.R., Boloor A., Borschmann R., Boufous S., Bragazzi N.L., Braithwaite D., Breitborde N.J.K., Brenner H., Britton G.B., Burns R.A., Burugina Nagaraja S., Butt Z.A., Caetano dos Santos F.L., Camera L.A., Campos-Nonato I.R., Campuzano Rincon J.C., Cardenas R., Carreras G., Carrero J.J., Carvalho F., Castaldelli-Maia J.M., Castaneda-Orjuela C.A., Castelpietra G., Catala-Lopez F., Cerin E., Chandan J.S., Chang H.-Y., Chang J.-C., Charan J., Chattu V.K., Chaturvedi S., Choi J.-Y.J., Chowdhury M.A.K., Christopher D.J., Chu D.-T., Chung M.T., Chung S.-C., Cicuttini F.M., Constantin T.V., Costa V.M., Dahlawi S.M.A., Dai H., Dai X., Damiani G., Dandona L., Dandona R., Daneshpajouhnejad P., Darwesh A.M., Davila-Cervantes C.A., Davletov K., De la Hoz F.P., De Leo D., Dervenis N., Desai R., Desalew A., Deuba K., Dharmaratne S.D., Dhungana G.P., Dianatinasab M., Dias da Silva D., Diaz D., Didarloo A., Djalalinia S., Dorostkar F., Doshi C.P., Doshmangir L., Doyle K.E., Duraes A.R., Ebrahimi Kalan M., Ebtehaj S., Edvardsson D., El Tantawi M., Elgendy I.Y., El-Jaafary S.I., Elsharkawy A., Eshrati B., Eskandarieh S., Esmaeilnejad S., Esmaeilzadeh F., Esteghamati S., Faro A., Farzadfar F., Fattahi N., Feigin V.L., Ferede T.Y., Fereshtehnejad S.-M., Fernandes E., Ferrara P., Filip I., Fischer F., Fisher J.L., Foigt N.A., Folayan M.O., Fomenkov A.A., Foroutan M., Fukumoto T., Gad M.M., Gaidhane A.M., Gallus S., Gebre T., Gebremedhin K.B., Gebremeskel G.G., Gebremeskel L., Gebreslassie A.A., Gesesew H.A., Ghadiri K., Ghafourifard M., Ghamari F., Ghashghaee A., Gilani S.A., Gnedovskaya E.V., Godinho M.A., Golechha M., Goli S., Gona P.N., Gopalani S.V., Gorini G., Grivna M., Gubari M.I.M., Gugnani H.C., Guimaraes R.A., Guo Y., Gupta R., Haagsma J.A., Hafezi-Nejad N., Haile T.G., Haj-Mirzaian A., Hall B.J., Hamadeh R.R., Hamagharib Abdullah K., Hamidi S., Handiso D.W., Hanif A., Hankey G.J., Haririan H., Haro J.M., Hasaballah A.I., Hashi A., Hassan A., Hassanipour S., Hassankhani H., Hayat K., Heidari-Soureshjani R., Herteliu C., Heydarpour F., Ho H.C., Hole M.K., Holla R., Hoogar P., Hosseini M., Hosseinzadeh M., Hostiuc M., Hostiuc S., Househ M., Hsairi M., Huda T.M., Humayun A., Hussain R., Hwang B.-F., Iavicoli I., Ibitoye S.E., Ilesanmi O.S., Ilic I.M., Ilic M.D., Inbaraj L.R., Intarut N., Iqbal U., Irvani S.S.N., Islam M.M., Islam S.M.S., Iso H., Ivers R.Q., Jahani M.A., Jakovljevic M., Jalali A., Janodia M.D., Javaheri T., Jeemon P., Jenabi E., Jha R.P., Jha V., Ji J.S., Jonas J.B., Jones K.M., Joukar F., Jozwiak J.J., Juliusson P.B., Jurisson M., Kabir A., Kabir Z., Kalankesh L.R., Kalhor R., Kamyari N., Kanchan T., Karch A., Karimi S.E., Kaur S., Kayode G.A., Keiyoro P.N., Khalid N., Khammarnia M., Khan M., Khan M.N., Khatab K., Khater M.M., Khatib M.N., Khayamzadeh M., Khazaie H., Khoja A.T., Kieling C., Kim Y.-E., Kim Y.J., Kimokoti R.W., Kisa A., Kisa S., Kivimaki M., Koolivand A., Kosen S., Koyanagi A., Krishan K., Kugbey N., Kumar G.A., Kumar M., Kumar N., Kurmi O.P., Kusuma D., La Vecchia C., Lacey B., Lal D.K., Lalloo R., Lan Q., Landires I., Lansingh V.C., Larsson A.O., Lasrado S., Lassi Z.S., Lauriola P., Lee P.H., Lee S.W.H., Leigh J., Leonardi M., Leung J., Levi M., Lewycka S., Li B., Li M.-C., Li S., Lim L.-L., Lim S.S., Liu X., Lorkowski S., Lotufo P.A., Lunevicius R., Maddison R., Mahasha P.W., Mahdavi M.M., Mahmoudi M., Majeed A., Maleki A., Malekzadeh R., Malta D.C., Mamun A.A., Mansouri B., Mansournia M.A., Martinez G., Martinez-Raga J., Martins-Melo F.R., Mason-Jones A.J., Masoumi S.Z., Mathur M.R., Maulik P.K., McGrath J.J., Mehndiratta M.M., Mehri F., Memiah P.T.N., Mendoza W., Menezes R.G., Mengesha E.W., Meretoja A., Meretoja T.J., Mestrovic T., Miazgowski B., Miazgowski T., Michalek I.M., Miller T.R., Mini G.K., Mirica A., Mirrakhimov E.M., Mirzaei H., Mirzaei M., Moazen B., Mohammad D.K., Mohammadi S., Mohammadian-Hafshejani A., Mohammadifard N., Mohammadpourhodki R., Mohammed S., Monasta L., Moradi G., Moradi-Lakeh M., Moradzadeh R., Moraga P., Morrison S.D., Mosapour A., Mousavi Khaneghah A., Mueller U.O., Muriithi M.K., Murray C.J.L., Muthupandian S., Naderi M., Nagarajan A.J., Naghavi M., Naimzada M.D., Nangia V., Nayak V.C., Nazari J., Ndejjo R., Negoi I., Negoi R.I., Netsere H.B., Nguefack-Tsague G., Nguyen D.N., Nguyen H.L.T., Nie J., Ningrum D.N.A., Nnaji C.A., Nomura S., Noubiap J.J., Nowak C., Nunez-Samudio V., Ogbo F.A., Oghenetega O.B., Oh I.-H., Oladnabi M., Olagunju A.T., Olusanya B.O., Olusanya J.O., Omar Bali A., Omer M.O., Onwujekwe O.E., Ortiz A., Otoiu A., Otstavnov N., Otstavnov S.S., Overland S., Owolabi M.O., P A M., Padubidri J.R., Pakshir K., Palladino R., Pana A., Panda-Jonas S., Pandey A., Panelo C.I.A., Park E.-K., Patten S.B., Peden A.E., Pepito V.C.F., Peprah E.K., Pereira J., Pesudovs K., Pham H.Q., Phillips M.R., Piradov M.A., Pirsaheb M., Postma M.J., Pottoo F.H., Pourjafar H., Pourshams A., Prada S.I., Pupillo E., Quazi Syed Z., Rabiee M.H., Rabiee N., Radfar A., Rafiee A., Raggi A., Rahim F., Rahimi-Movaghar V., Rahman M.H.U., Rahman M.A., Ramezanzadeh K., Ranabhat C.L., Rao S.J., Rashedi V., Rastogi P., Rathi P., Rawaf D.L., Rawaf S., Rawal L., Rawassizadeh R., Renzaho A.M.N., Rezaei N., Rezai M.S., Riahi S.M., Rickard J., Roever L., Ronfani L., Roth G.A., Rubagotti E., Rumisha S.F., Rwegerera G.M., Sabour S., Sachdev P.S., Saddik B., Sadeghi E., Saeedi Moghaddam S., Sagar R., Sahebkar A., Sahraian M.A., Sajadi S.M., Salem M.R., Salimzadeh H., Samy A.M., Sanabria J., Santric-Milicevic M.M., Saraswathy S.Y.I., Sarrafzadegan N., Sarveazad A., Sathish T., Sattin D., Saxena D., Saxena S., Schiavolin S., Schwebel D.C., Schwendicke F., Senthilkumaran S., Sepanlou S.G., Sha F., Shafaat O., Shahabi S., Shaheen A.A., Shaikh M.A., Shakiba S., Shamsi M., Shannawaz M., Sharafi K., Sheikh A., Sheikhbahaei S., Shetty B.S.K., Shi P., Shigematsu M., Shin J.I., Shiri R., Shuval K., Siabani S., Sigfusdottir I.D., Sigurvinsdottir R., Silva D.A.S., Silva J.P., Simonetti B., Singh J.A., Singh V., Sinke A.H., Skryabin V.Y., Slater H., Smith E.U.R., Sobhiyeh M.R., Sobngwi E., Soheili A., Somefun O.D., Sorrie M.B., Soyiri I.N., Sreeramareddy C.T., Stein D.J., Stokes M.A., Sudaryanto A., Sultan I., Tabares-Seisdedos R., Tabuchi T., Tadakamadla S.K., Taherkhani A., Tamiru A.T., Tareque M.I., Thankappan K.R., Thapar R., Thomas N., Titova M.V., Tonelli M., Tovani-Palone M.R., Tran B.X., Travillian R.S., Tsai A.C., Tsatsakis A., Tudor Car L., Uddin R., Unim B., Unnikrishnan B., Upadhyay E., Vacante M., Valadan Tahbaz S., Valdez P.R., Varughese S., Vasankari T.J., Venketasubramanian N., Villeneuve P.J., Violante F.S., Vlassov V., Vos T., Vu G.T., Waheed Y., Wamai R.G., Wang Y., Wang Y.-P., Westerman R., Wickramasinghe N.D., Wu A.-M., Wu C., Yahyazadeh Jabbari S.H., Yamagishi K., Yano Y., Yaya S., Yazdi-Feyzabadi V., Yeshitila Y.G., Yip P., Yonemoto N., Yoon S.-J., Younis M.Z., Yousefinezhadi T., Yu C., Yu Y., Yuce D., Zaidi S.S., Zaman S.B., Zamani M., Zamanian M., Zarafshan H., Zarei A., Zastrozhin M.S., Zhang Y., Zhang Z.-J., Zhao X.-J.G., Zhu C., Patton G.C., Viner R.M., Lee Kong Chian School of Medicine (LKCMedicine), Ward, J, Azzopardi, P, Francis, K, Santelli, J, Skirbekk, V, Sawyer, S, Kassebaum, N, Mokdad, A, Hay, S, Abd-Allah, F, Abdoli, A, Abdollahi, M, Abedi, A, Abolhassani, H, Abreu, L, Abrigo, M, Abu-Gharbieh, E, Abushouk, A, Adebayo, O, Adekanmbi, V, Adham, D, Advani, S, Afshari, K, Agrawal, A, Ahmad, T, Ahmadi, K, Ahmed, A, Aji, B, Akombi-Inyang, B, Alahdab, F, Al-Aly, Z, Alam, K, Alanezi, F, Alanzi, T, Alcalde-Rabanal, J, Alemu, B, Al-Hajj, S, Alhassan, R, Ali, S, Alicandro, G, Alijanzadeh, M, Aljunid, S, Almasi-Hashiani, A, Almasri, N, Al-Mekhlafi, H, Alonso, J, Al-Raddadi, R, Altirkawi, K, Alvis-Guzman, N, Amare, A, Amini, S, Aminorroaya, A, Amit, A, Amugsi, D, Ancuceanu, R, Anderlini, D, Andrei, C, Androudi, S, Ansari, F, Ansari, I, Antonio, C, Anvari, D, Anwer, R, Appiah, S, Arabloo, J, Arab-Zozani, M, Arnlov, J, Asaad, M, Asadi-Aliabadi, M, Asadi-Pooya, A, Atout, M, Ausloos, M, Avenyo, E, Avila-Burgos, L, Ayala Quintanilla, B, Ayano, G, Aynalem, Y, Azari, S, Azene, Z, Bakhshaei, M, Bakkannavar, S, Banach, M, Banik, P, Barboza, M, Barker-Collo, S, Barnighausen, T, Basu, S, Baune, B, Bayati, M, Bedi, N, Beghi, E, Bekuma, T, Bell, A, Bell, M, Benjet, C, Bensenor, I, Berhe, A, Berhe, K, Berman, A, Bhagavathula, A, Bhardwaj, N, Bhardwaj, P, Bhattacharyya, K, Bhattarai, S, Bhutta, Z, Bijani, A, Bikbov, B, Biondi, A, Birhanu, T, Biswas, R, Bohlouli, S, Bolla, S, Boloor, A, Borschmann, R, Boufous, S, Bragazzi, N, Braithwaite, D, Breitborde, N, Brenner, H, Britton, G, Burns, R, Burugina Nagaraja, S, Butt, Z, Caetano dos Santos, F, Camera, L, Campos-Nonato, I, Campuzano Rincon, J, Cardenas, R, Carreras, G, Carrero, J, Carvalho, F, Castaldelli-Maia, J, Castaneda-Orjuela, C, Castelpietra, G, Catala-Lopez, F, Cerin, E, Chandan, J, Chang, H, Chang, J, Charan, J, Chattu, V, Chaturvedi, S, Choi, J, Chowdhury, M, Christopher, D, Chu, D, Chung, M, Chung, S, Cicuttini, F, Constantin, T, Costa, V, Dahlawi, S, Dai, H, Dai, X, Damiani, G, Dandona, L, Dandona, R, Daneshpajouhnejad, P, Darwesh, A, Davila-Cervantes, C, Davletov, K, De la Hoz, F, De Leo, D, Dervenis, N, Desai, R, Desalew, A, Deuba, K, Dharmaratne, S, Dhungana, G, Dianatinasab, M, Dias da Silva, D, Diaz, D, Didarloo, A, Djalalinia, S, Dorostkar, F, Doshi, C, Doshmangir, L, Doyle, K, Duraes, A, Ebrahimi Kalan, M, Ebtehaj, S, Edvardsson, D, El Tantawi, M, Elgendy, I, El-Jaafary, S, Elsharkawy, A, Eshrati, B, Eskandarieh, S, Esmaeilnejad, S, Esmaeilzadeh, F, Esteghamati, S, Faro, A, Farzadfar, F, Fattahi, N, Feigin, V, Ferede, T, Fereshtehnejad, S, Fernandes, E, Ferrara, P, Filip, I, Fischer, F, Fisher, J, Foigt, N, Folayan, M, Fomenkov, A, Foroutan, M, Fukumoto, T, Gad, M, Gaidhane, A, Gallus, S, Gebre, T, Gebremedhin, K, Gebremeskel, G, Gebremeskel, L, Gebreslassie, A, Gesesew, H, Ghadiri, K, Ghafourifard, M, Ghamari, F, Ghashghaee, A, Gilani, S, Gnedovskaya, E, Godinho, M, Golechha, M, Goli, S, Gona, P, Gopalani, S, Gorini, G, Grivna, M, Gubari, M, Gugnani, H, Guimaraes, R, Guo, Y, Gupta, R, Haagsma, J, Hafezi-Nejad, N, Haile, T, Haj-Mirzaian, A, Hall, B, Hamadeh, R, Hamagharib Abdullah, K, Hamidi, S, Handiso, D, Hanif, A, Hankey, G, Haririan, H, Haro, J, Hasaballah, A, Hashi, A, Hassan, A, Hassanipour, S, Hassankhani, H, Hayat, K, Heidari-Soureshjani, R, Herteliu, C, Heydarpour, F, Ho, H, Hole, M, Holla, R, Hoogar, P, Hosseini, M, Hosseinzadeh, M, Hostiuc, M, Hostiuc, S, Househ, M, Hsairi, M, Huda, T, Humayun, A, Hussain, R, Hwang, B, Iavicoli, I, Ibitoye, S, Ilesanmi, O, Ilic, I, Ilic, M, Inbaraj, L, Intarut, N, Iqbal, U, Irvani, S, Islam, M, Islam, S, Iso, H, Ivers, R, Jahani, M, Jakovljevic, M, Jalali, A, Janodia, M, Javaheri, T, Jeemon, P, Jenabi, E, Jha, R, Jha, V, Ji, J, Jonas, J, Jones, K, Joukar, F, Jozwiak, J, Juliusson, P, Jurisson, M, Kabir, A, Kabir, Z, Kalankesh, L, Kalhor, R, Kamyari, N, Kanchan, T, Karch, A, Karimi, S, Kaur, S, Kayode, G, Keiyoro, P, Khalid, N, Khammarnia, M, Khan, M, Khatab, K, Khater, M, Khatib, M, Khayamzadeh, M, Khazaie, H, Khoja, A, Kieling, C, Kim, Y, Kimokoti, R, Kisa, A, Kisa, S, Kivimaki, M, Koolivand, A, Kosen, S, Koyanagi, A, Krishan, K, Kugbey, N, Kumar, G, Kumar, M, Kumar, N, Kurmi, O, Kusuma, D, La Vecchia, C, Lacey, B, Lal, D, Lalloo, R, Lan, Q, Landires, I, Lansingh, V, Larsson, A, Lasrado, S, Lassi, Z, Lauriola, P, Lee, P, Lee, S, Leigh, J, Leonardi, M, Leung, J, Levi, M, Lewycka, S, Li, B, Li, M, Li, S, Lim, L, Lim, S, Liu, X, Lorkowski, S, Lotufo, P, Lunevicius, R, Maddison, R, Mahasha, P, Mahdavi, M, Mahmoudi, M, Majeed, A, Maleki, A, Malekzadeh, R, Malta, D, Mamun, A, Mansouri, B, Mansournia, M, Martinez, G, Martinez-Raga, J, Martins-Melo, F, Mason-Jones, A, Masoumi, S, Mathur, M, Maulik, P, Mcgrath, J, Mehndiratta, M, Mehri, F, Memiah, P, Mendoza, W, Menezes, R, Mengesha, E, Meretoja, A, Meretoja, T, Mestrovic, T, Miazgowski, B, Miazgowski, T, Michalek, I, Miller, T, Mini, G, Mirica, A, Mirrakhimov, E, Mirzaei, H, Mirzaei, M, Moazen, B, Mohammad, D, Mohammadi, S, Mohammadian-Hafshejani, A, Mohammadifard, N, Mohammadpourhodki, R, Mohammed, S, Monasta, L, Moradi, G, Moradi-Lakeh, M, Moradzadeh, R, Moraga, P, Morrison, S, Mosapour, A, Mousavi Khaneghah, A, Mueller, U, Muriithi, M, Murray, C, Muthupandian, S, Naderi, M, Nagarajan, A, Naghavi, M, Naimzada, M, Nangia, V, Nayak, V, Nazari, J, Ndejjo, R, Negoi, I, Negoi, R, Netsere, H, Nguefack-Tsague, G, Nguyen, D, Nguyen, H, Nie, J, Ningrum, D, Nnaji, C, Nomura, S, Noubiap, J, Nowak, C, Nunez-Samudio, V, Ogbo, F, Oghenetega, O, Oh, I, Oladnabi, M, Olagunju, A, Olusanya, B, Olusanya, J, Omar Bali, A, Omer, M, Onwujekwe, O, Ortiz, A, Otoiu, A, Otstavnov, N, Otstavnov, S, Overland, S, Owolabi, M, P A, M, Padubidri, J, Pakshir, K, Palladino, R, Pana, A, Panda-Jonas, S, Pandey, A, Panelo, C, Park, E, Patten, S, Peden, A, Pepito, V, Peprah, E, Pereira, J, Pesudovs, K, Pham, H, Phillips, M, Piradov, M, Pirsaheb, M, Postma, M, Pottoo, F, Pourjafar, H, Pourshams, A, Prada, S, Pupillo, E, Quazi Syed, Z, Rabiee, M, Rabiee, N, Radfar, A, Rafiee, A, Raggi, A, Rahim, F, Rahimi-Movaghar, V, Rahman, M, Ramezanzadeh, K, Ranabhat, C, Rao, S, Rashedi, V, Rastogi, P, Rathi, P, Rawaf, D, Rawaf, S, Rawal, L, Rawassizadeh, R, Renzaho, A, Rezaei, N, Rezai, M, Riahi, S, Rickard, J, Roever, L, Ronfani, L, Roth, G, Rubagotti, E, Rumisha, S, Rwegerera, G, Sabour, S, Sachdev, P, Saddik, B, Sadeghi, E, Saeedi Moghaddam, S, Sagar, R, Sahebkar, A, Sahraian, M, Sajadi, S, Salem, M, Salimzadeh, H, Samy, A, Sanabria, J, Santric-Milicevic, M, Saraswathy, S, Sarrafzadegan, N, Sarveazad, A, Sathish, T, Sattin, D, Saxena, D, Saxena, S, Schiavolin, S, Schwebel, D, Schwendicke, F, Senthilkumaran, S, Sepanlou, S, Sha, F, Shafaat, O, Shahabi, S, Shaheen, A, Shaikh, M, Shakiba, S, Shamsi, M, Shannawaz, M, Sharafi, K, Sheikh, A, Sheikhbahaei, S, Shetty, B, Shi, P, Shigematsu, M, Shin, J, Shiri, R, Shuval, K, Siabani, S, Sigfusdottir, I, Sigurvinsdottir, R, Silva, D, Silva, J, Simonetti, B, Singh, J, Singh, V, Sinke, A, Skryabin, V, Slater, H, Smith, E, Sobhiyeh, M, Sobngwi, E, Soheili, A, Somefun, O, Sorrie, M, Soyiri, I, Sreeramareddy, C, Stein, D, Stokes, M, Sudaryanto, A, Sultan, I, Tabares-Seisdedos, R, Tabuchi, T, Tadakamadla, S, Taherkhani, A, Tamiru, A, Tareque, M, Thankappan, K, Thapar, R, Thomas, N, Titova, M, Tonelli, M, Tovani-Palone, M, Tran, B, Travillian, R, Tsai, A, Tsatsakis, A, Tudor Car, L, Uddin, R, Unim, B, Unnikrishnan, B, Upadhyay, E, Vacante, M, Valadan Tahbaz, S, Valdez, P, Varughese, S, Vasankari, T, Venketasubramanian, N, Villeneuve, P, Violante, F, Vlassov, V, Vos, T, Vu, G, Waheed, Y, Wamai, R, Wang, Y, Westerman, R, Wickramasinghe, N, Wu, A, Wu, C, Yahyazadeh Jabbari, S, Yamagishi, K, Yano, Y, Yaya, S, Yazdi-Feyzabadi, V, Yeshitila, Y, Yip, P, Yonemoto, N, Yoon, S, Younis, M, Yousefinezhadi, T, Yu, C, Yu, Y, Yuce, D, Zaidi, S, Zaman, S, Zamani, M, Zamanian, M, Zarafshan, H, Zarei, A, Zastrozhin, M, Zhang, Y, Zhang, Z, Zhao, X, Zhu, C, Patton, G, and Viner, R
- Subjects
Male ,Joves -- Mortalitat ,ADOLESCENT HEALTH ,CHILDREN ,Socioeconomic Factor ,Global Burden of Disease ,RA0421 ,Cause of Death ,Medicine ,Young adult ,Child ,11 Medical and Health Sciences ,Cause of death ,education.field_of_study ,Adolescent ,Age Distribution ,Female ,Humans ,Mortality ,Sex Distribution ,Socioeconomic Factors ,Young Adult ,Mortality rate ,Public Health, Global Health, Social Medicine and Epidemiology ,General Medicine ,Articles ,Hälsovetenskaper ,MIDDLE-INCOME ,MENTAL-HEALTH ,Adolescent health ,INTERVENTIONS ,Human ,SUICIDE ,Total fertility rate ,Population ,Adolescent Health ,Adolescents -- Mortalitat ,General & Internal Medicine ,Health Sciences ,QUALITY ,Medicine [Science] ,Social determinants of health ,INCOME COUNTRIES ,education ,business.industry ,TRENDS ,Folkhälsovetenskap, global hälsa, socialmedicin och epidemiologi ,Years of potential life lost ,INJURIES ,business ,Demography - Abstract
Background Documentation of patterns and long-term trends in mortality in young people, which reflect huge changes in demographic and social determinants of adolescent health, enables identification of global investment priorities for this age group. We aimed to analyse data on the number of deaths, years of life lost, and mortality rates by sex and age group in people aged 10–24 years in 204 countries and territories from 1950 to 2019 by use of estimates from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019. Methods We report trends in estimated total numbers of deaths and mortality rate per 100 000 population in young people aged 10–24 years by age group (10–14 years, 15–19 years, and 20–24 years) and sex in 204 countries and territories between 1950 and 2019 for all causes, and between 1980 and 2019 by cause of death. We analyse variation in outcomes by region, age group, and sex, and compare annual rate of change in mortality in young people aged 10–24 years with that in children aged 0–9 years from 1990 to 2019. We then analyse the association between mortality in people aged 10–24 years and socioeconomic development using the GBD Socio-demographic Index (SDI), a composite measure based on average national educational attainment in people older than 15 years, total fertility rate in people younger than 25 years, and income per capita. We assess the association between SDI and all-cause mortality in 2019, and analyse the ratio of observed to expected mortality by SDI using the most recent available data release (2017). Findings In 2019 there were 1·49 million deaths (95% uncertainty interval 1·39–1·59) worldwide in people aged 10–24 years, of which 61% occurred in males. 32·7% of all adolescent deaths were due to transport injuries, unintentional injuries, or interpersonal violence and conflict; 32·1% were due to communicable, nutritional, or maternal causes; 27·0% were due to non-communicable diseases; and 8·2% were due to self-harm. Since 1950, deaths in this age group decreased by 30·0% in females and 15·3% in males, and sex-based differences in mortality rate have widened in most regions of the world. Geographical variation has also increased, particularly in people aged 10–14 years. Since 1980, communicable and maternal causes of death have decreased sharply as a proportion of total deaths in most GBD super-regions, but remain some of the most common causes in sub-Saharan Africa and south Asia, where more than half of all adolescent deaths occur. Annual percentage decrease in all-cause mortality rate since 1990 in adolescents aged 15–19 years was 1·3% in males and 1·6% in females, almost half that of males aged 1–4 years (2·4%), and around a third less than in females aged 1–4 years (2·5%). The proportion of global deaths in people aged 0–24 years that occurred in people aged 10–24 years more than doubled between 1950 and 2019, from 9·5% to 21·6%. Interpretation Variation in adolescent mortality between countries and by sex is widening, driven by poor progress in reducing deaths in males and older adolescents. Improving global adolescent mortality will require action to address the specific vulnerabilities of this age group, which are being overlooked. Furthermore, indirect effects of the COVID-19 pandemic are likely to jeopardise efforts to improve health outcomes including mortality in young people aged 10–24 years. There is an urgent need to respond to the changing global burden of adolescent mortality, address inequities where they occur, and improve the availability and quality of primary mortality data in this age group. Funding Bill & Melinda Gates Foundation.
- Published
- 2021
9. Does aerobic exercise effect pain sensitisation in individuals with musculoskeletal pain? A systematic review
- Author
-
Tan, L, Cicuttini, FM, Fairley, J, Romero, L, Estee, M, Hussain, SM, Urquhart, DM, Tan, L, Cicuttini, FM, Fairley, J, Romero, L, Estee, M, Hussain, SM, and Urquhart, DM
- Abstract
BACKGROUND: Pain sensitisation plays a major role in musculoskeletal pain. However, effective treatments are limited, and although there is growing evidence that exercise may improve pain sensitisation, the amount and type of exercise remains unclear. This systematic review examines the evidence for an effect of aerobic exercise on pain sensitisation in musculoskeletal conditions. METHODS: Systematic searches of six electronic databases were conducted. Studies were included if they examined the relationship between aerobic physical activity and pain sensitisation in individuals with chronic musculoskeletal pain, but excluding specific patient subgroups such as fibromyalgia. Risk of bias was assessed using Cochrane methods and a qualitative analysis was conducted. RESULTS: Eleven studies (seven repeated measures studies and four clinical trials) of 590 participants were included. Eight studies had low to moderate risk of bias. All 11 studies found that aerobic exercise increased pressure pain thresholds or decreased pain ratings in those with musculoskeletal pain [median (minimum, maximum) improvement in pain sensitisation: 10.6% (2.2%, 24.1%)]. In these studies, the aerobic exercise involved walking or cycling, performed at a submaximal intensity but with incremental increases, for a 4-60 min duration. Improvement in pain sensitisation occurred after one session in the observational studies and after 2-12 weeks in the clinical trials. CONCLUSIONS: These findings provide evidence that aerobic exercise reduces pain sensitisation in individuals with musculoskeletal pain. Further work is needed to determine whether this translates to improved patient outcomes, including reduced disability and greater quality of life.
- Published
- 2022
10. Association between arthritis and cardiovascular risk factors in community-based adults: an opportunity to target cardiovascular risk
- Author
-
Sewell, J, Hussain, SM, Wang, Y, Wluka, AE, Lim, YZ, Carrington, MJ, Samaras, K, Cicuttini, FM, Sewell, J, Hussain, SM, Wang, Y, Wluka, AE, Lim, YZ, Carrington, MJ, Samaras, K, and Cicuttini, FM
- Abstract
BACKGROUND: Undertreated risk factors are major contributors to the burden of cardiovascular disease (CVD). Those with arthritis have an increased prevalence of CVD risk factors. CVD risk factors are often asymptomatic, which may be a barrier their treatment. Arthritis causes pain and immobility, and is a common reason for individuals to seek healthcare. Our aims were to (1) examine the relationship between arthritis and CVD risk factors in Australian adults, and (2) calculate the proportion of CVD risk factors that could be reduced if individuals with arthritis were targeted. METHODS: This cross-sectional study uses data from the 2017-18 Australian National Health Survey which included 13,776 participants, categorised into young (18-39 years), middle aged (40-64 years) and older (≥ 65 years) adults. Hypertension, height and weight were measured. Arthritis, dyslipidemia and diabetes were self-reported. The associations between arthritis and CVD risk factors were examined using logistic regression, and the population attributable fraction (PAF) of arthritis for each CVD risk factor was calculated. RESULTS: Arthritis was reported by 4.0% of young adults, 28.8% of middle-aged adults and 54.5% of older adults. Those with arthritis were at increased odds of obesity (2.07 fold in young, 1.75 fold in middle-aged and 1.89 fold in older adults), increased odds of diabetes (5.70 fold in young, 1.64 fold in middle-aged and 1.37 fold in older adults), increased odds of hypertension (2.72 fold in young, 1.78 fold in middle-aged and 1.48 fold in older adults) and an increased odds of dyslipidaemia (4.64 fold in young, 2.14 fold in middle-aged and 1.22 fold in older adults) compared to those without arthritis. This elevated chance remained significant even after adjusting for obesity, with the exception of diabetes in the older population. This elevated chance remained significant even after adjusting for obesity, with the exception of diabetes in the older population. The PAF of
- Published
- 2022
11. Efficacy of corticosteroids for hand osteoarthritis-a systematic review and meta-analysis of randomized controlled trials
- Author
-
Estee, MM, Cicuttini, FM, Page, MJ, Butala, AD, Wluka, AE, Hussain, SM, Wang, Y, Estee, MM, Cicuttini, FM, Page, MJ, Butala, AD, Wluka, AE, Hussain, SM, and Wang, Y
- Abstract
BACKGROUND: There is some evidence that corticosteroids may have a beneficial effect in hand osteoarthritis. We examined the efficacy of corticosteroids on symptoms and structural outcomes in hand osteoarthritis. METHODS: Ovid MEDLINE, Embase and Cochrane Central Register of Controlled Trials were searched from inception to October 2021 for randomized controlled trials investigating the efficacy of corticosteroids in hand osteoarthritis. Two authors independently screened records, extracted data, and assessed risk of bias using the RoB 2 tool. Standardized mean difference (SMD) or mean difference (MD) was calculated, and random-effects meta-analyses were performed. RESULTS: Of 13 included trials, 3 examined oral corticosteroids and clinical outcomes in any hand joints, 9 examined intra-articular injection of corticosteroids and clinical outcomes at the first carpometacarpal joint and one in the interphalangeal joints. In meta-analysis, oral corticosteroids reduced pain (SMD -0.53, 95% CI -0.79 to -0.28) and improved stiffness (MD -5.03, 95% CI -9.91 to -0.15; Australian Canadian Osteoarthritis Hand Index stiffness subscale) and function (SMD -0.37, 95% CI -0.63 to -0.12) at 4-6 weeks. However, there was no significant persistent effect on pain and function at 3 months which was 6-8 weeks after study medication was stopped. There was no significant effect of intra-articular corticosteroids on pain or function at 4-6 weeks or over 3-12 months in first carpometacarpal osteoarthritis. Two trials evaluated joint structure at 4-6 weeks: one study showed oral corticosteroids reduced synovial thickening, neither showed an effect on synovitis. CONCLUSIONS: There was low-certainty evidence for a medium effect of oral corticosteroids on pain relief and stiffness improvement and small-to-medium effect on functional improvement at 4-6 weeks, with no significant effect for intra-articular corticosteroids. Corticosteroids had no significant effect on any outcomes over longer term
- Published
- 2022
12. Effect of atorvastatin on skeletal muscles of patients with knee osteoarthritis: Post-hoc analysis of a randomised controlled trial.
- Author
-
Lim, YZ, Cicuttini, FM, Wluka, AE, Jones, G, Hill, CL, Forbes, AB, Tonkin, A, Berezovskaya, S, Tan, L, Ding, C, Wang, Y, Lim, YZ, Cicuttini, FM, Wluka, AE, Jones, G, Hill, CL, Forbes, AB, Tonkin, A, Berezovskaya, S, Tan, L, Ding, C, and Wang, Y
- Abstract
OBJECTIVE: Populations with knee osteoarthritis (KOA) are at increased risk of cardiovascular disease, due to higher prevalence of risk factors including dyslipidaemia, where statins are commonly prescribed. However, the effect of statins on muscles and symptoms in this population is unknown. Thus, this study examined the effect of atorvastatin on muscle properties in patients with symptomatic KOA. DESIGN: Post-hoc analysis of a 2-year multicentre randomised, double-blind, placebo-controlled trial. SETTING: Australian community. PARTICIPANTS: Participants aged 40-70 years (mean age 55.7 years, 55.6% female) with KOA who met the American College of Rheumatology clinical criteria received atorvastatin 40 mg daily (n = 151) or placebo (n = 153). MAIN OUTCOME MEASURES: Levels of creatinine kinase (CK), aspartate transaminase (AST), and alanine transaminase (ALT) at 1, 6, 12, and 24 months; muscle strength (by dynamometry) at 12 and 24 months; vastus medialis cross-sectional area (CSA) on magnetic resonance imaging at 24 months; and self-reported myalgia. RESULTS: There were no significant between-group differences in CK and AST at all timespoints. The atorvastatin group had higher ALT than placebo group at 1 (median 26 vs. 21, p = 0.004) and 6 (25 vs. 22, p = 0.007) months without significant between-group differences at 12 and 24 months. Muscle strength increased in both groups at 24 months without between-group differences [mean 8.2 (95% CI 3.5, 12.9) vs. 5.9 (1.3, 10.4), p = 0.49]. Change in vastus medialis CSA at 24 months favoured the atorvastatin group [0.11 (-0.10, 0.31) vs. -0.23 (-0.43, -0.03), p = 0.02] but of uncertain clinical significance. There was a trend for more myalgia in the atorvastatin group (8/151 vs. 2/153, p = 0.06) over 2 years, mostly occurring within 6 months (7/151 vs. 1/153, p = 0.04). CONCLUSIONS: In those with symptomatic KOA, despite a trend for more myalgia, there was no clear evidence of an adverse effect of atorvastatin on muscles, inc
- Published
- 2022
13. Recommendations for weight management in osteoarthritis: A systematic review of clinical practice guidelines.
- Author
-
Lim, YZ, Wong, J, Hussain, SM, Estee, MM, Zolio, L, Page, MJ, Harrison, CL, Wluka, AE, Wang, Y, Cicuttini, FM, Lim, YZ, Wong, J, Hussain, SM, Estee, MM, Zolio, L, Page, MJ, Harrison, CL, Wluka, AE, Wang, Y, and Cicuttini, FM
- Abstract
OBJECTIVE: While targeting obesity is central to osteoarthritis management, recent meta-analyses demonstrate only modest effects of weight loss on symptoms, and little on structure. The World Health Organisation recommends that effective management of obesity include prevention of weight gain, weight maintenance and weight loss. Therefore, we systematically reviewed the recommendations and approaches for management of obesity in clinical practice guidelines (CPGs) for osteoarthritis. DESIGN: Nine databases were searched (01.01.2010-15.03.2022) to identify guidelines informing the non-pharmacological management of osteoarthritis. Three reviewers appraised guidelines according to the AGREE II instrument, and independently extracted data on their characteristics. One author extracted and summarised guideline recommendations on weight management. This systematic review is registered on PROSPERO (CRD42021274195). RESULTS: Of the included fifteen CPGs (median AGREE II domain score 78.7%), weight loss was recommended for knee (12 of 13) and hip (10 of 11) but not hand (0 of 4) osteoarthritis. Combination approaches of diet and/or exercise were recommended for overweight or obese individuals in knee (8 of 12) and hip (4 of 10) osteoarthritis. Two guidelines specified ≥5% weight loss. One guideline specified strategies for maintenance of lost weight; none specifically recommended preventing weight gain. There was discordance between strength of recommendation for weight loss and level of evidence (3 of 15). CONCLUSION: Most CPGs for knee and hip osteoarthritis recommend weight loss to manage obesity in osteoarthritis. As steady weight accumulation is common in adults, preventing weight gain should also be considered as it is a missed opportunity to improve outcomes in osteoarthritis.
- Published
- 2022
14. Study protocol for a randomised controlled trial of diacerein versus placebo to treat knee osteoarthritis with effusion-synovitis (DICKENS).
- Author
-
Cai, G, Jones, G, Cicuttini, FM, Wluka, AE, Wang, Y, Hill, C, Keen, H, Antony, B, Wang, X, de Graaff, B, Thompson, M, Winzenberg, T, Buttigieg, K, Aitken, D, Cai, G, Jones, G, Cicuttini, FM, Wluka, AE, Wang, Y, Hill, C, Keen, H, Antony, B, Wang, X, de Graaff, B, Thompson, M, Winzenberg, T, Buttigieg, K, and Aitken, D
- Abstract
BACKGROUND: There is an unmet need for treatments for knee osteoarthritis (OA). Effusion-synovitis is a common inflammatory phenotype of knee OA and predicts knee pain and structural degradation. Anti-inflammatory therapies, such as diacerein, may be effective for this phenotype. While diacerein is recommended for alleviating pain in OA patients, evidence for its effectiveness is inconsistent, possibly because studies have not targeted patients with an inflammatory phenotype. Therefore, we will conduct a multi-centre, randomised, placebo-controlled double-blind trial to determine the effect of diacerein on changes in knee pain and effusion-synovitis over 24 weeks in patients with knee OA and magnetic resonance imaging (MRI)-defined effusion-synovitis. METHODS: We will recruit 260 patients with clinical knee OA, significant knee pain, and MRI-detected effusion-synovitis in Hobart, Melbourne, Adelaide, and Perth, Australia. They will be randomly allocated to receive either diacerein (50mg twice daily) or identical placebo for 24 weeks. MRI of the study knee will be performed at screening and after 24 weeks of intervention. The primary outcome is improvement in knee pain at 24 weeks as assessed by a 100-mm visual analogue scale (VAS). Secondary outcomes include improvement in volumetric (ml) and semi-quantitative (Whole-Organ Magnetic Resonance Imaging Score, 0-3) measurements of effusion-synovitis using MRI over 24 weeks, and improvement in knee pain (VAS) at 4, 8, 12, 16, and 20 weeks. Intention-to-treat analyses of primary and secondary outcomes will be performed as the primary analyses. Per protocol analyses will be performed as the secondary analyses. DISCUSSION: This study will provide high-quality evidence to determine whether diacerein improves pain, changes disease trajectory, and slows disease progression in OA patients with effusion-synovitis. If diacerein proves effective, this has the potential to significantly benefit the substantial proportion (up to 60%
- Published
- 2022
15. Association between socioeconomic status and joint replacement of the hip and knee: a population-based cohort study of older adults in Tasmania
- Author
-
Munugoda, IP, Brennan-Olsen, SL, Wills, K, Cai, G, Graves, SE, Lorimer, M, Cicuttini, FM, Callisaya, ML, Aitken, D, Jones, G, Munugoda, IP, Brennan-Olsen, SL, Wills, K, Cai, G, Graves, SE, Lorimer, M, Cicuttini, FM, Callisaya, ML, Aitken, D, and Jones, G
- Abstract
BACKGROUND: A socioeconomic gradient exists in the utilisation of total hip replacements (THR) and total knee replacements (TKR) for osteoarthritis. However, the relations between socioeconomic status (SES) and time to THR or TKR is unknown. AIM: To describe the association between SES and time to THR and TKR. METHODS: One thousand and seventy-two older adults residing in Tasmania, Australia, were studied. Incident primary THR and TKR were determined by data linkage to the Australian Orthopaedic Association National Joint Replacement Registry. At baseline, each participant's area-level SES was determined using the Index of Relative Socioeconomic Advantage and Disadvantage (IRSAD) from the Australian Bureau of Statistics' 2001 census data. The IRSAD was analysed in two ways: (i) categorised into quartiles, whereby quartile 1 represented the most socioeconomically disadvantaged group; and (ii) the cohort dichotomised at the quartile 1 cut-point. RESULTS: The mean age was 63.0 (±7.5) years and 51% were women. Over the median follow up of 12.9 (interquartile range: 12.2-13.9) years, 56 (5%) participants had a THR and 79 (7%) had a TKR. Compared with the most disadvantaged quartile, less disadvantaged participants were less likely to have a THR (i.e. less disadvantaged participants had a longer time to THR; hazard ratio (HR): 0.56; 95% confidence interval (CI) 0.32, 1.00) but not TKR (HR: 0.90; 95% CI 0.53, 1.54). However, the former became non-significant after adjustment for pain and radiographic osteoarthritis, suggesting that the associations may be mediated by these factors. CONCLUSIONS: The present study suggests that time to joint replacement was determined according to the symptoms/need of the participants rather than their SES.
- Published
- 2022
16. Examining resting-state functional connectivity in key hubs of the default mode network in chronic low back pain
- Author
-
Ng, SK, Urquhart, DM, Fitzgerald, PB, Cicuttini, FM, Kirkovski, Melissa, Maller, JJ, Enticott, Peter, Rossell, SL, Fitzgibbon, BM, Ng, SK, Urquhart, DM, Fitzgerald, PB, Cicuttini, FM, Kirkovski, Melissa, Maller, JJ, Enticott, Peter, Rossell, SL, and Fitzgibbon, BM
- Abstract
- Published
- 2021
17. Person-centred care in osteoarthritis and inflammatory arthritis: a scoping review of people's needs outside of healthcare
- Author
-
Fairley, JL, Seneviwickrama, M, Yeh, S, Anthony, S, Chou, L, Cicuttini, FM, Sullivan, K, Briggs, AM, Wluka, AE, Fairley, JL, Seneviwickrama, M, Yeh, S, Anthony, S, Chou, L, Cicuttini, FM, Sullivan, K, Briggs, AM, and Wluka, AE
- Abstract
BACKGROUND: Arthritis, regardless of cause, has significant physical, social and psychological impacts on patients. We aimed to identify the non-healthcare needs perceived by patients with inflammatory arthritis (IA) and osteoarthritis (OA), and to determine if these differ. METHODS: We electronically searched MEDLINE, PsycINFO, EMBASE and CINAHL (1990-2020) systematically to identify non-healthcare-related needs of people with IA or OA. All citations were screened and quality appraised by two reviewers. Data was extracted by a single reviewer. RESULTS: The search identified 7853 citations, with 31 studies included (12 for OA, 20 for IA). Six areas of need emerged and these were similar in both group These were: 1) Assistance with activities of daily living especially related to a lack of independence; 2) Social connectedness: need for social participation; 3) Financial security: worry about financial security and increased costs of health-seeking behaviours; 4) Occupational needs: desire to continue work for financial and social reasons, facilitated by flexibility of workplace conditions/environment; 5) Exercise and leisure: including limitation due to pain; 6) Transportation: limitations in ability to drive and take public transport due to mobility concerns. Many areas of need were linked; e.g. loss of employment and requiring support from family was associated with a sense of "failure" and loss of identity, as social isolation. CONCLUSIONS: This review highlights the pervasive impact of arthritis on peoples' lives, regardless of aetiology, albeit with a limited evidence base. Improved identification and targeting of non-healthcare needs of people with arthritis is likely to improve person-centred care.
- Published
- 2021
18. Topical corticosteroid for treatment of hand osteoarthritis: study protocol for a randomised controlled trial
- Author
-
Wang, Y, Hussain, SM, Gan, D, Lim, YZ, Estee, MM, Heritier, S, Wluka, AE, Cicuttini, FM, Wang, Y, Hussain, SM, Gan, D, Lim, YZ, Estee, MM, Heritier, S, Wluka, AE, and Cicuttini, FM
- Abstract
BACKGROUND: Hand osteoarthritis is a common and disabling chronic joint disease with a lack of effective therapies. Emerging evidence suggests the role of local inflammation in causing pain in hand osteoarthritis. Corticosteroids are potent anti-inflammatory drugs used in many rheumatic diseases. The aim of this randomised, double-blind, placebo-controlled trial is to determine whether topical corticosteroid reduces pain over 6 weeks in patients with hand osteoarthritis. METHODS: One hundred participants with hand osteoarthritis will be recruited from the community in Melbourne, Australia, and randomly allocated in a 1:1 ratio to receive either topical Diprosone OV or placebo ointment administered 3 times daily on the painful hand joints for 6 weeks. The primary outcome is pain reduction (assessed by 100 mm visual analogue scale) at 6 weeks. The secondary outcomes include changes in pain and function assessed using Functional Index for Hand Osteoarthritis, Australian Canadian Osteoarthritis Hand Index, Michigan Hand Outcomes Questionnaire, and tender and swollen joint count at 6 weeks. Adverse events will be recorded. The primary analysis will be by intention to treat, including all participants in their randomised groups. DISCUSSION: This study will provide high-quality evidence to determine whether topical corticosteroid reduces pain over 6 weeks in patients with hand osteoarthritis, with major clinical and public health importance by informing clinical practice guidelines for the management of hand osteoarthritis and reducing the burden of the disabling disease. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry (ANZCTR), ACTRN12620000599976 . Registered 22 May 2020.
- Published
- 2021
19. Effect of low-dose amitriptyline on reducing pain in clinical knee osteoarthritis compared to benztropine: study protocol of a randomised, double blind, placebo-controlled trial
- Author
-
Wluka, AE, Urquhart, DM, Teichtahl, AJ, Hussain, SM, Forbes, A, Arnold, C, Wang, Y, Cicuttini, FM, Wluka, AE, Urquhart, DM, Teichtahl, AJ, Hussain, SM, Forbes, A, Arnold, C, Wang, Y, and Cicuttini, FM
- Abstract
BACKGROUND: Knee osteoarthritis is a major cause of pain and disability. Pain control is poor, with most patients remaining in moderate to severe pain. This may be because central causes of pain, a common contributor to knee pain, are not affected by current treatment strategies. Antidepressants, such as amitriptyline, have been used to treat chronic pain in other conditions. The aim of this randomised, double blind, controlled trial, is to determine whether low dose amitriptyline reduces pain in people with painful knee osteoarthritis over 3 months compared to benztropine, an active placebo. METHODS/DESIGN: One hundred and sixty people with painful radiographic knee osteoarthritis will be recruited via clinicians, local and social media advertising. Participants will be randomly allocated in a 1:1 ratio to receive either low dose amitriptyline (25 mg) or active placebo (benztropine mesylate, 1 mg) for 3 months. The primary outcome is change from baseline in knee pain (WOMAC pain subscale) at 12 weeks. Secondary outcomes include change in function (total WOMAC) and the proportion of individuals achieving a substantial response (≥ 50% reduction in pain intensity, measured by Visual Analog Scale, VAS, from no pain to worst pain imaginable, 0-100 mm) and moderate response (≥ 30% reduction in pain intensity, measured by VAS) at 12 weeks. Intention to treat analyses will be performed. Subgroup analyses will be done. DISCUSSION: This study will provide high level evidence regarding the effectiveness of low dose amitriptyline compared to benztropine in reducing pain and improving function in knee OA. This trial has the potential to provide an effective new therapeutic approach for pain management in knee osteoarthritis, with the potential of ready translation into clinical practice, as it is repurposing an old drug, which is familiar to clinicians and with a well described safety record. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry prior to recruitme
- Published
- 2021
20. Is adiposity associated with back and lower limb pain? A systematic review
- Author
-
Alway, SE, Peiris, WL, Cicuttini, FM, Hussain, SM, Estee, MM, Romero, L, Ranger, TA, Fairley, JL, McLean, EC, Urquhart, DM, Alway, SE, Peiris, WL, Cicuttini, FM, Hussain, SM, Estee, MM, Romero, L, Ranger, TA, Fairley, JL, McLean, EC, and Urquhart, DM
- Abstract
BACKGROUND: Back and lower limb pain have a major impact on physical function and quality of life. While obesity is a modifiable risk factor for musculoskeletal pain, the role of adiposity is less clear. This systematic review aimed to examine the relationship between both adiposity and its distribution and back and lower limb pain. METHODS: A systematic search of electronic databases was conducted to identify studies that examined the association between anthropometric and/or direct measures of adiposity and site specific musculoskeletal pain. Risk of bias was assessed and a best evidence synthesis was performed. RESULTS: A total of 56 studies were identified which examined 4 pain regions, including the lower back (36 studies), hip (two studies), knee (13 studies) and foot (eight studies). 31(55%) studies were assessed as having low to moderate risk of bias. 17(30%) studies were cohort in design. The best evidence synthesis provided evidence of a relationship between central adiposity and low back and knee pain, but not hip or foot pain. There was also evidence of a longitudinal relationship between adiposity and the presence of back, knee and foot pain, as well as incident and increasing foot pain. CONCLUSIONS: This systematic review provides evidence of an association between both body fat and its central distribution and low back and knee pain, and a longitudinal relationship between adiposity and back, knee and foot pain. These results highlight the potential for targeting adiposity in the development of novel treatments at these sites.
- Published
- 2021
21. Obesity defined by body mass index and waist circumference and risk of total knee arthroplasty for osteoarthritis: A prospective cohort study
- Author
-
Farouk, O, Lim, YZ, Wang, Y, Cicuttini, FM, Giles, GG, Graves, S, Wluka, AE, Hussain, SM, Farouk, O, Lim, YZ, Wang, Y, Cicuttini, FM, Giles, GG, Graves, S, Wluka, AE, and Hussain, SM
- Abstract
OBJECTIVE: To examine the risk of total knee arthroplasty (TKA) due to osteoarthritis associated with obesity defined by body mass index (BMI) or waist circumference (WC) and whether there is discordance between these measures in assessing this risk. METHODS: 36,784 participants from the Melbourne Collaborative Cohort Study with BMI and WC measured at 1990-1994 were included. Obesity was defined by BMI (≥30 kg/m2) or WC (men ≥102cm, women ≥88cm). The incidence of TKA between January 2001 and December 2018 was determined by linking participant records to the National Joint Replacement Registry. RESULTS: Over 15.4±4.8 years, 2,683 participants underwent TKA. There were 20.4% participants with BMI-defined obesity, 20.8% with WC-defined obesity, and 73.6% without obesity defined by either BMI or WC. Obesity was classified as non-obese (misclassified obesity) in 11.7% of participants if BMI or WC alone was used to define obesity. BMI-defined obesity (HR 2.69, 95%CI 2.48-2.92), WC-defined obesity (HR 2.28, 95%CI 2.10-2.48), and obesity defined by either BMI or WC (HR 2.53, 95%CI 2.33-2.74) were associated with an increased risk of TKA. Compared with those without obesity, participants with misclassified obesity had an increased risk of TKA (HR 2.06, 95%CI 1.85-2.30). 22.7% of TKA in the community can be attributable to BMI-defined obesity, and a further 3.3% of TKA can be identified if WC was also used to define obesity. CONCLUSIONS: Both BMI and WC should be used to identify obese individuals who are at risk of TKA for osteoarthritis and should be targeted for prevention and treatment.
- Published
- 2021
22. Association between circulating 25-hydroxyvitamin D concentrations and hip replacement for osteoarthritis: a prospective cohort study
- Author
-
Hussain, SM, Wang, Y, Heath, AK, Giles, GG, English, DR, Eyles, DW, Williamson, EJ, Graves, SE, Wluka, AE, Cicuttini, FM, Hussain, SM, Wang, Y, Heath, AK, Giles, GG, English, DR, Eyles, DW, Williamson, EJ, Graves, SE, Wluka, AE, and Cicuttini, FM
- Abstract
BACKGROUND: To examine the association between circulating 25(OH)D concentrations and incidence of total hip replacement for osteoarthritis in a prospective cohort study. METHODS: This study examined a random sample of 2651 participants in the Melbourne Collaborative Cohort Study who had 25(OH)D concentrations measured from dried blood spots collected in 1990-1994. Participants who underwent total hip replacement for osteoarthritis between January 2001 and December 2018 were identified by linking the cohort records to the Australian Orthopaedic Association National Joint Replacement Registry. Cox proportional hazard regression was used to estimate hazard ratios (HR) and 95% confidence intervals (CI) of total hip replacement for osteoarthritis in relation to 25(OH)D concentrations, adjusted for confounders. RESULTS: Eighty-six men and eighty-seven women had a total hip replacement for osteoarthritis. Compared with men in the lowest (1st) quartile of 25(OH)D concentration, the HR for total hip replacement was 2.32 (95% CI 1.05, 5.13) for those in the 2nd quartile, 2.77 (95% CI 1.28, 6.00) for those in the 3rd quartile, and 1.73 (95% CI 0.75, 4.02) for those in the highest quartile of 25(OH)D concentrations (p for trend 0.02). There was little evidence of an association in women. CONCLUSIONS: Higher circulating 25(OH)D concentrations were associated with an increased risk of total hip replacement for osteoarthritis in men but not in women. Although the underlying mechanism warrants further investigation, our findings highlight the need to determine the optimal levels of circulating 25(OH)D to reduce the risk of hip osteoarthritis.
- Published
- 2021
23. Effect of Atorvastatin on Knee Cartilage Volume in Patients With Symptomatic Knee Osteoarthritis: Results From a Randomized Placebo-Controlled Trial
- Author
-
Wang, Y, Jones, G, Hill, C, Wluka, AE, Forbes, AB, Tonkin, A, Hussain, SM, Ding, C, Cicuttini, FM, Wang, Y, Jones, G, Hill, C, Wluka, AE, Forbes, AB, Tonkin, A, Hussain, SM, Ding, C, and Cicuttini, FM
- Abstract
OBJECTIVE: To determine whether atorvastatin slows tibial cartilage volume loss in patients with symptomatic knee osteoarthritis (OA) in a multicenter, randomized, double-blind, placebo-controlled trial. METHODS: Participants ages 40-70 years were randomized to receive oral atorvastatin (40 mg once daily) (n = 151) or matching placebo (n = 153). The primary end point was annual percentage change in tibial cartilage volume over 2 years, assessed using magnetic resonance imaging (MRI). The prespecified secondary end points were progression of cartilage defects and bone marrow lesions over 2 years, which were assessed using MRI and change in Western Ontario and McMaster Universities Osteoarthritis (WOMAC) Index pain, stiffness, and function scores. RESULTS: A total of 248 of 304 participants (81.6%) completed the trial (mean age 55.7 years; 55.6% women). The annual change in tibial cartilage volume differed minimally between the atorvastatin and placebo groups (mean change -1.66% versus -2.17%, between-group difference 0.50% [95% confidence interval (95% CI) -0.17%, 1.17%]). There were no significant differences in the progression of cartilage defects (odds ratio [OR] 0.86 [95% CI 0.52, 1.41]) or progression of bone marrow lesions (OR 1.00 [95% CI 0.62, 1.63]). Moreover, there were no significant differences in change in WOMAC pain, stiffness, or function scores over 2 years between the atorvastatin and placebo groups (mean change in pain score -36.0 versus -29.5, adjusted difference -2.7 [95% CI -27.1, 21.7]; mean change in stiffness score -14.2 versus -11.8, adjusted difference -0.2 [95% CI -12.2, 11.8]; mean change in function score -89.4 versus -87.5, adjusted difference 0.3 [95% CI -83.1, 83.6]). The incidence of adverse events (AEs) was similar between the atorvastatin and placebo groups (57 [37.7%] versus 52 [34.0%] experiencing AEs). CONCLUSION: Treatment with oral atorvastatin (40 mg once daily), compared to placebo, did not significantly reduce cartilage volu
- Published
- 2021
24. Patellar cartilage increase following ACL reconstruction with and without meniscal pathology: a two-year prospective MRI morphological study
- Author
-
Wang, X, Bennell, KL, Wang, Y, Fortin, K, Saxby, DJ, Killen, BA, Wrigley, T, Cicuttini, FM, Van Ginckel, A, Lloyd, DG, Feller, JA, Vertullo, CJ, Whitehead, T, Gallie, P, Bryant, AL, Wang, X, Bennell, KL, Wang, Y, Fortin, K, Saxby, DJ, Killen, BA, Wrigley, T, Cicuttini, FM, Van Ginckel, A, Lloyd, DG, Feller, JA, Vertullo, CJ, Whitehead, T, Gallie, P, and Bryant, AL
- Abstract
BACKGROUND: Anterior cruciate ligament reconstruction (ACLR) together with concomitant meniscal injury are risk factors for the development of tibiofemoral (TF) osteoarthritis (OA), but the potential effect on the patellofemoral (PF) joint is unclear. The aim of this study was to: (i) investigate change in patellar cartilage morphology in individuals 2.5 to 4.5 years after ACLR with or without concomitant meniscal pathology and in healthy controls, and (ii) examine the association between baseline patellar cartilage defects and patellar cartilage volume change. METHODS: Thirty two isolated ACLR participants, 25 ACLR participants with combined meniscal pathology and nine healthy controls underwent knee magnetic resonance imaging (MRI) with 2-year intervals (baseline = 2.5 years post-ACLR). Patellar cartilage volume and cartilage defects were assessed from MRI using validated methods. RESULTS: Both ACLR groups showed patellar cartilage volume increased over 2 years (p < 0.05), and isolated ACLR group had greater annual percentage cartilage volume increase compared with controls (mean difference 3.6, 95% confidence interval (CI) 1.0, 6.3%, p = 0.008) and combined ACLR group (mean difference 2.2, 95% CI 0.2, 4.2%, p = 0.028). Patellar cartilage defects regressed in the isolated ACLR group over 2 years (p = 0.02; Z = - 2.33; r = 0.3). Baseline patellar cartilage defect score was positively associated with annual percentage cartilage volume increase (Regression coefficient B = 0.014; 95% CI 0.001, 0.027; p = 0.03) in the pooled ACLR participants. CONCLUSIONS: Hypertrophic response was evident in the patellar cartilage of ACLR participants with and without meniscal pathology. Surprisingly, the increase in patellar cartilage volume was more pronounced in those with isolated ACLR. Although cartilage defects stabilised in the majority of ACLR participants, the severity of patellar cartilage defects at baseline influenced the magnitude of the cartilage hypertrophic response ov
- Published
- 2021
25. Evaluation of the Pain Impact Index for Community-Dwelling Older Adults Through the Application of Rasch Modelling
- Author
-
Gilmartin-Thomas, JF-M, Forbes, A, Liew, D, McNeil, JJ, Cicuttini, FM, Owen, AJ, Ernst, ME, Nelson, MR, Lockery, J, Ward, SA, Busija, L, Group, ASPREEI, Gilmartin-Thomas, JF-M, Forbes, A, Liew, D, McNeil, JJ, Cicuttini, FM, Owen, AJ, Ernst, ME, Nelson, MR, Lockery, J, Ward, SA, Busija, L, and Group, ASPREEI
- Abstract
OBJECTIVE: Evaluate the Pain Impact Index, a simple, brief, easy-to-use, and novel tool to assess the impact of chronic pain in community-dwelling older adults. METHODS: A Rasch modelling analysis was undertaken in Stata using a partial credit model suited to the Likert-type items that comprised the Index. The Index was evaluated for ordering of category thresholds, unidimensionality, overall fit to the Rasch model, measurement bias (Differential Item Functioning, DIF), targeting, and construct validity. RESULTS: The four-item Pain Impact Index was self-completed by 6454 community-dwelling Australians who were aged at least 70 years and experienced pain on most days. Two items showed evidence of threshold disordering, and this was resolved by collapsing response categories (from 5 to 3) for all items. The rescored Index conformed to the unidimensionality assumption and had satisfactory fit with the Rasch model (analyses conducted on a reduced sample size to mitigate the potential for overpowering: n = 377, P > 0.0125, power > 77%). When considering uniform DIF, the most frequent sources of measurement bias were age, knee pain, and upper back pain. When considering nonuniform DIF, the most frequent source of measurement bias was knee pain. The Index had good ability to differentiate between respondents with different levels of pain impact and had highest measurement precision for respondents located around the average level of pain impact in the study sample. Both convergent and discriminant validity of the Index were supported. CONCLUSION: The Pain Impact Index showed evidence of unidimensionality, was able to successfully differentiate between levels of pain impact, and had good evidence of construct validity.
- Published
- 2021
26. Association between clusters of back and joint pain with opioid use in middle-aged community-based women: a prospective cohort study
- Author
-
Hussain, SM, Wang, Y, Peeters, G, Wluka, AE, Mishra, GD, Teede, H, Urquhart, D, Brown, WJ, Cicuttini, FM, Hussain, SM, Wang, Y, Peeters, G, Wluka, AE, Mishra, GD, Teede, H, Urquhart, D, Brown, WJ, and Cicuttini, FM
- Abstract
BACKGROUND: To determine the relationship between clusters of back pain and joint pain and prescription opioid dispensing. METHODS: Of 11,221 middle-aged participants from the Australian Longitudinal Study of Women's Health, clusters of back pain and joint pain from 2001 to 2013 were identified using group-based trajectory modelling. Prescription opioid dispensing from 2003 to 2015 was identified by linking the cohort to Pharmaceutical Benefit Scheme dispensing data. Multinomial logistic regression was used to examine the association between back pain and joint pain clusters and dispensing of prescription opioids. The proportion of opioids dispensed in the population attributable to back and join pain was calculated. RESULTS: Over 12 years, 68.5 and 72.0% women reported frequent or persistent back pain and joint pain, respectively. There were three clusters ('none or infrequent', 'frequent' and 'persistent') for both back pain and joint pain. Those in the persistent back pain cluster had a 6.33 (95%CI 4.38-9.16) times increased risk of having > 50 opioid prescriptions and those in persistent joint pain cluster had a 6.19 (95%CI 4.18-9.16) times increased risk of having > 50 opioid prescriptions. Frequent and persistent back and joint pain clusters together explained 41.7% (95%CI 34.9-47.8%) of prescription opioid dispensing. Women in the frequent and persistent back pain and joint pain clusters were less educated and reported more depression and physical inactivity. CONCLUSION: Back pain and joint pain are major contributors to opioid prescription dispensing in community-based middle-aged women. Additional approaches to reduce opioid use, targeted at those with frequent and persistent back pain and joint pain, will be important in order to reduce the use of opioids and their consequent harm in this population.
- Published
- 2021
27. Physical activity particpation and cardiovascular fitness in people leaving with HIV. A one-year longitudinal study
- Author
-
Fillipas S, Cicuttini FM, Holland AE, and Cherry CL
- Subjects
Immunologic diseases. Allergy ,RC581-607 - Published
- 2012
- Full Text
- View/download PDF
28. Association between hip muscle cross-sectional area and hip pain and function in individuals with mild-to-moderate hip osteoarthritis: a cross-sectional study.
- Author
-
Peiris, WL, Cicuttini, FM, Constantinou, M, Yaqobi, A, Hussain, SM, Wluka, AE, Urquhart, D, Barrett, R, Kennedy, B, Wang, Y, Peiris, WL, Cicuttini, FM, Constantinou, M, Yaqobi, A, Hussain, SM, Wluka, AE, Urquhart, D, Barrett, R, Kennedy, B, and Wang, Y
- Abstract
BACKGROUND: To examine the associations between hip muscle cross-sectional area and hip pain and function in community-based individuals with mild-to-moderate hip osteoarthritis. METHODS: This study included 27 participants with mild-to-moderate hip osteoarthritis. Cross-sectional area of hip muscles, including psoas major, rectus femoris, gluteus maximus, gluteus medius and minimus, adductor longus and magnus, obturator internus, and obturator externus, were measured from magnetic resonance images. Hip pain and function were evaluated using the Hip Disability and Osteoarthritis Outcome Score (HOOS) categorised into 5 subscales: pain, symptoms, activity of daily living, sport and recreation function, and hip-related quality of life (for each subscale 0 representing extreme problems and 100 representing no problems). RESULTS: Mean age of the 27 participants was 63.2 (SD 7.6) years and 66.7% (n = 18) were female. After adjusting for age and gender, greater cross-sectional area of adductor longus and magnus was associated with a higher HOOS score in quality of life (regression coefficient 1.4, 95% confidence interval (CI) 0.2-2.7, p = 0.02), activity of daily living (regression coefficient 1.3, 95% CI 0.1-2.6, p = 0.04) and sport and recreation function (regression coefficient 1.6, 95% CI 0.1-3.0, p = 0.04). There was a trend towards an association between greater cross-sectional area of psoas major and a higher quality of life score (regression coefficient 3.6, 95% CI - 0.5 to 7.7, p = 0.08). The cross-sectional area of hip muscles was not significantly associated with HOOS pain or symptom score. CONCLUSION: Greater cross-sectional area of hip adductors was associated with better function and quality of life in individuals with mild-to-moderate hip osteoarthritis. Greater cross-sectional area of hip flexors might be associated with better quality of life. These findings, while need to be confirmed in longitudinal studies, suggest that targeting the hip adductor and fl
- Published
- 2020
29. Association between increased signal intensity at the proximal patellar tendon and patellofemoral geometry in community-based asymptomatic middle-aged adults: a cross-sectional study.
- Author
-
Little, RD, Smith, SE, Cicuttini, FM, Tanamas, SK, Wluka, AE, Hussain, SM, Urquhart, DM, Jones, G, Wang, Y, Little, RD, Smith, SE, Cicuttini, FM, Tanamas, SK, Wluka, AE, Hussain, SM, Urquhart, DM, Jones, G, and Wang, Y
- Abstract
BACKGROUND: Histological and epidemiological data suggest that increased signal intensity at the proximal patellar tendon on magnetic resonance imaging is a response to tendon loading. As patellofemoral geometry is a mediator of loading, we examined the association between patellofemoral geometry and the prevalence of increased signal intensity at the patellar tendon in community-based middle-aged adults. METHODS: Two hundred-one adults aged 25-60 years in a study of obesity and musculoskeletal health had the patellar tendon assessed from magnetic resonance imaging. Increased signal intensity at the proximal patellar tendon was defined as hyper-intense regions of characteristic pattern, size and distribution on both T1- and T2-weighted sequences. Indices of patellofemoral geometry, including Insall-Salvati ratio, patellofemoral congruence angle, sulcus angle, and lateral condyle-patella angle, were measured from magnetic resonance imaging using validated methods. Binary logistic regression was used to examine the association between patellofemoral geometrical indices and the prevalence of increased signal intensity at the patellar tendon. RESULTS: The prevalence of increased signal intensity at the patellar tendon was 37.3%. A greater Insall-Salvati ratio (odds ratio 0.80, 95% confidence interval 0.66-0.97 per 0.1 change in the ratio, p = 0.02), indicative of a higher-riding patella, and a larger patellofemoral congruence angle (odds ratio 0.91, 95% confidence interval 0.85-0.98 per 5 degree change in the angle, p = 0.01), indicating a more laterally placed patella, were associated with reduced odds of increased signal intensity at the patellar tendon. Sulcus angle and lateral condyle-patella angle were not significantly associated with the odds of increased signal intensity at the patellar tendon. CONCLUSIONS: In community-based asymptomatic middle-aged adults, increased signal intensity at the patellar tendon was common and associated with Insall-Salvati ratio and
- Published
- 2020
30. Rates, costs and determinants of lumbar spine imaging in population-based women born in 1973-1978: Data from the Australian Longitudinal Study on Women's Health.
- Author
-
Bowles, EJA, Wang, Y, Hussain, SM, Wluka, AE, Lim, YZ, Urquhart, DM, Mishra, GD, Teede, H, Doust, J, Brown, WJ, Cicuttini, FM, Bowles, EJA, Wang, Y, Hussain, SM, Wluka, AE, Lim, YZ, Urquhart, DM, Mishra, GD, Teede, H, Doust, J, Brown, WJ, and Cicuttini, FM
- Abstract
OBJECTIVE: There are concerns that lumbar spine imaging represents low value care. Our aim was to examine the use of lumbar spine imaging [radiography, computed tomography (CT), magnetic resonance imaging (MRI)] over 20 years, and costs and person-level characteristics of imaging in a large cohort of Australian women. METHODS: The Australian Longitudinal Study on Women's Health (ALSWH) is a longitudinal population-based survey of women randomly selected from national health insurance scheme (Medicare) database. This study examined 13458 women born in 1973-1978 who consented to link their ALSWH and Medical Benefits Scheme records. Self-reported data on demographics, body mass index, depression, physical and mental health, and back pain were collected in each survey performed in 1996, 2000, 2003, 2006, 2009, 2012, and 2015. Data on lumbar spine imaging from 1996 to 2015 were obtained from the Medical Benefits Scheme database. RESULTS: 38.9% of women underwent some form of lumbar spine imaging over 20 years. While radiography increased from 1996 to 2011 and decreased thereafter, CT and MRI continued to increase from 1996 to 2015. In women with self-reported back pain, depression and poorer physical health were associated with imaging, with no significant differences in types of imaging. Based on imaging rates in ALSWH, the estimated costs for Australian women aged 30-39 years were AU$51,735,649 over 2011-2015. CONCLUSIONS: Lumbar spine imaging was common in population-based Australian women, with rates increasing over 20 years. Depression and poor physical health were associated with lumbar spine imaging. Raising awareness of this in clinicians is likely to result in significant cost savings if clinical guidelines are followed, with the potential of freeing resources for high value care and health outcomes.
- Published
- 2020
31. Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study.
- Author
-
James, SL, Castle, CD, Dingels, ZV, Fox, JT, Hamilton, EB, Liu, Z, Roberts, NLS, Sylte, DO, Bertolacci, GJ, Cunningham, M, Henry, NJ, Catalá-López, F, Cerin, E, Chandan, JS, Chapman, JR, Chattu, VK, Chattu, SK, Chatziralli, I, Chaudhary, N, Cho, DY, Choi, J-YJ, LeGrand, KE, Kabir Chowdhury, MA, Christopher, DJ, Chu, D-T, Cicuttini, FM, Coelho, JM, Costa, VM, Dahlawi, SMA, Daryani, A, Dávila-Cervantes, CA, Leo, DD, Abdelalim, A, Demeke, FM, Demoz, GT, Demsie, DG, Deribe, K, Desai, R, Nasab, MD, Silva, DDD, Dibaji Forooshani, ZS, Do, HT, Doyle, KE, Abdollahpour, I, Driscoll, TR, Dubljanin, E, Adema, BD, Eagan, AW, Elemineh, DA, El-Jaafary, SI, El-Khatib, Z, Ellingsen, CL, Zaki, MES, Eskandarieh, S, Abdulkader, RS, Eyawo, O, Faris, PS, Faro, A, Farzadfar, F, Fereshtehnejad, S-M, Fernandes, E, Ferrara, P, Fischer, F, Folayan, MO, Fomenkov, AA, Abedi, A, Foroutan, M, Francis, JM, Franklin, RC, Fukumoto, T, Geberemariyam, BS, Gebremariam, H, Gebremedhin, KB, Gebremeskel, LG, Gebremeskel, GG, Gebremichael, B, Abegaz, KH, Gedefaw, GA, Geta, B, Getenet, AB, Ghafourifard, M, Ghamari, F, Gheshlagh, RG, Gholamian, A, Gilani, SA, Gill, TK, Goudarzian, AH, Abosetugn, AE, Goulart, AC, Grada, A, Grivna, M, Guimarães, RA, Guo, Y, Gupta, G, Haagsma, JA, Hall, BJ, Hamadeh, RR, Hamidi, S, Abushouk, AI, Handiso, DW, Haro, JM, Hasanzadeh, A, Hassan, S, Hassanipour, S, Hassankhani, H, Hassen, HY, Havmoeller, R, Hendrie, D, Heydarpour, F, Adebayo, OM, Híjar, M, Ho, HC, Hoang, CL, Hole, MK, Holla, R, Hossain, N, Hosseinzadeh, M, Hostiuc, S, Hu, G, Ibitoye, SE, Adsuar, JC, Ilesanmi, OS, Inbaraj, LR, Naghibi Irvani, SS, Mofizul Islam, M, Shariful Islam, SM, Ivers, RQ, Jahani, MA, Jakovljevic, M, Jalilian, F, Jayaraman, S, Advani, SM, Jayatilleke, AU, Jha, RP, John-Akinola, YO, Jonas, JB, Jones, KM, Joseph, N, Joukar, F, Jozwiak, JJ, Jungari, SB, Jürisson, M, Agudelo-Botero, M, Kabir, A, Kahsay, A, Kalankesh, LR, Kalhor, R, Kamil, TA, Kanchan, T, Kapoor, N, Karami, M, Kasaeian, A, Kassaye, HG, Ahmad, T, Kavetskyy, T, Kayode, GA, Keiyoro, PN, Kelbore, AG, Khader, YS, Khafaie, MA, Khalid, N, Khalil, IA, Khalilov, R, Khan, M, Ahmed, MB, Khan, EA, Khan, J, Khanna, T, Khazaei, S, Khazaie, H, Khundkar, R, Kiirithio, DN, Kim, Y-E, Kim, YJ, Kim, D, Ahmed, R, Kisa, S, Kisa, A, Komaki, H, Kondlahalli, SKM, Koolivand, A, Korshunov, VA, Koyanagi, A, Kraemer, MUG, Krishan, K, Defo, BK, Eddine Aichour, MT, Bicer, BK, Kugbey, N, Kumar, N, Kumar, M, Kumar, V, Kumaresh, G, Lami, FH, Lansingh, VC, Lasrado, S, Alahdab, F, Latifi, A, Lauriola, P, Vecchia, CL, Leasher, JL, Huey Lee, SW, Li, S, Liu, X, Lopez, AD, Lotufo, PA, Lyons, RA, Alanezi, FM, Machado, DB, Madadin, M, Abd El Razek, MM, Mahotra, NB, Majdan, M, Majeed, A, Maled, V, Malta, DC, Manafi, N, Manafi, A, Alema, NM, Manda, A-L, Manjunatha, N, Mansour-Ghanaei, F, Mansournia, MA, Maravilla, JC, Mason-Jones, AJ, Masoumi, SZ, Massenburg, BB, Maulik, PK, Mehndiratta, MM, Alemu, BW, Melketsedik, ZA, Memiah, PTN, Mendoza, W, Menezes, RG, Mengesha, MM, Meretoja, TJ, Meretoja, A, Merie, HE, Mestrovic, T, Miazgowski, B, Alghnam, SA, Miazgowski, T, Miller, TR, Mini, GK, Mirica, A, Mirrakhimov, EM, Mirzaei-Alavijeh, M, Mithra, P, Moazen, B, Moghadaszadeh, M, Mohamadi, E, Ali, BA, Mohammad, Y, Darwesh, AM, Mohammadian-Hafshejani, A, Mohammadpourhodki, R, Mohammed, S, Mohammed, JA, Mohebi, F, Mohseni Bandpei, MA, Molokhia, M, Monasta, L, Ali, S, Moodley, Y, Moradi, M, Moradi, G, Moradi-Lakeh, M, Moradzadeh, R, Morawska, L, Velásquez, IM, Morrison, SD, Mossie, TB, Muluneh, AG, Alinia, C, Musa, KI, Mustafa, G, Naderi, M, Nagarajan, AJ, Naik, G, Naimzada, MD, Najafi, F, Nangia, V, Nascimento, BR, Naserbakht, M, Alipour, V, Nayak, V, Nazari, J, Ndwandwe, DE, Negoi, I, Ngunjiri, JW, Nguyen, TH, Nguyen, CT, Nguyen, DN, Thi Nguyen, HL, Nikbakhsh, R, Aljunid, SM, Anggraini Ningrum, DN, Nnaji, CA, Ofori-Asenso, R, Ogbo, FA, Oghenetega, OB, Oh, I-H, Olagunju, AT, Olagunju, TO, Bali, AO, Onwujekwe, OE, Almasi-Hashiani, A, Orpana, HM, Ota, E, Otstavnov, N, Otstavnov, SS, P A, M, Padubidri, JR, Pakhale, S, Pakshir, K, Panda-Jonas, S, Park, E-K, Almasri, NA, Patel, SK, Pathak, A, Pati, S, Paulos, K, Peden, AE, Filipino Pepito, VC, Pereira, J, Phillips, MR, Polibin, RV, Polinder, S, Altirkawi, K, Pourmalek, F, Pourshams, A, Poustchi, H, Prakash, S, Angga Pribadi, DR, Puri, P, Syed, ZQ, Rabiee, N, Rabiee, M, Radfar, A, Abdeldayem Amer, YS, Rafay, A, Rafiee, A, Rafiei, A, Rahim, F, Rahimi, S, Rahman, MA, Rajabpour-Sanati, A, Rajati, F, Rakovac, I, Rao, SJ, Andrei, CL, Rashedi, V, Rastogi, P, Rathi, P, Rawaf, S, Rawal, L, Rawassizadeh, R, Renjith, V, Resnikoff, S, Rezapour, A, Ribeiro, AI, Ansari-Moghaddam, A, Rickard, J, Rios González, CM, Roever, L, Ronfani, L, Roshandel, G, Saddik, B, Safarpour, H, Safdarian, M, Mohammad Sajadi, S, Salamati, P, T Antonio, CA, Rashad Salem, MR, Salem, H, Salz, I, Samy, AM, Sanabria, J, Riera, LS, Santric Milicevic, MM, Sarker, AR, Sarveazad, A, Sathian, B, Anvari, D, Sawhney, M, Sayyah, M, Schwebel, DC, Seedat, S, Senthilkumaran, S, Seyedmousavi, S, Sha, F, Shaahmadi, F, Shahabi, S, Shaikh, MA, Yaw Appiah, SC, Shams-Beyranvand, M, Sheikh, A, Shigematsu, M, Shin, JI, Shiri, R, Siabani, S, Sigfusdottir, ID, Singh, JA, Singh, PK, Sinha, DN, Arabloo, J, Soheili, A, Soriano, JB, Sorrie, MB, Soyiri, IN, Stokes, MA, Sufiyan, MB, Sykes, BL, Tabarés-Seisdedos, R, Tabb, KM, Taddele, BW, Arab-Zozani, M, Tefera, YM, Tehrani-Banihashemi, A, Tekulu, GH, Tesema Tesema, AK, Tesfay, BE, Thapar, R, Titova, MV, Tlaye, KG, Tohidinik, HR, Topor-Madry, R, Arefi, Z, Tran, KB, Tran, BX, Tripathy, JP, Tsai, AC, Tsatsakis, A, Car, LT, Ullah, I, Ullah, S, Unnikrishnan, B, Upadhyay, E, Aremu, O, Uthman, OA, Valdez, PR, Vasankari, TJ, Veisani, Y, Venketasubramanian, N, Violante, FS, Vlassov, V, Waheed, Y, Wang, Y-P, Wiangkham, T, Ariani, F, Wolde, HF, Woldeyes, DH, Wondmeneh, TG, Wondmieneh, AB, Wu, A-M, Wyper, GMA, Yadav, R, Yadollahpour, A, Yano, Y, Yaya, S, Arora, A, Yazdi-Feyzabadi, V, Ye, P, Yip, P, Yisma, E, Yonemoto, N, Yoon, S-J, Youm, Y, Younis, MZ, Yousefi, Z, Yu, C, Asaad, M, Yu, Y, Moghadam, TZ, Zaidi, Z, Zaman, SB, Zamani, M, Zandian, H, Zarei, F, Zhang, Z-J, Zhang, Y, Ziapour, A, Ayala Quintanilla, BP, Zodpey, S, Dandona, R, Dharmaratne, SD, Hay, SI, Mokdad, AH, Pigott, DM, Reiner, RC, Vos, T, Ayano, G, Ayanore, MA, Azarian, G, Badawi, A, Badiye, AD, Baig, AA, Bairwa, M, Bakhtiari, A, Balachandran, A, Banach, M, Banerjee, SK, Banik, PC, Banstola, A, Barker-Collo, SL, Bärnighausen, TW, Barzegar, A, Bayati, M, Bazargan-Hejazi, S, Bedi, N, Behzadifar, M, Belete, H, Bennett, DA, Bensenor, IM, Berhe, K, Bhagavathula, AS, Bhardwaj, P, Bhat, AG, Bhattacharyya, K, Bhutta, ZA, Bibi, S, Bijani, A, Boloor, A, Borges, G, Borschmann, R, Borzì, AM, Boufous, S, Braithwaite, D, Briko, NI, Brugha, T, Budhathoki, SS, Car, J, Cárdenas, R, Carvalho, F, Castaldelli-Maia, JM, Castañeda-Orjuela, CA, Castelpietra, G, James, SL, Castle, CD, Dingels, ZV, Fox, JT, Hamilton, EB, Liu, Z, Roberts, NLS, Sylte, DO, Bertolacci, GJ, Cunningham, M, Henry, NJ, Catalá-López, F, Cerin, E, Chandan, JS, Chapman, JR, Chattu, VK, Chattu, SK, Chatziralli, I, Chaudhary, N, Cho, DY, Choi, J-YJ, LeGrand, KE, Kabir Chowdhury, MA, Christopher, DJ, Chu, D-T, Cicuttini, FM, Coelho, JM, Costa, VM, Dahlawi, SMA, Daryani, A, Dávila-Cervantes, CA, Leo, DD, Abdelalim, A, Demeke, FM, Demoz, GT, Demsie, DG, Deribe, K, Desai, R, Nasab, MD, Silva, DDD, Dibaji Forooshani, ZS, Do, HT, Doyle, KE, Abdollahpour, I, Driscoll, TR, Dubljanin, E, Adema, BD, Eagan, AW, Elemineh, DA, El-Jaafary, SI, El-Khatib, Z, Ellingsen, CL, Zaki, MES, Eskandarieh, S, Abdulkader, RS, Eyawo, O, Faris, PS, Faro, A, Farzadfar, F, Fereshtehnejad, S-M, Fernandes, E, Ferrara, P, Fischer, F, Folayan, MO, Fomenkov, AA, Abedi, A, Foroutan, M, Francis, JM, Franklin, RC, Fukumoto, T, Geberemariyam, BS, Gebremariam, H, Gebremedhin, KB, Gebremeskel, LG, Gebremeskel, GG, Gebremichael, B, Abegaz, KH, Gedefaw, GA, Geta, B, Getenet, AB, Ghafourifard, M, Ghamari, F, Gheshlagh, RG, Gholamian, A, Gilani, SA, Gill, TK, Goudarzian, AH, Abosetugn, AE, Goulart, AC, Grada, A, Grivna, M, Guimarães, RA, Guo, Y, Gupta, G, Haagsma, JA, Hall, BJ, Hamadeh, RR, Hamidi, S, Abushouk, AI, Handiso, DW, Haro, JM, Hasanzadeh, A, Hassan, S, Hassanipour, S, Hassankhani, H, Hassen, HY, Havmoeller, R, Hendrie, D, Heydarpour, F, Adebayo, OM, Híjar, M, Ho, HC, Hoang, CL, Hole, MK, Holla, R, Hossain, N, Hosseinzadeh, M, Hostiuc, S, Hu, G, Ibitoye, SE, Adsuar, JC, Ilesanmi, OS, Inbaraj, LR, Naghibi Irvani, SS, Mofizul Islam, M, Shariful Islam, SM, Ivers, RQ, Jahani, MA, Jakovljevic, M, Jalilian, F, Jayaraman, S, Advani, SM, Jayatilleke, AU, Jha, RP, John-Akinola, YO, Jonas, JB, Jones, KM, Joseph, N, Joukar, F, Jozwiak, JJ, Jungari, SB, Jürisson, M, Agudelo-Botero, M, Kabir, A, Kahsay, A, Kalankesh, LR, Kalhor, R, Kamil, TA, Kanchan, T, Kapoor, N, Karami, M, Kasaeian, A, Kassaye, HG, Ahmad, T, Kavetskyy, T, Kayode, GA, Keiyoro, PN, Kelbore, AG, Khader, YS, Khafaie, MA, Khalid, N, Khalil, IA, Khalilov, R, Khan, M, Ahmed, MB, Khan, EA, Khan, J, Khanna, T, Khazaei, S, Khazaie, H, Khundkar, R, Kiirithio, DN, Kim, Y-E, Kim, YJ, Kim, D, Ahmed, R, Kisa, S, Kisa, A, Komaki, H, Kondlahalli, SKM, Koolivand, A, Korshunov, VA, Koyanagi, A, Kraemer, MUG, Krishan, K, Defo, BK, Eddine Aichour, MT, Bicer, BK, Kugbey, N, Kumar, N, Kumar, M, Kumar, V, Kumaresh, G, Lami, FH, Lansingh, VC, Lasrado, S, Alahdab, F, Latifi, A, Lauriola, P, Vecchia, CL, Leasher, JL, Huey Lee, SW, Li, S, Liu, X, Lopez, AD, Lotufo, PA, Lyons, RA, Alanezi, FM, Machado, DB, Madadin, M, Abd El Razek, MM, Mahotra, NB, Majdan, M, Majeed, A, Maled, V, Malta, DC, Manafi, N, Manafi, A, Alema, NM, Manda, A-L, Manjunatha, N, Mansour-Ghanaei, F, Mansournia, MA, Maravilla, JC, Mason-Jones, AJ, Masoumi, SZ, Massenburg, BB, Maulik, PK, Mehndiratta, MM, Alemu, BW, Melketsedik, ZA, Memiah, PTN, Mendoza, W, Menezes, RG, Mengesha, MM, Meretoja, TJ, Meretoja, A, Merie, HE, Mestrovic, T, Miazgowski, B, Alghnam, SA, Miazgowski, T, Miller, TR, Mini, GK, Mirica, A, Mirrakhimov, EM, Mirzaei-Alavijeh, M, Mithra, P, Moazen, B, Moghadaszadeh, M, Mohamadi, E, Ali, BA, Mohammad, Y, Darwesh, AM, Mohammadian-Hafshejani, A, Mohammadpourhodki, R, Mohammed, S, Mohammed, JA, Mohebi, F, Mohseni Bandpei, MA, Molokhia, M, Monasta, L, Ali, S, Moodley, Y, Moradi, M, Moradi, G, Moradi-Lakeh, M, Moradzadeh, R, Morawska, L, Velásquez, IM, Morrison, SD, Mossie, TB, Muluneh, AG, Alinia, C, Musa, KI, Mustafa, G, Naderi, M, Nagarajan, AJ, Naik, G, Naimzada, MD, Najafi, F, Nangia, V, Nascimento, BR, Naserbakht, M, Alipour, V, Nayak, V, Nazari, J, Ndwandwe, DE, Negoi, I, Ngunjiri, JW, Nguyen, TH, Nguyen, CT, Nguyen, DN, Thi Nguyen, HL, Nikbakhsh, R, Aljunid, SM, Anggraini Ningrum, DN, Nnaji, CA, Ofori-Asenso, R, Ogbo, FA, Oghenetega, OB, Oh, I-H, Olagunju, AT, Olagunju, TO, Bali, AO, Onwujekwe, OE, Almasi-Hashiani, A, Orpana, HM, Ota, E, Otstavnov, N, Otstavnov, SS, P A, M, Padubidri, JR, Pakhale, S, Pakshir, K, Panda-Jonas, S, Park, E-K, Almasri, NA, Patel, SK, Pathak, A, Pati, S, Paulos, K, Peden, AE, Filipino Pepito, VC, Pereira, J, Phillips, MR, Polibin, RV, Polinder, S, Altirkawi, K, Pourmalek, F, Pourshams, A, Poustchi, H, Prakash, S, Angga Pribadi, DR, Puri, P, Syed, ZQ, Rabiee, N, Rabiee, M, Radfar, A, Abdeldayem Amer, YS, Rafay, A, Rafiee, A, Rafiei, A, Rahim, F, Rahimi, S, Rahman, MA, Rajabpour-Sanati, A, Rajati, F, Rakovac, I, Rao, SJ, Andrei, CL, Rashedi, V, Rastogi, P, Rathi, P, Rawaf, S, Rawal, L, Rawassizadeh, R, Renjith, V, Resnikoff, S, Rezapour, A, Ribeiro, AI, Ansari-Moghaddam, A, Rickard, J, Rios González, CM, Roever, L, Ronfani, L, Roshandel, G, Saddik, B, Safarpour, H, Safdarian, M, Mohammad Sajadi, S, Salamati, P, T Antonio, CA, Rashad Salem, MR, Salem, H, Salz, I, Samy, AM, Sanabria, J, Riera, LS, Santric Milicevic, MM, Sarker, AR, Sarveazad, A, Sathian, B, Anvari, D, Sawhney, M, Sayyah, M, Schwebel, DC, Seedat, S, Senthilkumaran, S, Seyedmousavi, S, Sha, F, Shaahmadi, F, Shahabi, S, Shaikh, MA, Yaw Appiah, SC, Shams-Beyranvand, M, Sheikh, A, Shigematsu, M, Shin, JI, Shiri, R, Siabani, S, Sigfusdottir, ID, Singh, JA, Singh, PK, Sinha, DN, Arabloo, J, Soheili, A, Soriano, JB, Sorrie, MB, Soyiri, IN, Stokes, MA, Sufiyan, MB, Sykes, BL, Tabarés-Seisdedos, R, Tabb, KM, Taddele, BW, Arab-Zozani, M, Tefera, YM, Tehrani-Banihashemi, A, Tekulu, GH, Tesema Tesema, AK, Tesfay, BE, Thapar, R, Titova, MV, Tlaye, KG, Tohidinik, HR, Topor-Madry, R, Arefi, Z, Tran, KB, Tran, BX, Tripathy, JP, Tsai, AC, Tsatsakis, A, Car, LT, Ullah, I, Ullah, S, Unnikrishnan, B, Upadhyay, E, Aremu, O, Uthman, OA, Valdez, PR, Vasankari, TJ, Veisani, Y, Venketasubramanian, N, Violante, FS, Vlassov, V, Waheed, Y, Wang, Y-P, Wiangkham, T, Ariani, F, Wolde, HF, Woldeyes, DH, Wondmeneh, TG, Wondmieneh, AB, Wu, A-M, Wyper, GMA, Yadav, R, Yadollahpour, A, Yano, Y, Yaya, S, Arora, A, Yazdi-Feyzabadi, V, Ye, P, Yip, P, Yisma, E, Yonemoto, N, Yoon, S-J, Youm, Y, Younis, MZ, Yousefi, Z, Yu, C, Asaad, M, Yu, Y, Moghadam, TZ, Zaidi, Z, Zaman, SB, Zamani, M, Zandian, H, Zarei, F, Zhang, Z-J, Zhang, Y, Ziapour, A, Ayala Quintanilla, BP, Zodpey, S, Dandona, R, Dharmaratne, SD, Hay, SI, Mokdad, AH, Pigott, DM, Reiner, RC, Vos, T, Ayano, G, Ayanore, MA, Azarian, G, Badawi, A, Badiye, AD, Baig, AA, Bairwa, M, Bakhtiari, A, Balachandran, A, Banach, M, Banerjee, SK, Banik, PC, Banstola, A, Barker-Collo, SL, Bärnighausen, TW, Barzegar, A, Bayati, M, Bazargan-Hejazi, S, Bedi, N, Behzadifar, M, Belete, H, Bennett, DA, Bensenor, IM, Berhe, K, Bhagavathula, AS, Bhardwaj, P, Bhat, AG, Bhattacharyya, K, Bhutta, ZA, Bibi, S, Bijani, A, Boloor, A, Borges, G, Borschmann, R, Borzì, AM, Boufous, S, Braithwaite, D, Briko, NI, Brugha, T, Budhathoki, SS, Car, J, Cárdenas, R, Carvalho, F, Castaldelli-Maia, JM, Castañeda-Orjuela, CA, and Castelpietra, G
- Abstract
BACKGROUND: While there is a long history of measuring death and disability from injuries, modern research methods must account for the wide spectrum of disability that can occur in an injury, and must provide estimates with sufficient demographic, geographical and temporal detail to be useful for policy makers. The Global Burden of Disease (GBD) 2017 study used methods to provide highly detailed estimates of global injury burden that meet these criteria. METHODS: In this study, we report and discuss the methods used in GBD 2017 for injury morbidity and mortality burden estimation. In summary, these methods included estimating cause-specific mortality for every cause of injury, and then estimating incidence for every cause of injury. Non-fatal disability for each cause is then calculated based on the probabilities of suffering from different types of bodily injury experienced. RESULTS: GBD 2017 produced morbidity and mortality estimates for 38 causes of injury. Estimates were produced in terms of incidence, prevalence, years lived with disability, cause-specific mortality, years of life lost and disability-adjusted life-years for a 28-year period for 22 age groups, 195 countries and both sexes. CONCLUSIONS: GBD 2017 demonstrated a complex and sophisticated series of analytical steps using the largest known database of morbidity and mortality data on injuries. GBD 2017 results should be used to help inform injury prevention policy making and resource allocation. We also identify important avenues for improving injury burden estimation in the future.
- Published
- 2020
32. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017
- Author
-
Kyu, Hh, Abate, D, Abate, Kh, Abay, Sm, Abbafati, C, Abbasi, N, Abbastabar, H, Abd-Allah, F, Abdela, J, Abdelalim, A, Abdollahpour, I, Abdulkader, Rs, Abebe, M, Abebe, Z, Abil, Oz, Aboyans, V, Abrham, Ar, Abu-Raddad, Lj, Abu-Rmeileh, Nme, Accrombessi, Mmk, Acharya, D, Acharya, P, Ackerman, In, Adamu, Aa, Adebayo, Om, Adekanmbi, V, Ademi, Z, Adetokunboh, Oo, Adib, Mg, Adsuar, Jc, Afanvi, Ka, Afarideh, M, Afshin, A, Agarwal, G, Agesa, Km, Aggarwal, R, Aghayan, Sa, Agrawal, A, Ahmadi, A, Ahmadi, M, Ahmadieh, H, Ahmed, Mb, Ahmed, S, Aichour, An, Aichour, I, Aichour, Mte, Akinyemiju, T, Akseer, N, Al-Aly, Z, Al-Eyadhy, A, Al-Mekhlafi, Hm, Al-Raddadi, Rm, Alahdab, F, Alam, K, Alam, T, Alashi, A, Alavian, Sm, Alene, Ka, Alijanzadeh, M, Alizadeh-Navaei, R, Aljunid, Sm, Alkerwi, A, Alla, F, Allebeck, P, Alonso, J, Alsharif, U, Altirkawi, K, Alvis-Guzman, N, Aminde, Ln, Amini, E, Amiresmaili, M, Ammar, W, Amoako, Ya, Anber, Nh, Andrei, Cl, Androudi, S, Animut, Md, Anjomshoa, M, Ansha, Mg, Antonio, Cat, Anwari, P, Arabloo, J, Aremu, O, Ärnlöv, J, Arora, A, Arora, M, Artaman, A, Aryal, Kk, Asayesh, H, Ataro, Z, Ausloos, M, Avila-Burgos, L, Avokpaho, Efga, Awasthi, A, Ayala, Quintanilla, Ayer, R, Azzopardi, Ps, Babazadeh, A, Badali, H, Balakrishnan, K, Bali, Ag, Banach, M, Banoub, Jam, Barac, A, Barboza, Ma, Barker-Collo, Sl, Bärnighausen, Tw, Barquera, S, Barrero, Lh, Bazargan-Hejazi, S, Bedi, N, Beghi, E, Behzadifar, M, Bekele, Bb, Bekru, Et, Belachew, Ab, Belay, Ya, Bell, Ml, Bello, Ak, Bennett, Da, Bensenor, Im, Berhane, A, Bernabe, E, Bernstein, Rs, Beuran, M, Beyranvand, T, Bhala, N, Bhatt, S, Bhaumik, S, Bhutta, Za, Biadgo, B, Biehl, Mh, Bijani, A, Bikbov, B, Bilano, V, Bililign, N, Bin, Sayeed, Bisanzio, D, Bjørge, T, Bleyer, A, Bobasa, Em, Bou-Orm, Ir, Boufous, S, Bourne, R, Brady, Oj, Brant, Lc, Brayne, C, Brazinova, A, Breitborde, Njk, Brenner, H, Briant, Ps, Briko, An, Britton, G, Brugha, T, Buchbinder, R, Busse, R, Butt, Za, Cahuana-Hurtado, L, Campuzano, Rincon, Cano, J, Cárdenas, R, Carrero, Jj, Carter, A, Carvalho, F, Castañeda-Orjuela, Ca, Castillo, Rivas, J, Castro, F, Catalá-López, F, Cercy, Km, Cerin, E, Chaiah, Y, Chang, Jc, Charlson, Fj, Chattu, Vk, Chiang, Pp, Chitheer, A, Choi, Jj, Christensen, H, Christopher, Dj, Chung, Sc, Cicuttini, Fm, Cirillo, Massimo, Collado-Mateo, D, Cooper, C, Cortesi, Pa, Cortinovis, M, Cousin, E, Criqui, Mh, Cromwell, Ea, Cross, M, Crump, Ja, Daba, Ak, Dachew, Ba, Dadi, Af, Dandona, L, Dandona, R, Dargan, Pi, Daryani, A, Das, Gupta, Das, R, Neves, J, Dasa, Tt, Davitoiu, Dv, De, La, Hoz, Fp, Leo, De, D, De, Neve, Jw, Steur, De, H, Degefa, Mg, Degenhardt, L, Deiparine, S, Demoz, Gt, Denova-Gutiérrez, E, Deribe, K, Dervenis, N, Des, Jarlais, Dey, S, Dharmaratne, Sd, Dhimal, M, Dinberu, Mt, Dirac, Ma, Djalalinia, S, Doan, L, Dokova, K, Doku, Dt, Dorsey, Er, Doyle, Ke, Driscoll, Tr, Dubey, M, Dubljanin, E, Duken, Ee, Duncan, Bb, Duraes, Ar, Ebrahimi, H, Ebrahimpour, S, Echko, Mm, Edessa, D, Edvardsson, D, Effiong, A, Eggen, Ae, Ehrlich, Jr, Bcheraoui, El, C, El-Khatib, Z, Elyazar, Irf, Enayati, A, Endalifer, Ml, Endries, Ay, Er, B, Erskine, He, Eskandarieh, S, Esteghamati, A, Esteghamati, S, Fakhim, H, Faramarzi, M, Fareed, M, Farhadi, F, Farid, Ta, Farinha, Cses, Farioli, A, Faro, A, Farzadfar, F, Fazaeli, Aa, Feigin, Vl, Fentahun, N, Fereshtehnejad, Sm, Fernandes, E, Fernandes, Jc, Ferrari, Aj, Ferreira, Ml, Filip, I, Fischer, F, Fitzmaurice, C, Foigt, Na, Foreman, Kj, Frank, Td, Fukumoto, T, Fullman, N, Fürst, T, Furtado, Jm, Gakidou, E, Gall, S, Gallus, S, Ganji, M, Garcia-Basteiro, Al, Gardner, Wm, Gebre, Ak, Gebremedhin, At, Gebremichael, Tg, Gelano, Tf, Geleijnse, Jm, Genova-Maleras, R, Geramo, Ycd, Gething, Pw, Gezae, Ke, Ghadami, Mr, Ghadiri, K, Ghasemi-Kasman, M, Ghimire, M, Ghoshal, Ag, Gill, Ps, Gill, Tk, Ginawi, Ia, Giussani, G, Gnedovskaya, Ev, Goldberg, Em, Goli, S, Gómez-Dantés, H, Gona, Pn, Gopalani, Sv, Gorman, Tm, Goulart, Ac, Goulart, Bng, Grada, A, Grosso, G, Gugnani, Hc, Guillemin, F, Guo, Y, Gupta, Pc, Gupta, R, Gupta, T, Gutiérrez, Ra, Gyawali, B, Haagsma, Ja, Hachinski, V, Hafezi-Nejad, N, Haghparast, Bidgoli, Hagos, Tb, Hailegiyorgis, Tt, Haj-Mirzaian, A, Hamadeh, Rr, Hamidi, S, Handal, Aj, Hankey, Gj, Hao, Y, Harb, Hl, Harikrishnan, S, Haririan, H, Haro, Jm, Hassankhani, H, Hassen, Hy, Havmoeller, R, Hay, Rj, Hay, Si, Hedayatizadeh-Omran, A, Heibati, B, Hendrie, D, Henok, A, Heredia-Pi, I, Herteliu, C, Heydarpour, F, Heydarpour, P, Hibstu, Dt, Hoek, Hw, Hoffman, Hj, Hole, Mk, Homaie, Rad, E, Hoogar, P, Hosgood, Hd, Hosseini, Sm, Hosseinzadeh, M, Hostiuc, M, Hostiuc, S, Hotez, Pj, Hoy, Dg, Hsairi, M, Htet, As, Huang, Jj, Iburg, Km, Ikeda, Ct, Ilesanmi, Os, Irvani, Ssn, Irvine, Cms, Islam, Sms, Islami, F, Jacobsen, Kh, Jahangiry, L, Jahanmehr, N, Jain, Sk, Jakovljevic, M, James, Sl, Jayatilleke, Au, Jeemon, P, Jha, Rp, Jha, V, Js, Ji, Johnson, Co, Jonas, Jb, Jonnagaddala, J, Jorjoran, Shushtari, Z, Joshi, A, Jozwiak, Jj, Jungari, Sb, Jürisson, M, Kabir, Z, Kadel, R, Kahsay, A, Kalani, R, Kanchan, T, Kar, C, Karami, M, Karami, Matin, B, Karch, A, Karema, C, Karimi, N, Karimi, Sm, Kasaeian, A, Kassa, Dh, Kassa, Gm, Kassa, Td, Kassebaum, Nj, Katikireddi, Sv, Kaul, A, Kawakami, N, Kazemi, Z, Karyani, Ak, Keighobadi, Mm, Keiyoro, Pn, Kemmer, L, Kemp, Gr, Kengne, Ap, Keren, A, Khader, Ys, Khafaei, B, Khafaie, Ma, Khajavi, A, Khalid, N, Khalil, Ia, Khan, Ea, Khan, Ms, Khan, Ma, Khang, Yh, Khater, Mm, Khazaei, M, Khoja, At, Khosravi, A, Khosravi, Mh, Kiadaliri, Aa, Kidanemariam, Zt, Kiirithio, Dn, Kim, Ci, Kim, D, Kim, Ye, Kim, Yj, Kimokoti, Rw, Kinfu, Y, Kisa, A, Kissimova-Skarbek, K, Knudsen, Aks, Kocarnik, Jm, Kochhar, S, Kokubo, Y, Kolola, T, Kopec, Ja, Kosen, S, Kotsakis, Ga, Koul, Pa, Koyanagi, A, Krishan, K, Krishnaswami, S, Krohn, Kj, Kuate, Defo, Kucuk, B, Bicer, B, Kumar, Ga, Kumar, M, Kuzin, I, Lad, Dp, Lad, Sd, Lafranconi, A, Lalloo, R, Lallukka, T, Lami, Fh, Lang, Jj, Langan, Sm, Lansingh, Vc, Latifi, A, Lau, Km, Lazarus, Jv, Leasher, Jl, Ledesma, Jr, Lee, Ph, Leigh, J, Leili, M, Leshargie, Ct, Leung, J, Levi, M, Lewycka, S, Li, S, Li, Y, Liang, X, Liao, Y, Liben, Ml, Lim, Ll, Lim, Ss, Limenih, Ma, Linn, S, Liu, S, Looker, Kj, Lopez, Ad, Lorkowski, S, Lotufo, Pa, Lozano, R, Lucas, Tcd, Lunevicius, R, Lyons, Ra, Ma, S, Macarayan, Erk, Mackay, Mt, Maddison, Er, Madotto, F, Maghavani, Dp, Mai, Ht, Majdan, M, Majdzadeh, R, Majeed, A, Malekzadeh, R, Malta, Dc, Mamun, Aa, Manda, Al, Manguerra, H, Mansournia, Ma, Mantilla, Herrera, Mantovani, Lg, Maravilla, Jc, Marcenes, W, Marks, A, Martins-Melo, Fr, Martopullo, I, März, W, Marzan, Mb, Massano, J, Massenburg, Bb, Mathur, Mr, Maulik, Pk, Mazidi, M, Mcalinden, C, Mcgrath, Jj, Mckee, M, Mcmahon, Bj, Mehata, S, Mehrotra, R, Mehta, Km, Mehta, V, Mejia-Rodriguez, F, Mekonen, T, Melese, A, Melku, M, Memiah, Ptn, Memish, Za, Mendoza, W, Mengistu, G, Mensah, Ga, Mereta, St, Meretoja, A, Meretoja, Tj, Mestrovic, T, Miazgowski, B, Miazgowski, T, Millear, Ai, Miller, Tr, Mini, Gk, Mirarefin, M, Mirica, A, Mirrakhimov, Em, Misganaw, At, Mitchell, Pb, Mitiku, H, Moazen, B, Mohajer, B, Mohammad, Ka, Mohammadi, M, Mohammadifard, N, Mohammadnia-Afrouzi, M, Mohammed, Ma, Mohammed, S, Mohebi, F, Mokdad, Ah, Molokhia, M, Monasta, L, Montañez, Jc, Moosazadeh, M, Moradi, G, Moradi, M, Moradi-Lakeh, M, Moradinazar, M, Moraga, P, Morawska, L, Moreno, Velásquez, I, Morgado-Da-Costa, J, Morrison, Sd, Moschos, Mm, Mousavi, Sm, Mruts, Kb, Muche, Aa, Muchie, Kf, Mueller, Uo, Muhammed, Os, Mukhopadhyay, S, Muller, K, Mumford, Je, Murthy, Gvs, Musa, Ki, Mustafa, G, Nabhan, Af, Nagata, C, Nagel, G, Naghavi, M, Naheed, A, Nahvijou, A, Naik, G, Najafi, F, Nam, Hs, Nangia, V, Nansseu, Jr, Neamati, N, Negoi, I, Negoi, Ri, Neupane, S, Newton, Crj, Ngunjiri, Jw, Nguyen, Aq, Nguyen, G, Nguyen, Ht, Nguyen, Hlt, Nguyen, Lh, Nguyen, M, Nguyen, Nb, Nguyen, Sh, Nichols, E, Ningrum, Dna, Nixon, Mr, Nomura, S, Noroozi, M, Norrving, B, Noubiap, Jj, Nouri, Hr, Shiadeh, Mn, Nowroozi, Mr, Nsoesie, Eo, Nyasulu, Ps, Odell, Cm, Ofori-Asenso, R, Ogbo, Fa, Ih, Oh, Oladimeji, O, Olagunju, At, Olagunju, To, Olivares, Pr, Olsen, He, Olusanya, Bo, Olusanya, Jo, Ong, Kl, Ong, Sk, Oren, E, Ortiz, A, Ota, E, Otstavnov, Ss, Øverland, S, Owolabi, Mo, P, A, M, Pacella, R, Pakhare, Ap, Pakpour, Ah, Pana, A, Panda-Jonas, S, Park, Ek, Park, J, Parry, Cdh, Parsian, H, Pasdar, Y, Patel, S, Patil, St, Patle, A, Patton, Gc, Paturi, Vr, Paudel, D, Paulson, Kr, Pearce, N, Pereira, A, Pereira, Dm, Perico, N, Pesudovs, K, Petzold, M, Pham, Hq, Phillips, Mr, Pigott, Dm, Pillay, Jd, Piradov, Ma, Pirsaheb, M, Pishgar, F, Plana-Ripoll, O, Polinder, S, Popova, S, Postma, Mj, Pourshams, A, Poustchi, H, Prabhakaran, D, Prakash, S, Prakash, V, Prasad, N, Purcell, Ca, Qorbani, M, Quistberg, Da, Radfar, A, Rafay, A, Rafiei, A, Rahim, F, Rahimi, K, Rahimi, Z, Rahimi-Movaghar, A, Rahimi-Movaghar, V, Rahman, M, Rahman, Mhu, Rahman, Ma, Rahman, Su, Rai, Rk, Rajati, F, Ranjan, P, Rao, Pc, Rasella, D, Rawaf, Dl, Rawaf, S, Reddy, Ks, Reiner, Rc, Reitsma, Mb, Remuzzi, G, Renzaho, Amn, Resnikoff, S, Rezaei, S, Rezai, Ms, Ribeiro, Alp, Roberts, Nls, Robinson, Sr, Roever, L, Ronfani, L, Roshandel, G, Rostami, A, Roth, Ga, Rothenbacher, D, Rubagotti, E, Sachdev, Ps, Sadat, N, Sadeghi, E, Saeedi, Moghaddam, S, Safari, H, Safari, Y, Safari-Faramani, R, Safdarian, M, Safi, S, Safiri, S, Sagar, R, Sahebkar, A, Sahraian, Ma, Sajadi, Hs, Salam, N, Salama, Js, Salamati, P, Saleem, Z, Salimi, Y, Salimzadeh, H, Salomon, Ja, Salvi, Ss, Salz, I, Samy, Am, Sanabria, J, Sanchez-Niño, Md, Santomauro, Df, Santos, Is, Santos, Jv, Santric, Milicevic, Sao, Mm, Jose, Bp, Sardana, M, Sarker, Ar, Sarmiento-Suárez, R, Sarrafzadegan, N, Sartorius, B, Sarvi, S, Sathian, B, Satpathy, M, Sawant, Ar, Sawhney, M, Saxena, S, Schaeffner, E, Schmidt, Mi, Schneider, Ijc, Schutte, Ae, Schwebel, Dc, Schwendicke, F, Scott, Jg, Sekerija, M, Sepanlou, Sg, Serván-Mori, E, Seyedmousavi, S, Shabaninejad, H, Shafieesabet, A, Shahbazi, M, Shaheen, Aa, Shaikh, Ma, Shams-Beyranvand, M, Shamsi, M, Sharafi, H, Sharafi, K, Sharif, M, Sharif-Alhoseini, M, Sharma, J, Sharma, R, She, J, Sheikh, A, Shi, P, Shibuya, K, Shiferaw, Ms, Shigematsu, M, Shiri, R, Shirkoohi, R, Shiue, I, Shokoohinia, Y, Shokraneh, F, Shoman, H, Shrime, Mg, Si, S, Siabani, S, Sibai, Am, Siddiqi, Tj, Sigfusdottir, Id, Sigurvinsdottir, R, Silva, Das, Silva, Jp, Silveira, Dga, Singam, Nsv, Singh, Ja, Singh, Np, Singh, V, Sinha, Dn, Skiadaresi, E, Skirbekk, V, Sliwa, K, Smith, Dl, Smith, M, Soares, Filho, Sobaih, Bh, Sobhani, S, Soofi, M, Sorensen, Rjd, Soyiri, In, Sposato, La, Sreeramareddy, Ct, Srinivasan, V, Stanaway, Jd, Starodubov, Vi, Stein, Dj, Steiner, C, Steiner, Tj, Stokes, Ma, Stovner, Lj, Subart, Ml, Sudaryanto, A, Sufiyan, Mb, Sulo, G, Sunguya, Bf, Sur, Pj, Sykes, Bl, Sylaja, Pn, Sylte, Do, Szoeke, Cei, Tabarés-Seisdedos, R, Tabuchi, T, Tadakamadla, Sk, Tandon, N, Tassew, Sg, Tavakkoli, M, Taveira, N, Taylor, Hr, Tehrani-Banihashemi, A, Tekalign, Tg, Tekelemedhin, Sw, Tekle, Mg, Temsah, Mh, Temsah, O, Terkawi, As, Tessema, B, Teweldemedhin, M, Thankappan, Kr, Theis, A, Thirunavukkarasu, S, Thomas, N, Tilahun, B, Qg, To, Tonelli, M, Topor-Madry, R, Torre, Ae, Tortajada-Girbés, M, Touvier, M, Tovani-Palone, Mr, Towbin, Ja, Tran, Bx, Tran, Kb, Troeger, Ce, Tsadik, Ag, Tsoi, D, Tudor, Car, L, Tyrovolas, S, Ukwaja, Kn, Ullah, I, Undurraga, Ea, Updike, Rl, Usman, Ms, Uthman, Oa, Vaduganathan, M, Vaezi, A, Valdez, Pr, Varavikova, E, Varughese, S, Vasankari, Tj, Venketasubramanian, N, Villafaina, S, Violante, Fs, Vladimirov, Sk, Vlassov, V, Vollset, Se, Vos, T, Vosoughi, K, Vujcic, Is, Wagnew, Fs, Waheed, Y, Wang, Y, Wang, Yp, Weiderpass, E, Weintraub, Rg, Weiss, Dj, Weldegebreal, F, Weldegwergs, Kg, Werdecker, A, West, Te, Westerman, R, Whiteford, Ha, Widecka, J, Wijeratne, T, Williams, Hc, Wilner, Lb, Wilson, S, Winkler, As, Wiyeh, Ab, Wiysonge, Cs, Wolfe, Cda, Woolf, Ad, Wyper, Gma, Xavier, D, Xu, G, Yadgir, S, Yahyazadeh, Jabbari, Yamada, T, Yan, Ll, Yano, Y, Yaseri, M, Yasin, Yj, Yeshaneh, A, Yimer, Em, Yip, P, Yisma, E, Yonemoto, N, Yoon, Sj, Yotebieng, M, Younis, Mz, Yousefifard, M, Yu, C, Zadnik, V, Zaidi, Z, Zaman, Sb, Zamani, M, Zandian, H, Zar, Hj, Zenebe, Zm, Zhou, M, Zipkin, B, Zodpey, S, Zucker, I, Zuhlke, Lj, Murray, Cjl., GBD 2017 DALYs & HALE Coll, Kyu, Hh, Abate, D, Abate, Kh, Abay, Sm, Abbafati, C, Abbasi, N, Abbastabar, H, Abd-Allah, F, Abdela, J, Abdelalim, A, Abdollahpour, I, Abdulkader, R, Abebe, M, Abebe, Z, Abil, Oz, Aboyans, V, Abrham, Ar, Abu-Raddad, Lj, Abu-Rmeileh, Nme, Accrombessi, Mmk, Acharya, D, Acharya, P, Ackerman, In, Adamu, Aa, Adebayo, Om, Adekanmbi, V, Ademi, Z, Adetokunboh, Oo, Adib, Mg, Adsuar, Jc, Afanvi, Ka, Afarideh, M, Afshin, A, Agarwal, G, Agesa, Km, Aggarwal, R, Aghayan, Sa, Agrawal, A, Ahmadi, A, Ahmadi, M, Ahmadieh, H, Ahmed, Mb, Ahmed, S, Aichour, An, Aichour, I, Aichour, Mte, Akinyemiju, T, Akseer, N, Al-Aly, Z, Al-Eyadhy, A, Al-Mekhlafi, Hm, Al-Raddadi, Rm, Alahdab, F, Alam, K, Alam, T, Alashi, A, Alavian, Sm, Alene, Ka, Alijanzadeh, M, Alizadeh-Navaei, R, Aljunid, Sm, Alkerwi, A, Alla, F, Allebeck, P, Alonso, J, Alsharif, U, Altirkawi, K, Alvis-Guzman, N, Aminde, Ln, Amini, E, Amiresmaili, M, Ammar, W, Amoako, Ya, Anber, Nh, Andrei, Cl, Androudi, S, Animut, Md, Anjomshoa, M, Ansha, Mg, Antonio, Cat, Anwari, P, Arabloo, J, Aremu, O, Ärnlöv, J, Arora, A, Arora, M, Artaman, A, Aryal, Kk, Asayesh, H, Ataro, Z, Ausloos, M, Avila-Burgos, L, Avokpaho, Efga, Awasthi, A, Ayala Quintanilla, Bp, Ayer, R, Azzopardi, P, Babazadeh, A, Badali, H, Balakrishnan, K, Bali, Ag, Banach, M, Banoub, Jam, Barac, A, Barboza, Ma, Barker-Collo, Sl, Bärnighausen, Tw, Barquera, S, Barrero, Lh, Bazargan-Hejazi, S, Bedi, N, Beghi, E, Behzadifar, M, Bekele, Bb, Bekru, Et, Belachew, Ab, Belay, Ya, Bell, Ml, Bello, Ak, Bennett, Da, Bensenor, Im, Berhane, A, Bernabe, E, Bernstein, R, Beuran, M, Beyranvand, T, Bhala, N, Bhatt, S, Bhaumik, S, Bhutta, Za, Biadgo, B, Biehl, Mh, Bijani, A, Bikbov, B, Bilano, V, Bililign, N, Bin Sayeed, M, Bisanzio, D, Bjørge, T, Bleyer, A, Bobasa, Em, Bou-Orm, Ir, Boufous, S, Bourne, R, Brady, Oj, Brant, Lc, Brayne, C, Brazinova, A, Breitborde, Njk, Brenner, H, Briant, P, Briko, An, Britton, G, Brugha, T, Buchbinder, R, Busse, R, Butt, Za, Cahuana-Hurtado, L, Campuzano Rincon, Jc, Cano, J, Cárdenas, R, Carrero, Jj, Carter, A, Carvalho, F, Castañeda-Orjuela, Ca, Castillo Rivas, J, Castro, F, Catalá-López, F, Cercy, Km, Cerin, E, Chaiah, Y, Chang, Jc, Charlson, Fj, Chattu, Vk, Chiang, Pp, Chitheer, A, Choi, Jj, Christensen, H, Christopher, Dj, Chung, Sc, Cicuttini, Fm, Cirillo, M, Collado-Mateo, D, Cooper, C, Cortesi, Pa, Cortinovis, M, Cousin, E, Criqui, Mh, Cromwell, Ea, Cross, M, Crump, Ja, Daba, Ak, Dachew, Ba, Dadi, Af, Dandona, L, Dandona, R, Dargan, Pi, Daryani, A, Das Gupta, R, Das Neves, J, Dasa, Tt, Davitoiu, Dv, De La Hoz, Fp, De Leo, D, De Neve, Jw, De Steur, H, Degefa, Mg, Degenhardt, L, Deiparine, S, Demoz, Gt, Denova-Gutiérrez, E, Deribe, K, Dervenis, N, Des Jarlais, Dc, Dey, S, Dharmaratne, Sd, Dhimal, M, Dinberu, Mt, Dirac, Ma, Djalalinia, S, Doan, L, Dokova, K, Doku, Dt, Dorsey, Er, Doyle, Ke, Driscoll, Tr, Dubey, M, Dubljanin, E, Duken, Ee, Duncan, Bb, Duraes, Ar, Ebrahimi, H, Ebrahimpour, S, Echko, Mm, Edessa, D, Edvardsson, D, Effiong, A, Eggen, Ae, Ehrlich, Jr, El Bcheraoui, C, El-Khatib, Z, Elyazar, Irf, Enayati, A, Endalifer, Ml, Endries, Ay, Er, B, Erskine, He, Eskandarieh, S, Esteghamati, A, Esteghamati, S, Fakhim, H, Faramarzi, M, Fareed, M, Farhadi, F, Farid, Ta, Farinha, Cse, Farioli, A, Faro, A, Farzadfar, F, Fazaeli, Aa, Feigin, Vl, Fentahun, N, Fereshtehnejad, Sm, Fernandes, E, Fernandes, Jc, Ferrari, Aj, Ferreira, Ml, Filip, I, Fischer, F, Fitzmaurice, C, Foigt, Na, Foreman, Kj, Frank, Td, Fukumoto, T, Fullman, N, Fürst, T, Furtado, Jm, Gakidou, E, Gall, S, Gallus, S, Ganji, M, Garcia-Basteiro, Al, Gardner, Wm, Gebre, Ak, Gebremedhin, At, Gebremichael, Tg, Gelano, Tf, Geleijnse, Jm, Genova-Maleras, R, Geramo, Ycd, Gething, Pw, Gezae, Ke, Ghadami, Mr, Ghadiri, K, Ghasemi-Kasman, M, Ghimire, M, Ghoshal, Ag, Gill, P, Gill, Tk, Ginawi, Ia, Giussani, G, Gnedovskaya, Ev, Goldberg, Em, Goli, S, Gómez-Dantés, H, Gona, Pn, Gopalani, Sv, Gorman, Tm, Goulart, Ac, Goulart, Bng, Grada, A, Grosso, G, Gugnani, Hc, Guillemin, F, Guo, Y, Gupta, Pc, Gupta, R, Gupta, T, Gutiérrez, Ra, Gyawali, B, Haagsma, Ja, Hachinski, V, Hafezi-Nejad, N, Haghparast Bidgoli, H, Hagos, Tb, Hailegiyorgis, Tt, Haj-Mirzaian, A, Hamadeh, Rr, Hamidi, S, Handal, Aj, Hankey, Gj, Hao, Y, Harb, Hl, Harikrishnan, S, Haririan, H, Haro, Jm, Hassankhani, H, Hassen, Hy, Havmoeller, R, Hay, Rj, Hay, Si, Hedayatizadeh-Omran, A, Heibati, B, Hendrie, D, Henok, A, Heredia-Pi, I, Herteliu, C, Heydarpour, F, Heydarpour, P, Hibstu, Dt, Hoek, Hw, Hoffman, Hj, Hole, Mk, Homaie Rad, E, Hoogar, P, Hosgood, Hd, Hosseini, Sm, Hosseinzadeh, M, Hostiuc, M, Hostiuc, S, Hotez, Pj, Hoy, Dg, Hsairi, M, Htet, A, Huang, Jj, Iburg, Km, Ikeda, Ct, Ilesanmi, O, Irvani, Ssn, Irvine, Cm, Islam, Sm, Islami, F, Jacobsen, Kh, Jahangiry, L, Jahanmehr, N, Jain, Sk, Jakovljevic, M, James, Sl, Jayatilleke, Au, Jeemon, P, Jha, Rp, Jha, V, Ji, J, Johnson, Co, Jonas, Jb, Jonnagaddala, J, Jorjoran Shushtari, Z, Joshi, A, Jozwiak, Jj, Jungari, Sb, Jürisson, M, Kabir, Z, Kadel, R, Kahsay, A, Kalani, R, Kanchan, T, Kar, C, Karami, M, Karami Matin, B, Karch, A, Karema, C, Karimi, N, Karimi, Sm, Kasaeian, A, Kassa, Dh, Kassa, Gm, Kassa, Td, Kassebaum, Nj, Katikireddi, Sv, Kaul, A, Kawakami, N, Kazemi, Z, Karyani, Ak, Keighobadi, Mm, Keiyoro, Pn, Kemmer, L, Kemp, Gr, Kengne, Ap, Keren, A, Khader, Y, Khafaei, B, Khafaie, Ma, Khajavi, A, Khalid, N, Khalil, Ia, Khan, Ea, Khan, M, Khan, Ma, Khang, Yh, Khater, Mm, Khazaei, M, Khoja, At, Khosravi, A, Khosravi, Mh, Kiadaliri, Aa, Kidanemariam, Zt, Kiirithio, Dn, Kim, Ci, Kim, D, Kim, Ye, Kim, Yj, Kimokoti, Rw, Kinfu, Y, Kisa, A, Kissimova-Skarbek, K, Knudsen, Ak, Kocarnik, Jm, Kochhar, S, Kokubo, Y, Kolola, T, Kopec, Ja, Kosen, S, Kotsakis, Ga, Koul, Pa, Koyanagi, A, Krishan, K, Krishnaswami, S, Krohn, Kj, Kuate Defo, B, Kucuk Bicer, B, Kumar, Ga, Kumar, M, Kuzin, I, Lad, Dp, Lad, Sd, Lafranconi, A, Lalloo, R, Lallukka, T, Lami, Fh, Lang, Jj, Langan, Sm, Lansingh, Vc, Latifi, A, Lau, Km, Lazarus, Jv, Leasher, Jl, Ledesma, Jr, Lee, Ph, Leigh, J, Leili, M, Leshargie, Ct, Leung, J, Levi, M, Lewycka, S, Li, S, Li, Y, Liang, X, Liao, Y, Liben, Ml, Lim, Ll, Lim, S, Limenih, Ma, Linn, S, Liu, S, Looker, Kj, Lopez, Ad, Lorkowski, S, Lotufo, Pa, Lozano, R, Lucas, Tcd, Lunevicius, R, Lyons, Ra, Ma, S, Macarayan, Erk, Mackay, Mt, Maddison, Er, Madotto, F, Maghavani, Dp, Mai, Ht, Majdan, M, Majdzadeh, R, Majeed, A, Malekzadeh, R, Malta, Dc, Mamun, Aa, Manda, Al, Manguerra, H, Mansournia, Ma, Mantilla Herrera, Am, Mantovani, Lg, Maravilla, Jc, Marcenes, W, Marks, A, Martins-Melo, Fr, Martopullo, I, März, W, Marzan, Mb, Massano, J, Massenburg, Bb, Mathur, Mr, Maulik, Pk, Mazidi, M, Mcalinden, C, Mcgrath, Jj, Mckee, M, Mcmahon, Bj, Mehata, S, Mehrotra, R, Mehta, Km, Mehta, V, Mejia-Rodriguez, F, Mekonen, T, Melese, A, Melku, M, Memiah, Ptn, Memish, Za, Mendoza, W, Mengistu, G, Mensah, Ga, Mereta, St, Meretoja, A, Meretoja, Tj, Mestrovic, T, Miazgowski, B, Miazgowski, T, Millear, Ai, Miller, Tr, Mini, Gk, Mirarefin, M, Mirica, A, Mirrakhimov, Em, Misganaw, At, Mitchell, Pb, Mitiku, H, Moazen, B, Mohajer, B, Mohammad, Ka, Mohammadi, M, Mohammadifard, N, Mohammadnia-Afrouzi, M, Mohammed, Ma, Mohammed, S, Mohebi, F, Mokdad, Ah, Molokhia, M, Monasta, L, Montañez, Jc, Moosazadeh, M, Moradi, G, Moradi, M, Moradi-Lakeh, M, Moradinazar, M, Moraga, P, Morawska, L, Moreno Velásquez, I, Morgado-Da-Costa, J, Morrison, Sd, Moschos, Mm, Mousavi, Sm, Mruts, Kb, Muche, Aa, Muchie, Kf, Mueller, Uo, Muhammed, O, Mukhopadhyay, S, Muller, K, Mumford, Je, Murthy, Gv, Musa, Ki, Mustafa, G, Nabhan, Af, Nagata, C, Nagel, G, Naghavi, M, Naheed, A, Nahvijou, A, Naik, G, Najafi, F, Nam, H, Nangia, V, Nansseu, Jr, Neamati, N, Negoi, I, Negoi, Ri, Neupane, S, Newton, Crj, Ngunjiri, Jw, Nguyen, Aq, Nguyen, G, Nguyen, Ht, Nguyen, Hlt, Nguyen, Lh, Nguyen, M, Nguyen, Nb, Nguyen, Sh, Nichols, E, Ningrum, Dna, Nixon, Mr, Nomura, S, Noroozi, M, Norrving, B, Noubiap, Jj, Nouri, Hr, Shiadeh, Mn, Nowroozi, Mr, Nsoesie, Eo, Nyasulu, P, Odell, Cm, Ofori-Asenso, R, Ogbo, Fa, Oh, Ih, Oladimeji, O, Olagunju, At, Olagunju, To, Olivares, Pr, Olsen, He, Olusanya, Bo, Olusanya, Jo, Ong, Kl, Ong, Sk, Oren, E, Ortiz, A, Ota, E, Otstavnov, S, Øverland, S, Owolabi, Mo, P A, M, Pacella, R, Pakhare, Ap, Pakpour, Ah, Pana, A, Panda-Jonas, S, Park, Ek, Park, J, Parry, Cdh, Parsian, H, Pasdar, Y, Patel, S, Patil, St, Patle, A, Patton, Gc, Paturi, Vr, Paudel, D, Paulson, Kr, Pearce, N, Pereira, A, Pereira, Dm, Perico, N, Pesudovs, K, Petzold, M, Pham, Hq, Phillips, Mr, Pigott, Dm, Pillay, Jd, Piradov, Ma, Pirsaheb, M, Pishgar, F, Plana-Ripoll, O, Polinder, S, Popova, S, Postma, Mj, Pourshams, A, Poustchi, H, Prabhakaran, D, Prakash, S, Prakash, V, Prasad, N, Purcell, Ca, Qorbani, M, Quistberg, Da, Radfar, A, Rafay, A, Rafiei, A, Rahim, F, Rahimi, K, Rahimi, Z, Rahimi-Movaghar, A, Rahimi-Movaghar, V, Rahman, M, Rahman, Mhu, Rahman, Ma, Rahman, Su, Rai, Rk, Rajati, F, Ranjan, P, Rao, Pc, Rasella, D, Rawaf, Dl, Rawaf, S, Reddy, K, Reiner, Rc, Reitsma, Mb, Remuzzi, G, Renzaho, Amn, Resnikoff, S, Rezaei, S, Rezai, M, Ribeiro, Alp, Roberts, Nl, Robinson, Sr, Roever, L, Ronfani, L, Roshandel, G, Rostami, A, Roth, Ga, Rothenbacher, D, Rubagotti, E, Sachdev, P, Sadat, N, Sadeghi, E, Saeedi Moghaddam, S, Safari, H, Safari, Y, Safari-Faramani, R, Safdarian, M, Safi, S, Safiri, S, Sagar, R, Sahebkar, A, Sahraian, Ma, Sajadi, H, Salam, N, Salama, J, Salamati, P, Saleem, Z, Salimi, Y, Salimzadeh, H, Salomon, Ja, Salvi, S, Salz, I, Samy, Am, Sanabria, J, Sanchez-Niño, Md, Santomauro, Df, Santos, I, Santos, Jv, Santric Milicevic, Mm, Sao Jose, Bp, Sardana, M, Sarker, Ar, Sarmiento-Suárez, R, Sarrafzadegan, N, Sartorius, B, Sarvi, S, Sathian, B, Satpathy, M, Sawant, Ar, Sawhney, M, Saxena, S, Schaeffner, E, Schmidt, Mi, Schneider, Ijc, Schutte, Ae, Schwebel, Dc, Schwendicke, F, Scott, Jg, Sekerija, M, Sepanlou, Sg, Serván-Mori, E, Seyedmousavi, S, Shabaninejad, H, Shafieesabet, A, Shahbazi, M, Shaheen, Aa, Shaikh, Ma, Shams-Beyranvand, M, Shamsi, M, Sharafi, H, Sharafi, K, Sharif, M, Sharif-Alhoseini, M, Sharma, J, Sharma, R, She, J, Sheikh, A, Shi, P, Shibuya, K, Shiferaw, M, Shigematsu, M, Shiri, R, Shirkoohi, R, Shiue, I, Shokoohinia, Y, Shokraneh, F, Shoman, H, Shrime, Mg, Si, S, Siabani, S, Sibai, Am, Siddiqi, Tj, Sigfusdottir, Id, Sigurvinsdottir, R, Silva, Da, Silva, Jp, Silveira, Dga, Singam, Nsv, Singh, Ja, Singh, Np, Singh, V, Sinha, Dn, Skiadaresi, E, Skirbekk, V, Sliwa, K, Smith, Dl, Smith, M, Soares Filho, Am, Sobaih, Bh, Sobhani, S, Soofi, M, Sorensen, Rjd, Soyiri, In, Sposato, La, Sreeramareddy, Ct, Srinivasan, V, Stanaway, Jd, Starodubov, Vi, Stein, Dj, Steiner, C, Steiner, Tj, Stokes, Ma, Stovner, Lj, Subart, Ml, Sudaryanto, A, Sufiyan, Mb, Sulo, G, Sunguya, Bf, Sur, Pj, Sykes, Bl, Sylaja, Pn, Sylte, Do, Szoeke, Cei, Tabarés-Seisdedos, R, Tabuchi, T, Tadakamadla, Sk, Tandon, N, Tassew, Sg, Tavakkoli, M, Taveira, N, Taylor, Hr, Tehrani-Banihashemi, A, Tekalign, Tg, Tekelemedhin, Sw, Tekle, Mg, Temsah, Mh, Temsah, O, Terkawi, A, Tessema, B, Teweldemedhin, M, Thankappan, Kr, Theis, A, Thirunavukkarasu, S, Thomas, N, Tilahun, B, To, Qg, Tonelli, M, Topor-Madry, R, Torre, Ae, Tortajada-Girbés, M, Touvier, M, Tovani-Palone, Mr, Towbin, Ja, Tran, Bx, Tran, Kb, Troeger, Ce, Tsadik, Ag, Tsoi, D, Tudor Car, L, Tyrovolas, S, Ukwaja, Kn, Ullah, I, Undurraga, Ea, Updike, Rl, Usman, M, Uthman, Oa, Vaduganathan, M, Vaezi, A, Valdez, Pr, Varavikova, E, Varughese, S, Vasankari, Tj, Venketasubramanian, N, Villafaina, S, Violante, F, Vladimirov, Sk, Vlassov, V, Vollset, Se, Vos, T, Vosoughi, K, Vujcic, I, Wagnew, F, Waheed, Y, Wang, Y, Wang, Yp, Weiderpass, E, Weintraub, Rg, Weiss, Dj, Weldegebreal, F, Weldegwergs, Kg, Werdecker, A, West, Te, Westerman, R, Whiteford, Ha, Widecka, J, Wijeratne, T, Williams, Hc, Wilner, Lb, Wilson, S, Winkler, A, Wiyeh, Ab, Wiysonge, C, Wolfe, Cda, Woolf, Ad, Wyper, Gma, Xavier, D, Xu, G, Yadgir, S, Yahyazadeh Jabbari, Sh, Yamada, T, Yan, Ll, Yano, Y, Yaseri, M, Yasin, Yj, Yeshaneh, A, Yimer, Em, Yip, P, Yisma, E, Yonemoto, N, Yoon, Sj, Yotebieng, M, Younis, Mz, Yousefifard, M, Yu, C, Zadnik, V, Zaidi, Z, Zaman, Sb, Zamani, M, Zandian, H, Zar, Hj, Zenebe, Zm, Zhou, M, Zipkin, B, Zodpey, S, Zucker, I, Zuhlke, Lj, Murray, Cjl., Medical Research Council (MRC), Bill & Melinda Gates Foundation, Kyu, H, Abate, K, Abay, S, Abil, O, Abrham, A, Abu-Raddad, L, Abu-Rmeileh, N, Accrombessi, M, Ackerman, I, Adamu, A, Adebayo, O, Adetokunboh, O, Adib, M, Adsuar, J, Afanvi, K, Agesa, K, Aghayan, S, Ahmed, M, Aichour, A, Aichour, M, Al-Mekhlafi, H, Al-Raddadi, R, Alavian, S, Alene, K, Aljunid, S, Aminde, L, Amoako, Y, Anber, N, Andrei, C, Animut, M, Ansha, M, Antonio, C, Arnlov, J, Aryal, K, Avokpaho, E, Ayala Quintanilla, B, Bali, A, Banoub, J, Barboza, M, Barker-Collo, S, Barnighausen, T, Barrero, L, Bekele, B, Bekru, E, Belachew, A, Belay, Y, Bell, M, Bello, A, Bennett, D, Bensenor, I, Bhutta, Z, Biehl, M, Bjorge, T, Bobasa, E, Bou-Orm, I, Brady, O, Brant, L, Breitborde, N, Briko, A, Butt, Z, Campuzano Rincon, J, Cardenas, R, Carrero, J, Castaneda-Orjuela, C, Rivas, J, Catala-Lopez, F, Cercy, K, Chang, J, Charlson, F, Chattu, V, Chiang, P, Choi, J, Christopher, D, Chung, S, Cicuttini, F, Cortesi, P, Criqui, M, Cromwell, E, Crump, J, Daba, A, Dachew, B, Dadi, A, Dargan, P, Dasa, T, Davitoiu, D, De La Hoz, F, De Neve, J, Degefa, M, Demoz, G, Denova-Gutierrez, E, Des Jarlais, D, Dharmaratne, S, Dinberu, M, Dirac, M, Doku, D, Dorsey, E, Doyle, K, Driscoll, T, Duken, E, Duncan, B, Duraes, A, Echko, M, Eggen, A, Ehrlich, J, Elyazar, I, Endalifer, M, Endries, A, Erskine, H, Farid, T, Sa Farinha, C, Fazaeli, A, Feigin, V, Fereshtehnejad, S, Fernandes, J, Ferrari, A, Ferreira, M, Foigt, N, Foreman, K, Frank, T, Furst, T, Furtado, J, Garcia-Basteiro, A, Gardner, W, Gebre, A, Gebremedhin, A, Gebremichael, T, Gelano, T, Geleijnse, J, Geramo, Y, Gething, P, Gezae, K, Ghadami, M, Ghoshal, A, Gill, T, Ginawi, I, Gnedovskaya, E, Goldberg, E, Gomez-Dantes, H, Gona, P, Gopalani, S, Gorman, T, Goulart, A, Goulart, B, Gugnani, H, Gupta, P, Gutierrez, R, Haagsma, J, Bidgoli, H, Hagos, T, Hailegiyorgis, T, Hamadeh, R, Handal, A, Hankey, G, Harb, H, Haro, J, Hassen, H, Hay, R, Hay, S, Hibstu, D, Hoek, H, Hoffman, H, Hole, M, Rad, E, Hosgood, H, Hosseini, S, Hotez, P, Hoy, D, Huang, J, Iburg, K, Ikeda, C, Irvani, S, Irvine, C, Islam, S, Jacobsen, K, Jain, S, James, S, Jayatilleke, A, Jha, R, Johnson, C, Jonas, J, Shushtari, Z, Jozwiak, J, Jungari, S, Jurisson, M, Karimi, S, Kassa, D, Kassa, G, Kassa, T, Kassebaum, N, Katikireddi, S, Kazemi Karyani, A, Keighobadi, M, Keiyoro, P, Kemp, G, Kengne, A, Khafaie, M, Khalil, I, Khan, E, Khang, Y, Khater, M, Khoja, A, Khosravi, M, Kiadaliri, A, Kidanemariam, Z, Kiirithio, D, Kim, C, Kim, Y, Kimokoti, R, Knudsen, A, Kocarnik, J, Kopec, J, Kotsakis, G, Koul, P, Krohn, K, Defo, B, Bicer, B, Kumar, G, Lad, D, Lad, S, Lami, F, Lang, J, Langan, S, Lansingh, V, Lau, K, Lazarus, J, Leasher, J, Ledesma, J, Lee, P, Leshargie, C, Liben, M, Lim, L, Limenih, M, Looker, K, Lopez, A, Lotufo, P, Lucas, T, Lyons, R, Macarayan, E, Mackay, M, Maddison, E, Maghavani, D, Mai, H, Malta, D, Mamun, A, Manda, A, Mansournia, M, Mantilla Herrera, A, Mantovani, L, Maravilla, J, Martins-Melo, F, Marz, W, Marzan, M, Massenburg, B, Mathur, M, Maulik, P, Mcgrath, J, Mcmahon, B, Mehta, K, Memiah, P, Memish, Z, Mensah, G, Mereta, S, Meretoja, T, Millear, A, Miller, T, Mini, G, Mirrakhimov, E, Misganaw, A, Mitchell, P, Mohammad, K, Mohammed, M, Mokdad, A, Montanez, J, Velasquez, I, Morrison, S, Moschos, M, Mousavi, S, Mruts, K, Muche, A, Muchie, K, Mueller, U, Mumford, J, Murthy, G, Musa, K, Nabhan, A, Nansseu, J, Negoi, R, Newton, C, Ngunjiri, J, Nguyen, A, Nguyen, H, Nguyen, L, Nguyen, N, Nguyen, S, Ningrum, D, Nixon, M, Noubiap, J, Nouri, H, Shiadeh, M, Nowroozi, M, Nsoesie, E, Odell, C, Ogbo, F, Oh, I, Olagunju, A, Olagunju, T, Olivares, P, Olsen, H, Olusanya, B, Olusanya, J, Ong, K, Ong, S, Overland, S, Owolabi, M, Mahesh, P, Pakhare, A, Pakpour, A, Park, E, Parry, C, Patil, S, Patton, G, Paturi, V, Paulson, K, Pereira, D, Pham, H, Phillips, M, Pigott, D, Pillay, J, Piradov, M, Postma, M, Purcell, C, Quistberg, D, Ur Rahman, M, Rahman, S, Rai, R, Rao, P, Rawaf, D, Reiner, R, Reitsma, M, Renzaho, A, Ribeiro, A, Roberts, N, Robinson, S, Roth, G, Sahraian, M, Salomon, J, Samy, A, Sanchez-Nino, M, Santomauro, D, Santos, J, Santric Milicevic, M, Sao Jose, B, Sarker, A, Sarmiento-Suarez, R, Sawant, A, Schmidt, M, Schneider, I, Schutte, A, Schwebel, D, Scott, J, Sepanlou, S, Servan-Mori, E, Shaheen, A, Shaikh, M, Shrime, M, Sibai, A, Siddiqi, T, Sigfusdottir, I, Silva, D, Silva, J, Silveira, D, Singam, N, Singh, J, Singh, N, Sinha, D, Smith, D, Filho, A, Sobaih, B, Sorensen, R, Soyiri, I, Sposato, L, Sreeramareddy, C, Stanaway, J, Starodubov, V, Stein, D, Steiner, T, Stokes, M, Stovner, L, Subart, M, Sufiyan, M, Sunguya, B, Sur, P, Sykes, B, Sylaja, P, Sylte, D, Szoeke, C, Tabares-Seisdedos, R, Tadakamadla, S, Tassew, S, Taylor, H, Tekalign, T, Tekelemedhin, S, Tekle, M, Temsah, M, Thankappan, K, To, Q, Torre, A, Tortajada-Girbes, M, Tovani-Palone, M, Towbin, J, Tran, B, Tran, K, Troeger, C, Tsadik, A, Ukwaja, K, Undurraga, E, Updike, R, Uthman, O, Valdez, P, Vasankari, T, Vladimirov, S, Vollset, S, Weintraub, R, Weiss, D, Weldegwergs, K, West, T, Whiteford, H, Williams, H, Wilner, L, Wiyeh, A, Wolfe, C, Woolf, A, Wyper, G, Yahyazadeh Jabbari, S, Yan, L, Yasin, Y, Yimer, E, Yoon, S, Younis, M, Zaman, S, Zar, H, Zenebe, Z, Zuhlke, L, Murray, C, Halk Sağlığı, Kyu, Hmwe Hmwe, Abate, Degu, Abate, Kalkidan Hassen, Abay, Solomon M, Abbafati, Cristiana, Abbasi, Nooshin, Abbastabar, Hedayat, Abd-Allah, Foad, Abdela, Jemal, Abdelalim, Ahmed, Abdollahpour, Ibrahim, Abdulkader, Rizwan Suliankatchi, Abebe, Molla, Abebe, Zegeye, Abil, Olifan Zewdie, Aboyans, Victor, Abrham, Aklilu Roba, Abu-Raddad, Laith Jamal, Abu-Rmeileh, Niveen M E, Accrombessi, Manfred Mario Kokou, Acharya, Dilaram, Acharya, Pawan, Ackerman, Ilana N, Adamu, Abdu A, Adebayo, Oladimeji M, Adekanmbi, Victor, Ademi, Zanfina, Adetokunboh, Olatunji O, Adib, Mina G, Adsuar, Jose C, Afanvi, Kossivi Agbelenko, Afarideh, Mohsen, Afshin, Ashkan, Agarwal, Gina, Agesa, Kareha M, Aggarwal, Rakesh, Aghayan, Sargis Aghasi, Agrawal, Anurag, Ahmadi, Alireza, Ahmadi, Mehdi, Ahmadieh, Hamid, Ahmed, Muktar Beshir, Ahmed, Sayem, Aichour, Amani Nidhal, Aichour, Ibtihel, Aichour, Miloud Taki Eddine, Akinyemiju, Tomi, Akseer, Nadia, Al-Aly, Ziyad, Al-Eyadhy, Ayman, Al-Mekhlafi, Hesham M, Al-Raddadi, Rajaa M, Alahdab, Fare, Alam, Khurshid, Alam, Tahiya, Alashi, Alaa, Alavian, Seyed Moayed, Alene, Kefyalew Addi, Alijanzadeh, Mehran, Alizadeh-Navaei, Reza, Aljunid, Syed Mohamed, Alkerwi, Ala'a, Alla, Françoi, Allebeck, Peter, Alonso, Jordi, Alsharif, Ubai, Altirkawi, Khalid, Alvis-Guzman, Nelson, Aminde, Leopold N, Amini, Erfan, Amiresmaili, Mohammadreza, Ammar, Walid, Amoako, Yaw Ampem, Anber, Nahla Hamed, Andrei, Catalina Liliana, Androudi, Sofia, Animut, Megbaru Debalkie, Anjomshoa, Mina, Ansha, Mustafa Geleto, Antonio, Carl Abelardo T, Anwari, Palwasha, Arabloo, Jalal, Aremu, Olatunde, Ärnlöv, Johan, Arora, Amit, Arora, Megha, Artaman, Al, Aryal, Krishna K, Asayesh, Hamid, Ataro, Zerihun, Ausloos, Marcel, Avila-Burgos, Leticia, Avokpaho, Euripide F G A, Awasthi, Ashish, Ayala Quintanilla, Beatriz Paulina, Ayer, Rakesh, Azzopardi, Peter S, Babazadeh, Arefeh, Badali, Hamid, Balakrishnan, Kalpana, Bali, Ayele Geleto, Banach, Maciej, Banoub, Joseph Adel Mattar, Barac, Aleksandra, Barboza, Miguel A, Barker-Collo, Suzanne Lyn, Bärnighausen, Till Winfried, Barquera, Simon, Barrero, Lope H, Bazargan-Hejazi, Shahrzad, Bedi, Neeraj, Beghi, Ettore, Behzadifar, Masoud, Behzadifar, Meysam, Bekele, Bayu Begashaw, Bekru, Eyasu Tamru, Belachew, Abate Bekele, Belay, Yihalem Abebe, Bell, Michelle L, Bello, Aminu K, Bennett, Derrick A, Bensenor, Isabela M, Berhane, Adugnaw, Bernabe, Eduardo, Bernstein, Robert S, Beuran, Mircea, Beyranvand, Tina, Bhala, Neeraj, Bhatt, Samir, Bhaumik, Soumyadeep, Bhutta, Zulfiqar A, Biadgo, Belete, Biehl, Molly H, Bijani, Ali, Bikbov, Bori, Bilano, Ver, Bililign, Nigu, Bin Sayeed, Muhammad Shahdaat, Bisanzio, Donal, Bjørge, Tone, Bleyer, Archie, Bobasa, Eshetu Mulisa, Bou-Orm, Ibrahim R, Boufous, Soufiane, Bourne, Rupert, Brady, Oliver J, Brant, Luisa C, Brayne, Carol, Brazinova, Alexandra, Breitborde, Nicholas J K, Brenner, Hermann, Briant, Paul Svitil, Briko, Andrey Nikolaevich, Britton, Gabrielle, Brugha, Traolach, Buchbinder, Rachelle, Busse, Reinhard, Butt, Zahid A, Cahuana-Hurtado, Lucero, Campuzano Rincon, Julio Cesar, Cano, Jorge, Cárdenas, Rosario, Carrero, Juan J, Carter, Austin, Carvalho, Félix, Castañeda-Orjuela, Carlos A, Castillo Rivas, Jacqueline, Castro, Franz, Catalá-López, Ferrán, Cercy, Kelly M, Cerin, Ester, Chaiah, Yazan, Chang, Jung-Chen, Charlson, Fiona J, Chattu, Vijay Kumar, Chiang, Peggy Pei-Chia, Chitheer, Abdulaal, Choi, Jee-Young J, Christensen, Hanne, Christopher, Devasahayam J, Chung, Sheng-Chia, Cicuttini, Flavia M, Cirillo, Massimo, Collado-Mateo, Daniel, Cooper, Cyru, Cortesi, Paolo Angelo, Cortinovis, Monica, Cousin, Ewerton, Criqui, Michael H, Cromwell, Elizabeth A, Cross, Marita, Crump, John A, Daba, Alemneh Kabeta, Dachew, Berihun Assefa, Dadi, Abel Fekadu, Dandona, Lalit, Dandona, Rakhi, Dargan, Paul I, Daryani, Ahmad, Das Gupta, Rajat, Das Neves, José, Dasa, Tamirat Tesfaye, Davitoiu, Dragos Virgil, De La Hoz, Fernando Pio, De Leo, Diego, De Neve, Jan-Walter, De Steur, Han, Degefa, Meaza Girma, Degenhardt, Louisa, Deiparine, Selina, Demoz, Gebre Teklemariam, Denova-Gutiérrez, Edgar, Deribe, Kebede, Dervenis, Nikolao, Des Jarlais, Don C, Dey, Subhojit, Dharmaratne, Samath D, Dhimal, Meghnath, Dinberu, Mesfin Tadese, Dirac, M Ashworth, Djalalinia, Shirin, Doan, Linh, Dokova, Klara, Doku, David Teye, Dorsey, E Ray, Doyle, Kerrie E, Driscoll, Tim Robert, Dubey, Manisha, Dubljanin, Eleonora, Duken, Eyasu Ejeta, Duncan, Bruce B, Duraes, Andre R, Ebrahimi, Hedyeh, Ebrahimpour, Soheil, Echko, Michelle M, Edessa, Dumessa, Edvardsson, David, Effiong, Andem, Eggen, Anne Elise, Ehrlich, Joshua R, El Bcheraoui, Charbel, El-Khatib, Ziad, Elyazar, Iqbal R F, Enayati, Ahmadali, Endalifer, Melese Linger, Endries, Aman Yesuf, Er, Benjamin, Erskine, Holly E, Eskandarieh, Sharareh, Esteghamati, Alireza, Esteghamati, Sadaf, Fakhim, Hamed, Faramarzi, Mahbobeh, Fareed, Mohammad, Farhadi, Farzaneh, Farid, Talha A, Farinha, Carla Sofia E sá, Farioli, Andrea, Faro, Andre, Farzadfar, Farshad, Fazaeli, Ali Akbar, Feigin, Valery L, Fentahun, Netsanet, Fereshtehnejad, Seyed-Mohammad, Fernandes, Eduarda, Fernandes, Joao C, Ferrari, Alize J, Ferreira, Manuela L, Filip, Irina, Fischer, Florian, Fitzmaurice, Christina, Foigt, Nataliya A, Foreman, Kyle J, Frank, Tahvi D, Fukumoto, Takeshi, Fullman, Nancy, Fürst, Thoma, Furtado, João M, Gakidou, Emmanuela, Gall, Seana, Gallus, Silvano, Ganji, Morsaleh, Garcia-Basteiro, Alberto L, Gardner, William M, Gebre, Abadi Kahsu, Gebremedhin, Amanuel Tesfay, Gebremichael, Teklu Gebrehiwo, Gelano, Tilayie Feto, Geleijnse, Johanna M, Genova-Maleras, Ricard, Geramo, Yilma Chisha Dea, Gething, Peter W, Gezae, Kebede Embaye, Ghadami, Mohammad Rasoul, Ghadiri, Keyghobad, Ghasemi-Kasman, Maryam, Ghimire, Mamata, Ghoshal, Aloke Gopal, Gill, Paramjit Singh, Gill, Tiffany K, Ginawi, Ibrahim Abdelmageed, Giussani, Giorgia, Gnedovskaya, Elena V, Goldberg, Ellen M, Goli, Sriniva, Gómez-Dantés, Hector, Gona, Philimon N, Gopalani, Sameer Vali, Gorman, Taren M, Goulart, Alessandra C, Goulart, Bárbara Niegia Garcia, Grada, Ayman, Grosso, Giuseppe, Gugnani, Harish Chander, Guillemin, Franci, Guo, Yuming, Gupta, Prakash C, Gupta, Rahul, Gupta, Rajeev, Gupta, Tanush, Gutiérrez, Reyna Alma, Gyawali, Bishal, Haagsma, Juanita A, Hachinski, Vladimir, Hafezi-Nejad, Nima, Haghparast Bidgoli, Hassan, Hagos, Tekleberhan B, Hailegiyorgis, Tewodros Tesfa, Haj-Mirzaian, Arvin, Haj-Mirzaian, Arya, Hamadeh, Randah R, Hamidi, Samer, Handal, Alexis J, Hankey, Graeme J, Hao, Yuantao, Harb, Hilda L, Harikrishnan, Sivadasanpillai, Haririan, Hamidreza, Haro, Josep Maria, Hassankhani, Hadi, Hassen, Hamid Yimam, Havmoeller, Rasmu, Hay, Roderick J, Hay, Simon I, Hedayatizadeh-Omran, Akbar, Heibati, Behzad, Hendrie, Delia, Henok, Andualem, Heredia-Pi, Ileana, Herteliu, Claudiu, Heydarpour, Fatemeh, Heydarpour, Pouria, Hibstu, Desalegn Tsegaw, Hoek, Hans W, Hoffman, Howard J, Hole, Michael K, Homaie Rad, Enayatollah, Hoogar, Praveen, Hosgood, H Dean, Hosseini, Seyed Mostafa, Hosseinzadeh, Mehdi, Hostiuc, Mihaela, Hostiuc, Sorin, Hotez, Peter J, Hoy, Damian G, Hsairi, Mohamed, Htet, Aung Soe, Huang, John J, Iburg, Kim Moesgaard, Ikeda, Chad Thoma, Ilesanmi, Olayinka Stephen, Irvani, Seyed Sina Naghibi, Irvine, Caleb Mackay Salpeter, Islam, Sheikh Mohammed Shariful, Islami, Farhad, Jacobsen, Kathryn H, Jahangiry, Leila, Jahanmehr, Nader, Jain, Sudhir Kumar, Jakovljevic, Mihajlo, James, Spencer L, Jayatilleke, Achala Upendra, Jeemon, Panniyammakal, Jha, Ravi Prakash, Jha, Vivekanand, Ji, John S, Johnson, Catherine O, Jonas, Jost B, Jonnagaddala, Jitendra, Jorjoran Shushtari, Zahra, Joshi, Ankur, Jozwiak, Jacek Jerzy, Jungari, Suresh Banayya, Jürisson, Mikk, Kabir, Zubair, Kadel, Rajendra, Kahsay, Amaha, Kalani, Rizwan, Kanchan, Tanuj, Kar, Chittaranjan, Karami, Manoochehr, Karami Matin, Behzad, Karch, André, Karema, Corine, Karimi, Narge, Karimi, Seyed M, Kasaeian, Amir, Kassa, Dessalegn H, Kassa, Getachew Mullu, Kassa, Tesfaye Dessale, Kassebaum, Nicholas J, Katikireddi, Srinivasa Vittal, Kaul, Anil, Kawakami, Norito, Kazemi, Zhila, Karyani, Ali Kazemi, Keighobadi, Masoud Masoud, Keiyoro, Peter Njenga, Kemmer, Laura, Kemp, Grant Rodger, Kengne, Andre Pascal, Keren, Andre, Khader, Yousef Saleh, Khafaei, Behzad, Khafaie, Morteza Abdullatif, Khajavi, Alireza, Khalid, Nauman, Khalil, Ibrahim A, Khan, Ejaz Ahmad, Khan, Muhammad Shahzeb, Khan, Muhammad Ali, Khang, Young-Ho, Khater, Mona M, Khazaei, Mohammad, Khoja, Abdullah T, Khosravi, Ardeshir, Khosravi, Mohammad Hossein, Kiadaliri, Aliasghar A, Kidanemariam, Zelalem Teklemariam, Kiirithio, Daniel N, Kim, Cho-Il, Kim, Daniel, Kim, Young-Eun, Kim, Yun Jin, Kimokoti, Ruth W, Kinfu, Yohanne, Kisa, Adnan, Kissimova-Skarbek, Katarzyna, Knudsen, Ann Kristin Skrindo, Kocarnik, Jonathan M, Kochhar, Sonali, Kokubo, Yoshihiro, Kolola, Tufa, Kopec, Jacek A, Kosen, Soewarta, Kotsakis, Georgios A, Koul, Parvaiz A, Koyanagi, Ai, Krishan, Kewal, Krishnaswami, Sanjay, Krohn, Kristopher J, Kuate Defo, Barthelemy, Kucuk Bicer, Burcu, Kumar, G Anil, Kumar, Manasi, Kuzin, Igor, Lad, Deepesh P, Lad, Sheetal D, Lafranconi, Alessandra, Lalloo, Ratilal, Lallukka, Tea, Lami, Faris Hasan, Lang, Justin J, Langan, Sinéad M, Lansingh, Van C, Latifi, Arman, Lau, Kathryn Mei-Ming, Lazarus, Jeffrey V, Leasher, Janet L, Ledesma, Jorge R, Lee, Paul H, Leigh, Jame, Leili, Mostafa, Leshargie, Cheru Tesema, Leung, Janni, Levi, Miriam, Lewycka, Sonia, Li, Shanshan, Li, Yichong, Liang, Xiaofeng, Liao, Yu, Liben, Misgan Legesse, Lim, Lee-Ling, Lim, Stephen S, Limenih, Miteku Andualem, Linn, Shai, Liu, Shiwei, Looker, Katharine J, Lopez, Alan D, Lorkowski, Stefan, Lotufo, Paulo A, Lozano, Rafael, Lucas, Tim C D, Lunevicius, Raimunda, Lyons, Ronan A, Ma, Stefan, Macarayan, Erlyn Rachelle King, Mackay, Mark T, Maddison, Emilie R, Madotto, Fabiana, Maghavani, Dhaval P, Mai, Hue Thi, Majdan, Marek, Majdzadeh, Reza, Majeed, Azeem, Malekzadeh, Reza, Malta, Deborah Carvalho, Mamun, Abdullah A, Manda, Ana-Laura, Manguerra, Helena, Mansournia, Mohammad Ali, Mantilla Herrera, Ana Maria, Mantovani, Lorenzo Giovanni, Maravilla, Joemer C, Marcenes, Wagner, Marks, Ashley, Martins-Melo, Francisco Rogerlândio, Martopullo, Ira, März, Winfried, Marzan, Melvin B, Massano, João, Massenburg, Benjamin Ballard, Mathur, Manu Raj, Maulik, Pallab K, Mazidi, Mohsen, McAlinden, Colm, McGrath, John J, McKee, Martin, McMahon, Brian J, Mehata, Suresh, Mehrotra, Ravi, Mehta, Kala M, Mehta, Varshil, Mejia-Rodriguez, Fabiola, Mekonen, Tesfa, Melese, Addisu, Melku, Mulugeta, Memiah, Peter T N, Memish, Ziad A, Mendoza, Walter, Mengistu, Getnet, Mensah, George A, Mereta, Seid Tiku, Meretoja, Atte, Meretoja, Tuomo J, Mestrovic, Tomislav, Miazgowski, Bartosz, Miazgowski, Tomasz, Millear, Anoushka I, Miller, Ted R, Mini, G.K., Mirarefin, Mojde, Mirica, Andreea, Mirrakhimov, Erkin M, Misganaw, Awoke Temesgen, Mitchell, Philip B, Mitiku, Habtamu, Moazen, Babak, Mohajer, Bahram, Mohammad, Karzan Abdulmuhsin, Mohammadi, Moslem, Mohammadifard, Noushin, Mohammadnia-Afrouzi, Mousa, Mohammed, Mohammed A, Mohammed, Shafiu, Mohebi, Farnam, Mokdad, Ali H, Molokhia, Mariam, Monasta, Lorenzo, Montañez, Julio Cesar, Moosazadeh, Mahmood, Moradi, Ghobad, Moradi, Mahmoudreza, Moradi-Lakeh, Maziar, Moradinazar, Mehdi, Moraga, Paula, Morawska, Lidia, Moreno Velásquez, Ilai, Morgado-Da-Costa, Joana, Morrison, Shane Dougla, Moschos, Marilita M, Mousavi, Seyyed Meysam, Mruts, Kalayu Brhane, Muche, Achenef Asmamaw, Muchie, Kindie Fentahun, Mueller, Ulrich Otto, Muhammed, Oumer Sada, Mukhopadhyay, Satinath, Muller, Kate, Mumford, John Everett, Murthy, G.V.S., Musa, Kamarul Imran, Mustafa, Ghulam, Nabhan, Ashraf F, Nagata, Chie, Nagel, Gabriele, Naghavi, Mohsen, Naheed, Aliya, Nahvijou, Azin, Naik, Gurudatta, Najafi, Farid, Nam, Hae Sung, Nangia, Vinay, Nansseu, Jobert Richie, Neamati, Nahid, Negoi, Ionut, Negoi, Ruxandra Irina, Neupane, Suba, Newton, Charles Richard Jame, Ngunjiri, Josephine W, Nguyen, Anh Quynh, Nguyen, Grant, Nguyen, Ha Thu, Nguyen, Huong Lan Thi, Nguyen, Huong Thanh, Nguyen, Long Hoang, Nguyen, Minh, Nguyen, Nam Ba, Nguyen, Son Hoang, Nichols, Emma, Ningrum, Dina Nur Anggraini, Nixon, Molly R, Nomura, Shuhei, Noroozi, Mehdi, Norrving, Bo, Noubiap, Jean Jacque, Nouri, Hamid Reza, Shiadeh, Malihe Nourollahpour, Nowroozi, Mohammad Reza, Nsoesie, Elaine O, Nyasulu, Peter S, Odell, Christopher M, Ofori-Asenso, Richard, Ogbo, Felix Akpojene, Oh, In-Hwan, Oladimeji, Olanrewaju, Olagunju, Andrew T, Olagunju, Tinuke O, Olivares, Pedro R, Olsen, Helen Elizabeth, Olusanya, Bolajoko Olubukunola, Olusanya, Jacob Olusegun, Ong, Kanyin L, Ong, Sok King, Oren, Eyal, Ortiz, Alberto, Ota, Erika, Otstavnov, Stanislav S, Øverland, Simon, Owolabi, Mayowa Ojo, P A, Mahesh, Pacella, Rosana, Pakhare, Abhijit P, Pakpour, Amir H, Pana, Adrian, Panda-Jonas, Songhomitra, Park, Eun-Kee, Park, Jame, Parry, Charles D H, Parsian, Hadi, Pasdar, Yahya, Patel, Shanti, Patil, Snehal T, Patle, Ajay, Patton, George C, Paturi, Vishnupriya Rao, Paudel, Deepak, Paulson, Katherine R, Pearce, Neil, Pereira, Alexandre, Pereira, David M, Perico, Norberto, Pesudovs, Konrad, Petzold, Max, Pham, Hai Quang, Phillips, Michael R, Pigott, David M, Pillay, Julian David, Piradov, Michael A, Pirsaheb, Meghdad, Pishgar, Farhad, Plana-Ripoll, Oleguer, Polinder, Suzanne, Popova, Svetlana, Postma, Maarten J, Pourshams, Akram, Poustchi, Hossein, Prabhakaran, Dorairaj, Prakash, Swayam, Prakash, V., Prasad, Narayan, Purcell, Caroline A, Qorbani, Mostafa, Quistberg, D Alex, Radfar, Amir, Rafay, Anwar, Rafiei, Alireza, Rahim, Fakher, Rahimi, Kazem, Rahimi, Zohreh, Rahimi-Movaghar, Afarin, Rahimi-Movaghar, Vafa, Rahman, Mahfuzar, Rahman, Mohammad Hifz Ur, Rahman, Muhammad Aziz, Rahman, Sajjad Ur, Rai, Rajesh Kumar, Rajati, Fatemeh, Ranjan, Prabhat, Rao, Puja C, Rasella, Davide, Rawaf, David Laith, Rawaf, Salman, Reddy, K Srinath, Reiner, Robert C, Reitsma, Marissa Bettay, Remuzzi, Giuseppe, Renzaho, Andre M N, Resnikoff, Serge, Rezaei, Satar, Rezai, Mohammad Sadegh, Ribeiro, Antonio Luiz P, Roberts, Nicholas L S, Robinson, Stephen R, Roever, Leonardo, Ronfani, Luca, Roshandel, Gholamreza, Rostami, Ali, Roth, Gregory A, Rothenbacher, Dietrich, Rubagotti, Enrico, Sachdev, Perminder S, Sadat, Nafi, Sadeghi, Ehsan, Saeedi Moghaddam, Sahar, Safari, Hosein, Safari, Yahya, Safari-Faramani, Roya, Safdarian, Mahdi, Safi, Sare, Safiri, Saeid, Sagar, Rajesh, Sahebkar, Amirhossein, Sahraian, Mohammad Ali, Sajadi, Haniye Sadat, Salam, Nasir, Salama, Joseph S, Salamati, Payman, Saleem, Zikria, Salimi, Yahya, Salimzadeh, Hamideh, Salomon, Joshua A, Salvi, Sundeep Santosh, Salz, Inbal, Samy, Abdallah M, Sanabria, Juan, Sanchez-Niño, Maria Dolore, Santomauro, Damian Francesco, Santos, Itamar S, Santos, João Vasco, Santric Milicevic, Milena M, Sao Jose, Bruno Piassi, Sardana, Mayank, Sarker, Abdur Razzaque, Sarmiento-Suárez, Rodrigo, Sarrafzadegan, Nizal, Sartorius, Benn, Sarvi, Shahabeddin, Sathian, Brijesh, Satpathy, Maheswar, Sawant, Arundhati R, Sawhney, Monika, Saxena, Sonia, Schaeffner, Elke, Schmidt, Maria Inê, Schneider, Ione J C, Schutte, Aletta Elisabeth, Schwebel, David C, Schwendicke, Falk, Scott, James G, Sekerija, Mario, Sepanlou, Sadaf G, Serván-Mori, Edson, Seyedmousavi, Seyedmojtaba, Shabaninejad, Hosein, Shafieesabet, Azadeh, Shahbazi, Mehdi, Shaheen, Amira A, Shaikh, Masood Ali, Shams-Beyranvand, Mehran, Shamsi, Mohammadbagher, Sharafi, Heidar, Sharafi, Kiomar, Sharif, Mehdi, Sharif-Alhoseini, Mahdi, Sharma, Jayendra, Sharma, Rajesh, She, Jun, Sheikh, Aziz, Shi, Peilin, Shibuya, Kenji, Shiferaw, Mekonnen Sisay, Shigematsu, Mika, Shiri, Rahman, Shirkoohi, Reza, Shiue, Ivy, Shokoohinia, Yalda, Shokraneh, Farhad, Shoman, Haitham, Shrime, Mark G, Si, Si, Siabani, Soraya, Sibai, Abla Mehio, Siddiqi, Tariq J, Sigfusdottir, Inga Dora, Sigurvinsdottir, Rannveig, Silva, Diego Augusto Santo, Silva, João Pedro, Silveira, Dayane Gabriele Alve, Singam, Narayana Sarma Venkata, Singh, Jasvinder A, Singh, Narinder Pal, Singh, Virendra, Sinha, Dhirendra Narain, Skiadaresi, Eirini, Skirbekk, Vegard, Sliwa, Karen, Smith, David L, Smith, Mari, Soares Filho, Adauto Martin, Sobaih, Badr Hasan, Sobhani, Soheila, Soofi, Moslem, Sorensen, Reed J D, Soyiri, Ireneous N, Sposato, Luciano A, Sreeramareddy, Chandrashekhar T, Srinivasan, Vinay, Stanaway, Jeffrey D, Starodubov, Vladimir I, Stein, Dan J, Steiner, Caitlyn, Steiner, Timothy J, Stokes, Mark A, Stovner, Lars Jacob, Subart, Michelle L, Sudaryanto, Agu, Sufiyan, Mu'awiyyah Babale, Sulo, Gerhard, Sunguya, Bruno F, Sur, Patrick John, Sykes, Bryan L, Sylaja, P.N., Sylte, Dillon O, Szoeke, Cassandra E I, Tabarés-Seisdedos, Rafael, Tabuchi, Takahiro, Tadakamadla, Santosh Kumar, Tandon, Nikhil, Tassew, Segen Gebremeskel, Tavakkoli, Mohammad, Taveira, Nuno, Taylor, Hugh R, Tehrani-Banihashemi, Arash, Tekalign, Tigist Gashaw, Tekelemedhin, Shishay Wahdey, Tekle, Merhawi Gebremedhin, Temsah, Mohamad-Hani, Temsah, Omar, Terkawi, Abdullah Sulieman, Tessema, Belay, Teweldemedhin, Mebrahtu, Thankappan, Kavumpurathu Raman, Theis, Andrew, Thirunavukkarasu, Sathish, Thomas, Nihal, Tilahun, Binyam, To, Quyen G, Tonelli, Marcello, Topor-Madry, Roman, Torre, Anna E, Tortajada-Girbés, Miguel, Touvier, Mathilde, Tovani-Palone, Marcos Roberto, Towbin, Jeffrey A, Tran, Bach Xuan, Tran, Khanh Bao, Troeger, Christopher E, Tsadik, Afewerki Gebremeskel, Tsoi, Derrick, Tudor Car, Lorainne, Tyrovolas, Stefano, Ukwaja, Kingsley Nnanna, Ullah, Irfan, Undurraga, Eduardo A, Updike, Rachel L, Usman, Muhammad Shariq, Uthman, Olalekan A, Vaduganathan, Muthiah, Vaezi, Afsane, Valdez, Pascual R, Varavikova, Elena, Varughese, Santosh, Vasankari, Tommi Juhani, Venketasubramanian, Narayanaswamy, Villafaina, Santo, Violante, Francesco S, Vladimirov, Sergey Konstantinovitch, Vlassov, Vasily, Vollset, Stein Emil, Vos, Theo, Vosoughi, Kia, Vujcic, Isidora S, Wagnew, Fasil Shiferaw, Waheed, Yasir, Wang, Yafeng, Wang, Yuan-Pang, Weiderpass, Elisabete, Weintraub, Robert G, Weiss, Daniel J, Weldegebreal, Fitsum, Weldegwergs, Kidu Gidey, Werdecker, Andrea, West, T Eoin, Westerman, Ronny, Whiteford, Harvey A, Widecka, Justyna, Wijeratne, Tissa, Williams, Hywel C, Wilner, Lauren B, Wilson, Shadrach, Winkler, Andrea Sylvia, Wiyeh, Alison B, Wiysonge, Charles Shey, Wolfe, Charles D A, Woolf, Anthony D, Wyper, Grant M A, Xavier, Deni, Xu, Gelin, Yadgir, Simon, Yahyazadeh Jabbari, Seyed Hossein, Yamada, Tomohide, Yan, Lijing L, Yano, Yuichiro, Yaseri, Mehdi, Yasin, Yasin Jemal, Yeshaneh, Alex, Yimer, Ebrahim M, Yip, Paul, Yisma, Engida, Yonemoto, Naohiro, Yoon, Seok-Jun, Yotebieng, Marcel, Younis, Mustafa Z, Yousefifard, Mahmoud, Yu, Chuanhua, Zadnik, Vesna, Zaidi, Zoubida, Zaman, Sojib Bin, Zamani, Mohammad, Zandian, Hamed, Zar, Heather J, Zenebe, Zerihun Menlkalew, Zhou, Maigeng, Zipkin, Ben, Zodpey, Sanjay, Zucker, Inbar, Zuhlke, Liesl Joanna, and Murray, Christopher J L
- Subjects
Male ,Health Status ,health statu ,HALE ,mortality rate ,communicable disease ,DALYs ,Global Burden of Disease ,Risk Factors ,Prevalence ,Medicine and Health Sciences ,Singapore ,OUTCOMES ,disability-adjusted life year ,international cooperation ,Medicine (all) ,11 Medical And Health Sciences ,Central African Republic ,newborn disease ,IRON-DEFICIENCY ,AIDS ,priority journal ,Bahrain ,disease severity ,Female ,Quality-Adjusted Life Years ,cerebrovascular accident ,Ukraine ,Life Sciences & Biomedicine ,INTERVENTIONS ,Slovakia ,DISORDERS ,Burundi ,WEIGHTS ,GBD 2017 DALYs and HALE Collaborators ,Communicable Diseases ,Article ,STYLE ,Medicine, General & Internal ,Life Expectancy ,General & Internal Medicine ,Humans ,Disabled Persons ,human ,Healthy Lifestyle ,HALE, DALYs, global burden of disease ,Mortality ,Aged ,Science & Technology ,Mortality, Premature ,HIV ,ischemic heart disease ,major clinical study ,PREVENTION ,non communicable disease ,GBD, disability-adjusted life-years ,age ,sex factor ,Socioeconomic Factors ,Algeria ,Federation of Bosnia and Herzegovina ,lower respiratory tract infection ,Wounds and Injuries ,GENDER ,Human medicine ,trend study ,chronic obstructive lung disease - Abstract
Background How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure of disability-adjusted life years (DALYs), a composite measure of disease burden capturing both premature mortality and prevalence and severity of ill health, for 359 diseases and injuries for 195 countries and territories over the past 28 years. Methods We used data for age-specific mortality rates, years of life lost (YLLs) due to premature mortality, and years lived with disability (YLDs) from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 to calculate HALE and DALYs from 1990 to 2017. We calculated HALE using age-specific mortality rates and YLDs per capita for each location, age, sex, and year. We calculated DALYs for 359 causes as the sum of YLLs and YLDs. We assessed how observed HALE and DALYs differed by country and sex from expected trends based on Sociodemographic Index (SDI). We also analysed HALE by decomposing years of life gained into years spent in good health and in poor health, between 1990 and 2017, and extra years lived by females compared with males. Findings Globally, from 1990 to 2017, life expectancy at birth increased by 7.4 years (95% uncertainty interval 74-7.8), from 65.6 years (65.3-65- 8) in 1990 to 73.0 years (72.7-73.3) in 2017. The increase in years of life varied from 5.1 years (5.0-5.3) in high SDI countries to 12.0 years (11.3-12.8) in low SDI countries. Of the additional years of life expected at birth, 26.3% (20.1-33.1) were expected to be spent in poor health in high SDI countries compared with 11.7% (8.8-15.1) in low-middle SDI countries. HALE at birth increased by 6.3 years (5.9-6.7), from 57.0 years (54.6-59.1) in 1990 to 63.3 years (60.5-65.7) in 2017. The increase varied from 3.8 years (3.4-4.1) in high SDI countries to 10.5 years (9.8-11.2) in low SDI countries. Even larger variations in HALE than these were observed between countries, ranging from 1.0 year (0.4-1.7) in Saint Vincent and the Grenadines (62.4 years [59.9-64.7] in 1990 to 63.5 years [60.9-65.8] in 2017) to 23.7 years (21.9-25.6) in Eritrea (30.7 years [28.9-32.2] in 1990 to 54.4 years [51.5-57.1] in 2017). In most countries, the increase in HALE was smaller than the increase in overall life expectancy, indicating more years lived in poor health. In 180 of 195 countries and territories, females were expected to live longer than males in 2017, with extra years lived varying from 1.4 years (0.6-2.3) in Algeria to 11.9 years (10.9-12.9) in Ukraine. Of the extra years gained, the proportion spent in poor health varied largely across countries, with less than 20% of additional years spent in poor health in Bosnia and Herzegovina, Burundi, and Slovakia, whereas in Bahrain all the extra years were spent in poor health. In 2017, the highest estimate of HALE at birth was in Singapore for both females (75.8 years [72.4-78.7]) and males (72.6 years [69 " 8-75.0]) and the lowest estimates were in Central African Republic (47.0 years [43.7-50.2] for females and 42.8 years [40.1-45.6] for males). Globally, in 2017, the five leading causes of DALYs were neonatal disorders, ischaemic heart disease, stroke, lower respiratory infections, and chronic obstructive pulmonary disease. Between 1990 and 2017, age-standardised DALY rates decreased by 41.3% (38.8-43.5) for communicable diseases and by 49"8% (47.9-51.6) for neonatal disorders. For non-communicable diseases, global DALYs increased by 40.1% (36.8-43.0), although age-standardised DALY rates decreased by 18.1% (16.0-20.2). Interpretation With increasing life expectancy in most countries, the question of whether the additional years of life gained are spent in good health or poor health has been increasingly relevant because of the potential policy implications, such as health-care provisions and extending retirement ages. In some locations, a large proportion of those additional years are spent in poor health. Large inequalities in HALE and disease burden exist across countries in different SDI quintiles and between sexes. The burden of disabling conditions has serious implications for health system planning and health-related expenditures. Despite the progress made in reducing the burden of communicable diseases and neonatal disorders in low S DI countries, the speed of this progress could be increased by scaling up proven interventions. The global trends among non-communicable diseases indicate that more effort is needed to maximise HALE, such as risk prevention and attention to upstream determinants of health. Copyright (C) 2018 The Author(s). Published by Elsevier Ltd.
- Published
- 2018
33. Tibiofemoral joint structural change from 2.5 to 4.5years following ACL reconstruction with and without combined meniscal pathology
- Author
-
Wang, X, Bennell, KL, Wang, Y, Wrigley, TV, Van Ginckel, A, Fortin, K, Saxby, DJ, Cicuttini, FM, Lloyd, DG, Vertullo, CJ, Feller, JA, Whitehead, T, Gallie, P, Bryant, AL, Wang, X, Bennell, KL, Wang, Y, Wrigley, TV, Van Ginckel, A, Fortin, K, Saxby, DJ, Cicuttini, FM, Lloyd, DG, Vertullo, CJ, Feller, JA, Whitehead, T, Gallie, P, and Bryant, AL
- Abstract
BACKGROUND: People who have had anterior cruciate ligament reconstruction (ACLR) are at a high risk of developing tibiofemoral joint (TFJ) osteoarthritis (OA), with concomitant meniscal injury elevating this risk. This study aimed to investigate OA-related morphological change over 2 years in the TFJ among individuals who have undergone ACLR with or without concomitant meniscal pathology and in healthy controls. A secondary aim was to examine associations of baseline TFJ cartilage defects and bone marrow lesions (BML) scores with tibial cartilage volume change in ACLR groups. METHODS: Fifty seven ACLR participants aged 18-40 years (32 isolated ACLR, 25 combined meniscal pathology) underwent knee magnetic resonance imaging (MRI) 2.5 and 4.5 years post-surgery. Nine healthy controls underwent knee MRI at the ~ 2-year intervals. Tibial cartilage volume, TFJ cartilage defects and BMLs were assessed from MRI. RESULTS: For both ACLR groups, medial and lateral tibial cartilage volume increased over 2 years (P < 0.05). Isolated ACLR group had greater annual percentage increase in lateral tibial cartilage volume compared with controls and with the combined group (P = 0.03). Cartilage defects remained unchanged across groups. Both ACLR groups showed more lateral tibia BML regression compared with controls (P = 0.04). Baseline cartilage defects score was positively associated with cartilage volume increase at lateral tibia (P = 0.002) while baseline BMLs score was inversely related to medial tibia cartilage volume increase (P = 0.001) in the pooled ACLR group. CONCLUSIONS: Tibial cartilage hypertrophy was apparent in ACLR knees from 2.5 to 4.5 years post-surgery and was partly dependent upon meniscal status together with the nature and location of the underlying pathology at baseline. Magnitude and direction of change in joint pathologies (i.e., cartilage defects, BMLs) were less predictable and either remained stable or improved over follow-up.
- Published
- 2019
34. Association between metformin use and disease progression in obese people with knee osteoarthritis: data from the Osteoarthritis Initiativea prospective cohort study
- Author
-
Wang, Y, Hussain, SM, Wluka, AE, Lim, YZ, Abram, F, Pelletier, J-P, Martel-Pelletier, J, Cicuttini, FM, Wang, Y, Hussain, SM, Wluka, AE, Lim, YZ, Abram, F, Pelletier, J-P, Martel-Pelletier, J, and Cicuttini, FM
- Abstract
OBJECTIVE: To examine whether metformin use was associated with knee cartilage volume loss over 4 years and risk of total knee replacement over 6 years in obese individuals with knee osteoarthritis. METHODS: This study analysed the Osteoarthritis Initiative participants with radiographic knee osteoarthritis (Kellgren-Lawrence grade ≥ 2) who were obese (body mass index [BMI] ≥ 30 kg/m2). Participants were classified as metformin users if they self-reported regular metformin use at baseline, 1-year and 2-year follow-up (n = 56). Non-users of metformin were defined as participants who did not report the use of metformin at any visit from baseline to 4-year follow-up (n = 762). Medial and lateral cartilage volume (femoral condyle and tibial plateau) were assessed using magnetic resonance imaging at baseline and 4 years. Total knee replacement over 6 years was assessed. General linear model and binary logistic regression were used for statistical analyses. RESULTS: The rate of medial cartilage volume loss was lower in metformin users compared with non-users (0.71% vs. 1.57% per annum), with a difference of - 0.86% per annum (95% CI - 1.58% to - 0.15%, p = 0.02), after adjustment for age, gender, BMI, pain score, Kellgren-Lawrence grade, self-reported diabetes, and weight change over 4 years. Metformin use was associated with a trend towards a significant reduction in risk of total knee replacement over 6 years (odds ratio 0.30, 95% CI 0.07-1.30, p = 0.11), after adjustment for age, gender, BMI, Kellgren-Lawrence grade, pain score, and self-reported diabetes. CONCLUSIONS: These data suggest that metformin use may have a beneficial effect on long-term knee joint outcomes in those with knee osteoarthritis and obesity. Randomised controlled trials are needed to confirm these findings and determine whether metformin would be a potential disease-modifying drug for knee osteoarthritis with the obese phenotype.
- Published
- 2019
35. How does tibial cartilage volume relate to symptoms in subjects with knee osteoarthritis?
- Author
-
Wluka, AE, Wolfe, R, Stuckey, S, and Cicuttini, FM
- Subjects
Health - Abstract
Background: No consistent relationship between the severity of symptoms of knee osteoarthritis (OA) and radiographic change has been demonstrated. Objectives: To determine the relationship between symptoms of knee OA and [...]
- Published
- 2004
36. Knee pain as a predictor of structural progression over 4 years: data from the Osteoarthritis Initiative, a prospective cohort study
- Author
-
Wang, Y, Teichtahl, AJ, Abram, F, Hussain, SM, Pelletier, J-P, Cicuttini, FM, Martel-Pelletier, J, Wang, Y, Teichtahl, AJ, Abram, F, Hussain, SM, Pelletier, J-P, Cicuttini, FM, and Martel-Pelletier, J
- Abstract
BACKGROUND: There is evidence that knee pain not only is a consequence of structural deterioration in osteoarthritis (OA) but also contributes to structural progression. Clarifying this is important because targeting the factors related to knee pain may offer a clinical approach for slowing the progression of knee OA. The aim of this study was to examine whether knee pain over 1 year predicted cartilage volume loss, incidence and progression of radiographic osteoarthritis (ROA) over 4 years. METHODS: Osteoarthritis Initiative participants with no ROA (Kellgren-Lawrence grade ≤ 1) (n = 2120) and with ROA (Kellgren-Lawrence grade > 2) (n = 2249) were examined. Knee pain was assessed at baseline and 1 year using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Knee pain patterns were categorised as no pain (WOMAC pain < 5 at baseline and 1 year), fluctuating pain (WOMAC pain > 5 at either time point) and persistent pain (WOMAC pain > 5 at both time points). Cartilage volume, incidence and progression of ROA were assessed using magnetic resonance imaging and x-rays at baseline and 4-years. RESULTS: In both non-ROA and ROA, greater baseline WOMAC knee pain score was associated with increased medial and lateral cartilage volume loss (p ≤ 0.001), incidence (OR 1.07, 95% CI 1.01-1.13) and progression (OR 1.07, 95% CI 1.03-1.10) of ROA. Non-ROA and ROA participants with fluctuating and persistent knee pain had increased cartilage volume loss compared with those with no pain (p for trend ≤ 0.01). Non-ROA participants with fluctuating knee pain had increased risk of incident ROA (OR 1.62, 95% CI 1.04-2.54), corresponding to a number needed to harm of 19.5. In ROA the risk of progressive ROA increased in participants with persistent knee pain (OR 1.82, 95% CI 1.28-2.60), corresponding to a number needed to harm of 9.6. CONCLUSIONS: Knee pain over 1 year predicted accelerated cartilage volume loss and increased risk of incident and progressive ROA. Ear
- Published
- 2018
37. Patients' perceived needs of osteoarthritis health information: A systematic scoping review
- Author
-
Agarwal, S, Chou, L, Ellis, L, Papandony, M, Seneviwickrama, KLMD, Cicuttini, FM, Sullivan, K, Teichtahl, AJ, Wang, Y, Briggs, AM, Wluka, A, Agarwal, S, Chou, L, Ellis, L, Papandony, M, Seneviwickrama, KLMD, Cicuttini, FM, Sullivan, K, Teichtahl, AJ, Wang, Y, Briggs, AM, and Wluka, A
- Abstract
BACKGROUND: Optimal management of osteoarthritis requires active patient participation. Understanding patients' perceived health information needs is important in order to optimize health service delivery and health outcomes in osteoarthritis. We aimed to review the existing literature regarding patients' perceived health information needs for OA. METHODS: A systematic scoping review was performed of publications in MEDLINE, EMBASE, CINAHL and PsycINFO (1990-2016). Descriptive data regarding study design and methodology were extracted and risk of bias assessed. Aggregates of patients' perceived needs of osteoarthritis health information were categorized. RESULTS: 30 studies from 2876 were included: 16 qualitative, 11 quantitative and 3 mixed-methods studies. Three areas of perceived need emerged: (1) Need for clear communication: terms used were misunderstood or had unintended connotations. Patients wanted clear explanations. (2) Need for information from various sources: patients wanted accessible health professionals with specialist knowledge of arthritis. The Internet, whilst a source of information, was acknowledged to have dubious reliability. Print media, television, support groups, family and friends were utilised to fulfil diverse information needs. (3) Needs of information content: patients desired more information about diagnosis, prognosis, management and prevention. CONCLUSIONS: Patients desire more information regarding the diagnosis of osteoarthritis, its impact on daily life and its long-term prognosis. They want more information not only about pharmacological management options, but also non-pharmacological options to help them manage their symptoms. Also, patients wanted this information to be delivered in a clear manner from multiple sources of health information. To address these gaps, more effective communication strategies are required. The use of a variety of sources and modes of delivery may enable the provision of complementary material to pr
- Published
- 2018
38. Effect of a low-intensity, self-management lifestyle intervention on knee pain in community-based young to middle-aged rural women: a cluster randomised controlled trial
- Author
-
Wang, Y, Lombard, C, Hussain, SM, Harrison, C, Kozica, S, Brady, SRE, Teede, H, Cicuttini, FM, Wang, Y, Lombard, C, Hussain, SM, Harrison, C, Kozica, S, Brady, SRE, Teede, H, and Cicuttini, FM
- Abstract
BACKGROUND: Knee pain is common with obesity and weight gain being important risk factors. Previous clinical trials have focused on overweight or obese adults with knee pain and osteoarthritis and demonstrated modest effects of intense weight loss programs on reducing knee pain despite very significant weight loss. There has been no lifestyle intervention that targets community-based adults to test its effect on prevention of knee pain. We aimed to determine the effect of a simple low-intensity self-management lifestyle intervention (HeLP-her), proven in randomised controlled trials to improve lifestyle and prevent weight gain, on knee pain in community-based young to middle-aged rural women. METHODS: A 1-year pragmatic, cluster randomised controlled trial was conducted in 649 community-based women (aged 18-50 years) to receive either the HeLP-her program (consisting of one group session, monthly SMS text messages, one phone coaching session, and a program manual) or one general women's health education session. Secondary analyses were performed in 390 women who had knee pain measured using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) at baseline and 12-month follow-up. "Any knee pain" was defined as a WOMAC pain score ≥ 1. Knee pain worsening was defined as an increase in WOMAC pain score over 12 months. RESULTS: Thirty-five percent of women had "any knee pain" at baseline. The risk of knee pain worsening did not differ between the intervention and control groups over 12 months. For women with any knee pain at baseline, those in the intervention arm had a lower risk of knee pain worsening compared with those in the control arm (OR 0.37, 95% CI 0.14-1.01, p = 0.05), with a stronger effect observed in women with body mass index ≥ 25 kg/m2 (OR 0.28, 95% CI 0.09-0.87, p = 0.03). CONCLUSIONS: In community-based young to middle-aged women, a simple low-intensity lifestyle program reduced the risk of knee pain worsening in those with any knee
- Published
- 2018
39. Female Reproductive and Hormonal Factors and Incidence of Primary Total Knee Arthroplasty Due to Osteoarthritis
- Author
-
Hussain, SM, Wang, Y, Giles, GG, Graves, S, Wluka, A, Cicuttini, FM, Hussain, SM, Wang, Y, Giles, GG, Graves, S, Wluka, A, and Cicuttini, FM
- Abstract
OBJECTIVE: To examine the associations of female reproductive and hormonal factors with incidence of total knee arthroplasty (TKA) for osteoarthritis (OA), and to determine whether the associations differ according to overweight/obesity status. METHODS: This study included 22,289 women in the Melbourne Collaborative Cohort Study. Data on age at menarche, pregnancy, parity, years of menstruation, oral contraceptive (OC) use, menopausal status, and hormone replacement therapy (HRT) were collected in 1990-1994. Incidence of TKA during 2001-2013 was determined by linking cohort records to the Australian Orthopaedic Association National Joint Replacement Registry. All analyses were adjusted for age, body mass index (BMI) at midlife, change in BMI (from early reproductive age to midlife), country of birth, physical activity, smoking, and education level. RESULTS: Over the course of 12.7 years, 1,208 TKAs for OA were identified. Ever being pregnant was associated with increased risk of TKA (hazard ratio [HR] 1.32 [95% confidence interval (95% CI) 1.06-1.63]). Parity was positively associated with risk of TKA (P for trend = 0.003). OC users had increased risk of TKA compared with non-users (for OC use of <5 years, HR 1.25 [95% CI 1.08-1.45]; for OC use of ≥5 years, HR 1.17 [95% CI 1.00-1.37]). A 1-year increase in menstruation was associated with a 1% decrease in risk of TKA (HR 0.99 [95% CI 0.97-0.99]). These associations remained significant only in women of normal weight at early reproductive age. Current HRT users had increased risk of TKA compared with non-users (HR 1.37 [95% CI 1.14-1.64]); the association was significant only in non-obese women at midlife. CONCLUSION: Reproductive and hormonal factors were associated with risk of knee OA. These associations remained significant in women of normal weight at early reproductive age and in non-obese women at midlife. Further work is needed to understand the complex effect of these factors on knee OA.
- Published
- 2018
40. Cartilage quantitative T2 relaxation time 2-4 years following isolated anterior cruciate ligament reconstruction
- Author
-
Wang, X, Wrigley, TV, Bennell, KL, Wang, Y, Fortin, K, Cicuttini, FM, Lloyd, DG, Bryant, AL, Wang, X, Wrigley, TV, Bennell, KL, Wang, Y, Fortin, K, Cicuttini, FM, Lloyd, DG, and Bryant, AL
- Published
- 2018
41. Patients' perceived needs for allied health, and complementary and alternative medicines for low back pain: A systematic scoping review
- Author
-
Chou, L, Ranger, TA, Peiris, W, Cicuttini, FM, Urquhart, DM, Briggs, AM, Wluka, AE, Chou, L, Ranger, TA, Peiris, W, Cicuttini, FM, Urquhart, DM, Briggs, AM, and Wluka, AE
- Abstract
OBJECTIVES: Allied health and complementary and alternative medicines (CAM) are therapeutic therapies commonly accessed by consumers to manage low back pain (LBP). We aimed to identify the literature regarding patients' perceived needs for physiotherapy, chiropractic therapy and CAM for the management of LBP. METHODS: A systematic scoping review of MEDLINE, EMBASE, CINAHL and PsycINFO (1990-2016) was conducted to identify studies examining patients' perceived needs for allied health and CAM for LBP. Data regarding study design and methodology were extracted. Areas of patients' perceived need for allied health and CAM were aggregated. RESULTS: Forty-four studies from 2202 were included: 25 qualitative, 18 quantitative and 1 mixed-methods study. Three areas of need emerged: (i) physiotherapy was viewed as important, particularly when individually tailored. However, patients had concerns about adherence, adverse outcomes and correct exercise technique. (ii) Chiropractic therapy was perceived to be effective and needed by some patients, but others were concerned about adverse outcomes. (iii) An inconsistent need for CAM was identified with some patients perceiving a need, while others questioning the legitimacy and short-term duration of these therapies. CONCLUSIONS: Our findings regarding patients' perceived needs for allied health and CAM for LBP may assist in informing development of more patient-centred guidelines and service models for LBP. Understanding patients' concerns regarding active-based physiotherapy, which is recommended in most guidelines, and issues surrounding chiropractic and CAM, which are generally not, may help inform management that better aligns patient's perceived needs with effective treatments, to improve outcomes for both patients and the health-care system.
- Published
- 2018
42. Patients' perceived needs for medical services for non-specific low back pain: A systematic scoping review
- Author
-
Laws, MB, Chou, L, Ranger, TA, Peiris, W, Cicuttini, FM, Urquhart, DM, Sullivan, K, Seneviwickrama, M, Briggs, AM, Wluka, AE, Laws, MB, Chou, L, Ranger, TA, Peiris, W, Cicuttini, FM, Urquhart, DM, Sullivan, K, Seneviwickrama, M, Briggs, AM, and Wluka, AE
- Abstract
BACKGROUND: An improved understanding of patients' perceived needs for medical services for low back pain (LBP) will enable healthcare providers to better align service provision with patient expectations, thus improving patient and health care system outcomes. Thus, we aimed to identify the existing literature regarding patients' perceived needs for medical services for LBP. METHODS: A systematic scoping review was performed of publications identified from MEDLINE, EMBASE, CINAHL and PsycINFO (1990-2016). Descriptive data regarding each study, its design and methodology were extracted and risk of bias assessed. Aggregates of patients' perceived needs for medical services for LBP were categorised. RESULTS: 50 studies (35 qualitative, 14 quantitative and 1 mixed-methods study) from 1829 were relevant. Four areas of perceived need emerged: (1) Patients with LBP sought healthcare from medical practitioners to obtain a diagnosis, receive management options, sickness certification and legitimation for their LBP. However, there was dissatisfaction with the cursory and superficial approach of care. (2) Patients had concerns about pharmacotherapy, with few studies reporting on patients' preferences for medications. (3) Of the few studies which examined the patients' perceived need of invasive therapies, these found that patients avoided injections and surgeries (4) Patients desired spinal imaging for diagnostic purposes and legitimation of symptoms. CONCLUSIONS: Across many different patient populations with data obtained from a variety of study designs, common themes emerged which highlighted areas of patient dissatisfaction with the medical management of LBP, in particular, the superficial approach to care perceived by patients and concerns regarding pharmacotherapy. Patients perceive unmet needs from medical services, including the need to obtain a diagnosis, the desire for pain control and the preference for spinal imaging. These issues need to be considered in developi
- Published
- 2018
43. Could low birth weight and preterm birth be associated with significant burden of hip osteoarthritis? A systematic review
- Author
-
Hussain, SM, Ackerman, IN, Wang, Y, Zomer, E, Cicuttini, FM, Hussain, SM, Ackerman, IN, Wang, Y, Zomer, E, and Cicuttini, FM
- Abstract
BACKGROUND: Approaches for the prevention and treatment of hip osteoarthritis (OA) remain limited. There are recent data suggesting that low birth weight (LBW) and preterm birth may be risk factors for hip osteoarthritis. This has the potential to change the current paradigm of hip osteoarthritis prevention by targeting early life factors. The aim of this review was to examine the available evidence for an association of LBW and preterm birth with hip OA. The potential cost implications associated with total hip arthroplasty were also evaluated. METHODS: Ovid Medline, EMBASE, and Cinahl were searched up until August 2017 using MeSH terms and key words. Methodological quality was evaluated using the National Heart Lung and Blood Institute (NHLBI) quality assessment tool. Qualitative evidence synthesis was performed to summarise the results. Bradford Hill's criteria for causation including the temporal relationship, consistency, strength of the association, specificity, dose-response relationship, and analogy were used to assess the evidence for causation. Economic modelling was used to calculate the potential economic burden associated with LBW or preterm birth related total hip arthroplasty using Australian data from 2012 to 2015. RESULTS: Five studies, ranging from high to low quality, were included. Hip bone shape abnormalities examined included developmental hip dysplasia and immature hip, and hip osteoarthritis included osteophytes and total hip arthroplasty. A causal link between low birth weight or preterm birth and hip osteoarthritis was found. Of the 30,477 total hip arthroplasties performed for hip osteoarthritis in Australia in 2015, 5791 were estimated to be born preterm and 5273 with low birth weight. This equated to a potential total hip arthroplasty cost of AU$145,136,082 and AU$132,150,222 for these subgroups, respectively. CONCLUSION: Available data suggest that low birth weight and preterm birth are associated with hip bone shape abnormalities and h
- Published
- 2018
44. Relationship of weight and obesity with the risk of knee and hip arthroplasty for osteoarthritis across different levels of physical performance: a prospective cohort study
- Author
-
Hussain, SM, primary, Wang, Y, additional, Shaw, JE, additional, Wluka, AE, additional, Graves, S, additional, Gambhir, M, additional, and Cicuttini, FM, additional
- Published
- 2018
- Full Text
- View/download PDF
45. Relationships Between Tibiofemoral Contact Forces and Cartilage Morphology at 2 to 3 Years After Single-Bundle Hamstring Anterior Cruciate Ligament Reconstruction and in Healthy Knees
- Author
-
Saxby, DJ, Bryant, AL, Wang, X, Modenese, L, Gerus, P, Konrath, JM, Bennell, KL, Fortin, K, Wrigley, T, Cicuttini, FM, Vertullo, CJ, Feller, JA, Whitehead, T, Gallie, P, Lloyd, DG, Saxby, DJ, Bryant, AL, Wang, X, Modenese, L, Gerus, P, Konrath, JM, Bennell, KL, Fortin, K, Wrigley, T, Cicuttini, FM, Vertullo, CJ, Feller, JA, Whitehead, T, Gallie, P, and Lloyd, DG
- Abstract
BACKGROUND: Prevention of knee osteoarthritis (OA) following anterior cruciate ligament (ACL) rupture and reconstruction is vital. Risk of postreconstruction knee OA is markedly increased by concurrent meniscal injury. It is unclear whether reconstruction results in normal relationships between tibiofemoral contact forces and cartilage morphology and whether meniscal injury modulates these relationships. HYPOTHESES: Since patients with isolated reconstructions (ie, without meniscal injury) are at lower risk for knee OA, we predicted that relationships between tibiofemoral contact forces and cartilage morphology would be similar to those of normal, healthy knees 2 to 3 years postreconstruction. In knees with meniscal injuries, these relationships would be similar to those reported in patients with knee OA, reflecting early degenerative changes. STUDY DESIGN: Cross-sectional study; Level of evidence, 3. METHODS: Three groups were examined: (1) 62 patients who received single-bundle hamstring reconstruction with an intact, uninjured meniscus (mean age, 29.8 ± 6.4 years; mean weight, 74.9 ± 13.3 kg); (2) 38 patients with similar reconstruction with additional meniscal injury (ie, tear, repair) or partial resection (mean age, 30.6 ± 6.6 years; mean weight, 83.3 ± 14.3 kg); and (3) 30 ligament-normal, healthy individuals (mean age, 28.3 ± 5.2 years; mean weight, 74.9 ± 14.9 kg) serving as controls. All patients underwent magnetic resonance imaging to measure the medial and lateral tibial articular cartilage morphology (volumes and thicknesses). An electromyography-driven neuromusculoskeletal model determined medial and lateral tibiofemoral contact forces during walking. General linear models were used to assess relationships between tibiofemoral contact forces and cartilage morphology. RESULTS: In control knees, cartilage was thicker compared with that of isolated and meniscal-injured ACL-reconstructed knees, while greater contact forces were related to both greater tibia
- Published
- 2017
46. Associations between systemic bone mineral density and early knee cartilage changes in middle-aged adults without clinical knee disease: a prospective cohort study
- Author
-
Teichtahl, AJ, Wang, Y, Wluka, A, Strauss, BJ, Proietto, J, Dixon, JB, Jones, G, Cicuttini, FM, Teichtahl, AJ, Wang, Y, Wluka, A, Strauss, BJ, Proietto, J, Dixon, JB, Jones, G, and Cicuttini, FM
- Abstract
BACKGROUND: Osteoarthritis has a high prevalence in people with high bone mineral density (BMD). Nevertheless, whether high systemic BMD predates early structural features of knee osteoarthritis is unclear. This study examined the association between systemic BMD and knee cartilage defect progression and cartilage volume loss in middle-aged people without clinical knee disease. METHODS: Adults (n = 153) aged 25-60 years had total body, lumbar spine, and total hip BMD assessed by dual-energy X-ray absorptiometry at baseline (2005-2008), and tibial cartilage volume and tibiofemoral cartilage defects assessed by magnetic resonance imaging at baseline and follow up (2008-2010). RESULTS: Higher spine BMD was associated with increased risk for progression of medial (OR = 1.45, 95% CI 1.10, 1.91) and lateral (OR = 1.30, 95% CI 1.00, 1.67) tibiofemoral cartilage defects. Total hip BMD was also positively associated with the progression of medial (OR = 1.63, 95% CI 1.10, 2.41) and lateral (OR = 1.53, 95% CI 1.08, 2.18) tibiofemoral cartilage defects. Greater total body, spine, and total hip BMD were associated with increased rate of lateral tibial cartilage volume loss (for every 1 g/10 cm2 increase in total body BMD: B = 0.44%, 95% CI 0.17%, 0.71%; spine BMD: 0.17%, 95% CI 0.04%, 0.30%; total hip BMD: 0.29%, 95% CI 0.13%, 0.45%), with no significant associations for medial tibial cartilage volume loss. CONCLUSION: In middle-aged people without clinical knee disease, higher systemic BMD was associated with increased early knee cartilage damage. Further work is needed to clarify the effect of systemic BMD at different stages of the pathway from health through to disease in knee osteoarthritis, as new therapies targeting bone are developed for the management of knee osteoarthritis.
- Published
- 2017
47. Predictors of Back Pain in Middle-Aged Women: Data From the Australian Longitudinal Study of Women's Health
- Author
-
Brady, SRE, Hussain, SM, Brown, WJ, Heritier, S, Wang, Y, Teede, H, Urquhart, DM, Cicuttini, FM, Brady, SRE, Hussain, SM, Brown, WJ, Heritier, S, Wang, Y, Teede, H, Urquhart, DM, and Cicuttini, FM
- Abstract
OBJECTIVE: Back pain causes greater disability worldwide than any other condition, with women more likely to experience back pain than men. Our aim was to identify modifiable risk factors for back pain in middle-aged women. METHODS: Women born between 1946 and 1951 were randomly selected from the national health insurance scheme database to participate in The Australian Longitudinal Study on Women's Health. Self-reported data on back pain in the last 12 months, and on weight, physical activity, and other sociodemographic factors, were collected in 1998, 2001, 2004, 2007, 2010, and 2013. In 1998, a total of 12,338 women completed the survey and 10,011 (74%) completed the 2013 survey. RESULTS: At baseline, median (range) age was 49.5 years (44.6-53.5 years), and 54% reported back pain. In multivariate analysis, baseline weight and depression were positive predictors of back pain over each 3-year survey interval and over the following 15 years, whereas participation in vigorous physical activity was protective. The effects of weight on back pain were most marked in women with a body mass index of ≥25 kg/m2 . CONCLUSION: Back pain is common in middle-aged women. Increased weight, weight gain, and depression were independent predictors of back pain over 15 years, whereas participation in vigorous physical activity was protective. Targeting these lifestyle factors is an important area for future research on reducing the burden of back pain in middle-aged women.
- Published
- 2017
48. Cartilage morphology at 2-3 years following anterior cruciate ligament reconstruction with or without concomitant meniscal pathology
- Author
-
Wang, X, Wang, Y, Bennell, KL, Wrigley, TV, Cicuttini, FM, Fortin, K, Saxby, DJ, Van Ginckel, A, Dempsey, AR, Grigg, N, Vertullo, C, Feller, JA, Whitehead, T, Lloyd, DG, Bryant, AL, Wang, X, Wang, Y, Bennell, KL, Wrigley, TV, Cicuttini, FM, Fortin, K, Saxby, DJ, Van Ginckel, A, Dempsey, AR, Grigg, N, Vertullo, C, Feller, JA, Whitehead, T, Lloyd, DG, and Bryant, AL
- Abstract
PURPOSE: To examine differences in cartilage morphology between young adults 2-3 years post-anterior cruciate ligament reconstruction (ACLR), with or without meniscal pathology, and control participants. METHODS: Knee MRI was performed on 130 participants aged 18-40 years (62 with isolated ACLR, 38 with combined ACLR and meniscal pathology, and 30 healthy controls). Cartilage defects, cartilage volume and bone marrow lesions (BMLs) were assessed from MRI using validated methods. RESULTS: Cartilage defects were more prevalent in the isolated ACLR (69 %) and combined group (84 %) than in controls (10 %, P < 0.001). Furthermore, the combined group showed higher prevalence of cartilage defects on medial femoral condyle (OR 4.7, 95 % CI 1.3-16.6) and patella (OR 7.8, 95 % CI 1.5-40.7) than the isolated ACLR group. Cartilage volume was lower in both ACLR groups compared with controls (medial tibia, lateral tibia and patella, P < 0.05), whilst prevalence of BMLs was higher on lateral tibia (P < 0.001), with no significant differences between the two ACLR groups for either measure. CONCLUSIONS: Cartilage morphology was worse in ACLR patients compared with healthy controls. ACLR patients with associated meniscal pathology have a higher prevalence of cartilage defects than ACLR patients without meniscal pathology. The findings suggest that concomitant meniscal pathology may lead to a greater risk of future OA than isolated ACLR. LEVEL OF EVIDENCE: III.
- Published
- 2017
49. Relationship of weight and obesity with the risk of knee and hip arthroplasty for osteoarthritis across different levels of physical performance: a prospective cohort study.
- Author
-
Hussain, SM, Wang, Y, Shaw, JE, Wluka, AE, Graves, S, Gambhir, M, Cicuttini, FM, Hussain, S M, Shaw, J E, Wluka, A E, and Cicuttini, F M
- Subjects
OBESITY ,TOTAL hip replacement ,TOTAL knee replacement ,OSTEOARTHRITIS ,BODY mass index ,CONFIDENCE intervals ,OBESITY complications ,COMPARATIVE studies ,HIP joint diseases ,KNEE diseases ,LONGITUDINAL method ,RESEARCH methodology ,MEDICAL cooperation ,MOTOR ability ,RESEARCH ,TIME ,EVALUATION research - Abstract
Objective: To examine the association between obesity and knee and hip arthroplasty for osteoarthritis across a range of physical performance.Method: The body mass index and physical performance (on the 36-item Short Form Health Survey) of 9135 Australian Diabetes, Obesity and Lifestyle Study participants were measured in 1999-2000. The incidence of knee and hip arthroplasty during 2002-2011 was determined by linking the cohort records to the Australian Orthopaedic Association National Joint Replacement Registry.Results: Over 9.1 ± 2.3 years (mean ± sd)) of follow-up, 317 participants had knee and 202 had hip arthroplasty for osteoarthritis. Using those with neither obesity nor significantly impaired physical performance as the reference group, participants with both obesity and significantly impaired physical performance had a higher knee arthroplasty risk [hazard ratio (HR) = 5.25, 95% confidence interval (CI) 3.85-7.14] than those with obesity alone (HR = 2.49, 95% CI 1.81-3.44) or impaired physical performance alone (HR = 2.19, 95% CI 1.59-3.02). Similar results were observed for hip arthroplasty (obesity and impaired physical performance: HR = 2.67, 95% CI 1.72-4.15; obesity alone: HR = 1.65, 95% CI 1.08-2.51; impaired physical performance alone: HR = 1.83, 95% CI 1.26-2.66). Among overweight/obese patients, 5 kg greater baseline weight increased the knee arthroplasty risk across all levels of physical performance, and hip arthroplasty risk in those with the highest level of physical performance.Conclusion: Although impaired physical performance is an independent risk factor for knee and hip arthroplasty, greater weight increased knee arthroplasty for overweight/obese participants at all levels of physical performance, but hip arthroplasty only in those with good physical performance. Targeting weight loss has the potential to reduce the risk of knee arthroplasty and improve patient outcomes, even in those with poor physical performance. [ABSTRACT FROM AUTHOR]- Published
- 2019
- Full Text
- View/download PDF
50. Associations between television viewing and physical activity and low back pain in community-based adults
- Author
-
Hussain, SM, Urquhart, DM, Wang, Y, Dunstan, David, Shaw, JE, Magliano, DJ, Wluka, AE, Cicuttini, FM, Hussain, SM, Urquhart, DM, Wang, Y, Dunstan, David, Shaw, JE, Magliano, DJ, Wluka, AE, and Cicuttini, FM
- Published
- 2016
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.